
<html lang="en"     class="pb-page"  data-request-id="bbe5366f-6c25-4238-84bf-ecf2acf6db83"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2014.57.issue-1;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm401456d;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes" /></meta><meta name="dc.Creator" content="Martin H.  Bolli" /></meta><meta name="dc.Creator" content="Jörg  Velker" /></meta><meta name="dc.Creator" content="Claus  Müller" /></meta><meta name="dc.Creator" content="Boris  Mathys" /></meta><meta name="dc.Creator" content="Magdalena  Birker" /></meta><meta name="dc.Creator" content="Roberto  Bravo" /></meta><meta name="dc.Creator" content="Daniel  Bur" /></meta><meta name="dc.Creator" content="Ruben  de Kanter" /></meta><meta name="dc.Creator" content="Patrick  Hess" /></meta><meta name="dc.Creator" content="Christopher  Kohl" /></meta><meta name="dc.Creator" content="David  Lehmann" /></meta><meta name="dc.Creator" content="Solange  Meyer" /></meta><meta name="dc.Creator" content="Oliver  Nayler" /></meta><meta name="dc.Creator" content="Markus  Rey" /></meta><meta name="dc.Creator" content="Michael  Scherz" /></meta><meta name="dc.Creator" content="Beat  Steiner" /></meta><meta name="dc.Description" content="Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P1 receptor agonists. Here, we discuss our effort..." /></meta><meta name="Description" content="Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P1 receptor agonists. Here, we discuss our effort..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 17, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401456d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401456d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401456d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401456d" /></link>
        
    
    

<title>Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401456d" /></meta><meta property="og:title" content="Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0024.jpeg" /></meta><meta property="og:description" content="Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P1 receptor agonists. Here, we discuss our efforts to simplify the bicyclohexane fused thiophene head. In a first step the bicyclohexane moiety could be replaced by a simpler, less rigid cyclohexane ring without compromising the S1P receptor affinity profile of these novel compounds. In a second step, the thiophene head was simplified even further by replacing the cyclohexane ring with an isobutyl group attached either to position 4 or position 5 of the thiophene. These structurally much simpler headgroups again furnished potent and selective S1P1 agonists (e.g., 87), which efficiently and dose dependently reduced the number of circulating lymphocytes upon oral administration to male Wistar rats. For several compounds discussed in this report lymphatic transport is an important route of absorption that may offer opportunities for a tissue targeted approach with minimal plasma exposure." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401456d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401456d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401456d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401456d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401456d&amp;href=/doi/10.1021/jm401456d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 78-97</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401311d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401457n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel S1P<sub>1</sub> Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+H.++Bolli">Martin H. Bolli</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Velker">Jörg Velker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claus++M%C3%BCller">Claus Müller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Mathys">Boris Mathys</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magdalena++Birker">Magdalena Birker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Bravo">Roberto Bravo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bur">Daniel Bur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruben++de+Kanter">Ruben de Kanter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Hess">Patrick Hess</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Kohl">Christopher Kohl</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Lehmann">David Lehmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Solange++Meyer">Solange Meyer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Nayler">Oliver Nayler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Rey">Markus Rey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Scherz">Michael Scherz</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beat++Steiner">Beat Steiner</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Drug Discovery Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 61 565 65 65. Fax: +41 61 565 65 00. E-mail: <a href="/cdn-cgi/l/email-protection#2b464a595f42450549444747426b4a485f4e4742444505484446"><span class="__cf_email__" data-cfemail="b0ddd1c2c4d9de9ed2dfdcdcd9f0d1d3c4d5dcd9dfde9ed3dfdd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401456d&amp;href=/doi/10.1021%2Fjm401456d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 78–97</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 17, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 September 2013</li><li><span class="item_label"><b>Published</b> online</span>17 December 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 January 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401456d" title="DOI URL">https://doi.org/10.1021/jm401456d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D78%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BH.%2BBolli%252C%2BJ%25C3%25B6rg%2BVelker%252C%2BClaus%2BM%25C3%25BCller%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D1%26contentID%3Djm401456d%26title%3DNovel%2BS1P1%2BReceptor%2BAgonists%2B-%2BPart%2B2%253A%2BFrom%2BBicyclo%255B3.1.0%255Dhexane-Fused%2BThiophenes%2Bto%2BIsobutyl%2BSubstituted%2BThiophenes%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D97%26publicationDate%3DJanuary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401456d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2174</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401456d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;H. Bolli&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Velker&quot;},{&quot;first_name&quot;:&quot;Claus&quot;,&quot;last_name&quot;:&quot;Müller&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Mathys&quot;},{&quot;first_name&quot;:&quot;Magdalena&quot;,&quot;last_name&quot;:&quot;Birker&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Bravo&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bur&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;de Kanter&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Hess&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Kohl&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Lehmann&quot;},{&quot;first_name&quot;:&quot;Solange&quot;,&quot;last_name&quot;:&quot;Meyer&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Nayler&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Rey&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Scherz&quot;},{&quot;first_name&quot;:&quot;Beat&quot;,&quot;last_name&quot;:&quot;Steiner&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;78-97&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401456d&quot;},&quot;abstract&quot;:&quot;Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P1 receptor agonists. Here, we discuss our efforts to simplify the bicyclohexane fused thiophene head. In a first step the bicyclohexane moiety could be replaced by a simpler, less rigid cyclohexane ring without compromising the S1P receptor affinity profile of these novel compounds. In a second step, the thiophene head was simplified even further by replacing the cyclohexane ring with an isobutyl group attached either to position 4 or position 5 of the thiophene. These structurally much simpler headgroups again furnished potent and selective S1P1 agonists (e.g., 87), which efficiently and dose dependently reduced the number of circulating lymphocytes upon oral administration to male Wistar rats. For several compounds discussed in this report lymphatic transport is an important route of absorption that may offer opportunities for a tissue targeted approach with mi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401456d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401456d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401456d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401456d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401456d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401456d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401456d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401456d&amp;href=/doi/10.1021/jm401456d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401456d" /></input><a href="/doi/pdf/10.1021/jm401456d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26pmid%3D24345087%26genre%3Darticle%26aulast%3DBolli%26date%3D2014%26atitle%3DNovel%2BS1P1%2BReceptor%2BAgonists%2B-%2BPart%2B2%253A%2BFrom%2BBicyclo%255B3.1.0%255Dhexane-Fused%2BThiophenes%2Bto%2BIsobutyl%2BSubstituted%2BThiophenes%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D1%26spage%3D78%26epage%3D97%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291749" title="Thiophenes">Thiophenes</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jmcmar.2014.57.issue-1/production/jmcmar.2014.57.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P<sub>1</sub> receptor agonists. Here, we discuss our efforts to simplify the bicyclohexane fused thiophene head. In a first step the bicyclohexane moiety could be replaced by a simpler, less rigid cyclohexane ring without compromising the S1P receptor affinity profile of these novel compounds. In a second step, the thiophene head was simplified even further by replacing the cyclohexane ring with an isobutyl group attached either to position 4 or position 5 of the thiophene. These structurally much simpler headgroups again furnished potent and selective S1P<sub>1</sub> agonists (e.g., <b>87</b>), which efficiently and dose dependently reduced the number of circulating lymphocytes upon oral administration to male Wistar rats. For several compounds discussed in this report lymphatic transport is an important route of absorption that may offer opportunities for a tissue targeted approach with minimal plasma exposure.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine 1-phosphate (S1P, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) exerts a wealth of cellular effects such as cell survival, proliferation, or migration by acting intracellularly as well as extracellularly.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8">(1-8)</a> The extracellular signaling of S1P through five S1P receptors, numbered S1P<sub>1</sub> through S1P<sub>5,</sub><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> has been characterized in great detail, and the large body of data has been summarized in several review articles.<a onclick="showRef(event, 'ref7 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref7 ref10 ref11 ref12 ref13">(7, 10-13)</a> The pharmacological consequences of the different S1P–S1P receptor signaling cascades have been studied in many organs and tissues such as the nervous system,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> the lung,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> the cardiovascular system,<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26">(18-26)</a> the cells of the immune system,<a onclick="showRef(event, 'ref11 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref11 ref27 ref28">(11, 27, 28)</a> and bone tissue,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and as a consequence, S1P receptor modulators have been proposed to be useful in a large number of pathological situations including autoimmune diseases, graft versus host disease, asthma, cardiovascular diseases, and cancer.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of sphingosine 1-phosphate and fingolimod (FTY720).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Of particular interest is that lymphocytes exposed to a (synthetic) S1P<sub>1</sub> receptor agonist are sequestered to lymphoid organs and removed from circulation. This has first been described for fingolimod (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which is phosphorylated in vivo to become a potent nonselective S1P<sub>1–5</sub> receptor agonist.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(33-40)</a> The S1P concentration gradient<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> that exists between blood plasma and lymph is seen as the driving force for T-lymphocytes to exit the lymph nodes and re-enter systemic circulation.<a onclick="showRef(event, 'ref11 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref11 ref42 ref43">(11, 42, 43)</a> Activation of the S1P<sub>1</sub> receptor is thought to lead to receptor internalization and thus desensitization of the cell toward the external S1P gradient. The desensitized lymphocytes can no longer leave the lymph node, and according to this model, the S1P<sub>1</sub> agonist acts as a “functional antagonist”. Indeed, recent studies demonstrated that S1P<sub>1</sub> antagonists are able to sequester lymphocytes from circulation.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> By use of S1P<sub>1</sub> receptor knockout mice<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> and S1P<sub>1</sub> selective agonists,<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48-50)</a> it has been demonstrated that targeting S1P<sub>1</sub> is sufficient to cause lymphocyte sequestration to lymphoid organs. On the other hand, activation of the S1P<sub>3</sub> pathway has been reported to cause heart rate reduction<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a> and vaso- and bronchoconstriction in rodents.<a onclick="showRef(event, 'ref17 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref17 ref54 ref55">(17, 54, 55)</a> It is noteworthy, however, that in the rat selectivty against the S1P<sub>3</sub> receptor is not sufficient for a compound to be devoid of effects on heart rate and that the experimental design (e.g., single dose vs multiple dose regimen, conscious vs anesthetized animals) impacts the study outcome.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> In fact, the recent study by Fryer et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> suggests that in the rat, the observed heart rate reduction is caused by S1P<sub>1</sub> receptor agonism while the arterial blood pressure increase is triggered by S1P<sub>3</sub> activation. In addition, there is growing evidence that the transient heart rate reduction observed in humans is triggered by S1P<sub>1</sub> receptor activation.<a onclick="showRef(event, 'ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60 ref61">(58-61)</a></div><div class="NLM_p">Today fingolimod is approved to treat patients suffering from multiple sclerosis (MS),<a onclick="showRef(event, 'ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref62 ref63 ref64">(62-64)</a> and several S1P<sub>1</sub> agonists such as ponesimod,<a onclick="showRef(event, 'ref65 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67 ref68">(65-68)</a> siponimod (BAF312),<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69-71)</a> ONO-4641 (structure undisclosed),<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> CS-0777,<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> KRP-203,<a onclick="showRef(event, 'ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77">(75-77)</a> RPC-1063 (structure undisclosed),<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> and MT-1303 (structure undisclosed)<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> entered clinical trials for MS and other diseases. In addition, an overwhelming number of patents claiming novel selective S1P<sub>1</sub> receptor agonists have been published in the past few years.<a onclick="showRef(event, 'ref80 ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82 ref83">(80-83)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the original HTS hit <b>1</b> and compounds <b>2</b>, <b>3</b>, and <b>4</b> as examples of novel lead series derived thereof.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In our previous account<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> we described the discovery of a novel series of selective S1P<sub>1</sub> receptor agonists. Efforts aimed at replacing the chemically unstable acylpyrazole moiety present in the original HTS hit structure <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) led to the discovery of a series of bicyclo[3.1.0]hexane fused thiophene derivatives (e.g., <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with high affinity and selectivity for the S1P<sub>1</sub> receptor. In addition, several representatives of this class of 3-carene derivatives not only exhibited good PK properties but also efficiently reduced the number of circulating lymphocytes in the rat. In this report we discuss our attempts to simplify the structure of these S1P<sub>1</sub> receptor agonists without compromising their favorable pharmacological profile. First, we considered opening of the 3-carene derived bicyclo[3.1.0]hexane moiety in <b>2</b> to a cyclohexane ring to give analogue <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Indeed, the cyclohexane fused thiophene <b>3</b> was as potent on the S1P<sub>1</sub> receptor (EC<sub>50</sub> = 0.5 nM) as the bicyclo[3.1.0]hexane derivative <b>2</b> (EC<sub>50</sub> 1.2 nM). In a second step, the cyclohexane ring was opened to give the 4-isopropylthiophene <b>4</b>. This further simplified compound showed an EC<sub>50</sub> value of 2.7 nM for S1P<sub>1</sub>. On the basis of these observations, we decided to explore the scope of the cyclohexane fused and the isobutyl substituted thiophene derivatives in detail.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div class="NLM_p">The synthesis of the 4,5,6,7-tetrahydrobenzothiophene-1-carboxylic acid scaffold is analogous to the one of the bicyclo[3.1.0]hexane fused thiophene we discussed in our previous report<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Thus, 4,4-dimethylcyclohexanone <b>5</b> is formylated with ethyl formate in THF in the presence of potassium <i>tert</i>-butylate to give aldehyde <b>6</b> (or a tautomer) in good yield. Chlorination to the vinyl chloride <b>7</b> was effected by treating <b>6</b> with oxalyl chloride in chloroform. The chloride <b>7</b> was then reacted using ethyl 2-mercaptoacetate,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and subsequent cyclization and ester hydrolysis produced the thiophenecarboxylic acid derivative <b>8</b> in good yield. It is important to note that we occasionally observed rapid, spontaneous decomposition of concentrated crude <b>7</b> when it was allowed to stand at room temperature. We therefore did not purify crude <b>7</b> any further but immediately subjected it to the substitution–cyclization sequence using ethyl mercaptoacetate. Deprotonating <b>8</b> using an excess (2.3–2.7 equiv) of <i>tert</i>- or <i>sec</i>-butyllithium at −70 to −78 °C gave the corresponding dianion which was then reacted with the appriopriate iodoalkane to yield the 5-alkylated thiophenecarboxylic acids <b>9</b>–<b>11</b>. On the other hand, exposing <b>8</b> to <i>N</i>-iodosuccinimide led to the corresponding 5-iodothiophene-2-carboxylic acid derivative which could be transformed to the 5-methoxythiophene <b>12</b> in an Ullmann-type reaction.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Treating the carboxylic acids <b>8</b>–<b>12</b> with methyllithium furnished the corresponding methyl ketones <b>13</b>–<b>17</b>. The 5-trifluoromethylthiophene derivative <b>20</b> was prepared by first transforming the carboxylic acid <b>8</b> to the corresponding Weinreb amide<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Subsequent electrophilic substitution of the thiophene carbanion with iodine gave 5-iodothiophene <b>18</b> which was reacted with methyl chlorodifluoroacetate<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> to furnish 5-trifluoromethylthiophene <b>19</b> in good yield. Finally, transforming the Weinreb amide to the corresponding methyl ketone using methyl lithium established compound <b>20</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of the Cyclohexane Fused Thiophen-2-ylcarboxylic Acids <b>8</b>–<b>12</b> and Methyl Ketones <b>13</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 1–24 h, 73–89% (distillation); (b) oxalyl chloride, DCM or CHCl<sub>3</sub>, 0–30 °C, 1–18 h, 81–89% crude; (c) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, THF, rt, 1 h; (d) NaOEt, EtOH, 50–75 °C, 1–18 h; (e) 2 N aqueous LiOH or NaOH, H<sub>2</sub>O, 70 °C, 2–3 h, 57–64% (over four steps); (f) <i>tert</i>- or <i>sec</i>-BuLi, THF, iodoalkane, −78 to −70 °C, 2–18 h, 53–86%; (g) NIS, CH<sub>3</sub>Cl/HOAc 1:1, rt, 24 h, 58%; or <b>8</b> as ethyl ester, Br<sub>2</sub>, AcOH, 50 °C, 4 h, 81%; (h) Cu(I) triflate, Cs<sub>2</sub>CO<sub>3</sub>, MeOH, 95 °C, 24 h (sealed vessel), 16–58%; (i) MeLi, diethyl ether, 20–30 °C, 1–2 h, 17–80%.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 5-Trifluoromethylthiophen-2-yl Methyl Ketone Derivative <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>O</i>-dimethylhydroxylamine HCl, TBTU, Hünig’s base, DMSO, DMF, rt, 2 h, 95%; (b) LDA, I<sub>2</sub>, THF, −78 °C, 30 min, 52%; (c) ClF<sub>2</sub>COOMe, CuI, KF, DMF, 135 °C, 4 h, 92%; (d) MeLi, diethyl ether, 20–30 °C, 1–2 h, 75%.</p></p></figure><div class="NLM_p">The preparation of target compounds <b>21</b>–<b>33</b> is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. First, the methyl ketone <b>14</b> was reacted with 4-hydroxy-3,5-dimethylbenzaldehyde or 3-(4-formyl-2,6-dimethylphenyl)propenoic acid,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and the corresponding condensation product was hydrogenated to give phenol <b>21</b> or carboxylic acid <b>33</b>, respectively. Further elaboration of side chains attached to phenol <b>21</b> as summarized in step c furnished the target compounds <b>22</b>–<b>32</b>. Starting from the appropriate thiophene derivatives <b>13</b>–<b>17</b>, the preparation of the corresponding glycolamide derivatives <b>34</b>–<b>39</b> was carried out in analogy to the pathway outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The corresponding oxadiazole analogues <b>40</b>–<b>44</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Thus, coupling of the thiophenecarboxylic acids <b>8</b>–<b>11</b> with 3-ethyl-4,<i>N</i>-dihydroxy-5-methylbenzamidine followed by thermal dehydration to form the oxadiazole ring (step a) and subsequent elaboration of the polar side chain (steps b–d) produced the compounds <b>40</b>–<b>43</b>. Alternatively, as illustrated with the methoxythiophene derivative <b>44</b>, the thiophene-2-carboxylic acid can also be coupled and cyclized with an <i>N</i>-hydroxybenzamidine building block already incorporating the glycolamide side chain.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-hydroxy-3,5-dimethylbenzaldehyde, 1 N HCl in 2-propanol, EtOH, rt, 1–2 h, 65–87%; (b) 1 bar H<sub>2</sub>, Pd/C, EtOH, rt, 1–5 h, 78–96% (<b>21</b>); or 3-(4-formyl-2,6-dimethylphenyl)propenoic acid, NaOH, MeOH, rt, 3–18 h, 60–75%; (b) 10 bar H<sub>2</sub>, Pd/C, EtOH, Hünig’s base, 50–65 °C, 2–4 d; 45–78% (<b>33</b>); (c) 2-bromoethanol, 3-bromopropanol or (<i>R</i>)- or (<i>S</i>)-3-chloropropane-1,2-diol, 2 N aqueous NaOH, 2-propanol, 70 °C, 4–8 h, 57–74% (<b>22</b>–<b>25</b>); or <b>22</b> or <b>23</b>, methanesulfonyl chloride, Hünig’s base, DCM, rt, 1 h, quantitative crude, then appropriate amine, Hünig’s base, DMF, 75 °C, 7 h, 58–67% (<b>26</b>, <b>27</b>, <b>28</b>); or epichlorohydrin, 3 N aqueous NaOH, 2-propanol, rt, 16–21 h, 57–91%, then 7 N NH<sub>3</sub> in MeOH, 65 °C, 18 h (63–91%, <b>29</b>), then glycolic acid, Hünig’s base, TBTU, DCM, rt, 1–2 h, 45–67% (<b>3</b>); or epichlorohydrin as for <b>3</b>, then 2-aminoethanol, β-alanine or azetidine-3-carboxylic acid, EtOH, H<sub>2</sub>O, Hünig’s base, 85 °C, 5 h, 58–67% (<b>30</b>, <b>31</b>, <b>32</b>).</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Target Compounds Incorporating a [1,2,4]Oxadiazole Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-ethyl-4,<i>N</i>-dihydroxy-5-methylbenzamidine, TBTU, DMF, rt, 18 h, then dioxane, 100 °C, 20 h, 59–71%; (b) (<i>R</i>)- or <i>rac</i>-epichlorohydrin, isopropanol, 3 N aqueous NaOH, rt, 20 h, 53–84%; (c) 7 N NH<sub>3</sub> in methanol, 65 °C, 18 h, 86% quantitative (crude); (d) glycolic acid, TBTU, Hünig’s base, DCM, rt, 2–4 h, 36–70%; (e) (for <b>44</b>) (<i>S</i>)-<i>N</i>-(3-(2-ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methylphenoxy)-2-hydroxypropyl)-2-hydroxyacetamide, EDC, HOBt, DMF, rt, 24 h, then dioxane, 100 °C, 24 h, 6%.</p></p></figure><div class="NLM_p">The thiophenecarboxylic acids <b>59</b>, <b>62</b>, <b>66</b>, <b>69</b>, and <b>72</b> and the thienyl methyl ketones <b>60</b>, <b>63</b>, <b>67</b>, <b>70</b>, and <b>73</b> required to prepare target compounds <b>54</b>–<b>57</b> and <b>45</b>–<b>50</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), respectively, were obtained following the pathway outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The precursor of <b>59</b>, 4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic acid <b>58</b> (for target compounds <b>45</b> and <b>54</b>), is commercially available. Preparation of <b>62</b> (for <b>47</b> and <b>55</b>) relied on 4,4-diethylcyclohexanone <b>61</b>.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> Spiro[2.5]octan-6-one <b>65</b> needed for the preparation of <b>66</b> (for <b>48</b> and <b>56</b>) was prepared starting from acetal <b>64</b> following literature procedures.<a onclick="showRef(event, 'ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94">(92-94)</a> The starting material for thiophenecarboxylic acid <b>69</b> (for <b>49</b> and <b>57</b>), spiro[4.5]decan-8-one <b>68</b>, was also prepared following literature procedures.<a onclick="showRef(event, 'ref91 ref95'); return false;" href="javascript:void(0);" class="ref ref91 ref95">(91, 95)</a> 4-Methylcyclohexanone <b>71</b> needed for the synthesis of thiophene <b>72</b> (for <b>50</b>) is commercially available. The carboxylic acids <b>59</b>, <b>62</b>, <b>66</b>, <b>69</b>, and <b>72</b> were then transformed to the corresponding ketones <b>60</b>, <b>63</b>, <b>67</b>, <b>70</b>, and <b>73</b>, respectively, by treating them with methyllithium. Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> outlines the synthetic access to 5-hydroxytetrahydrobenzo[<i>c</i>]thiophenes <b>77</b> and <b>78</b> which served as starting materials for the preparation of <b>51</b> and <b>52</b>, respectively. In brief, thiophene-2-carboxylic acid <b>74</b> was obtained from cyclohexanone <b>64</b> following our standard formylation–chlorination–substitution–cyclization–alkylation sequence. Weinreb amide<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> formation followed by acetal cleavage delivered ketone <b>75</b> which was then reduced to the corresponding alcohol <b>76</b>. Exposing Weinreb amides <b>76</b> and <b>75</b> to the methyl Grignard reagent produced methyl ketones <b>77</b> and <b>78</b>, respectively. On the other hand, reductive amination of ketone <b>75</b> with dimethylamine followed by Grignard reaction furnished the racemic ketone <b>79</b> in good yield (steps k and l). Starting from the appropriate thiophenyl methyl ketones and thiophene-2-carboxylic acids shown in Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, compounds <b>45</b>–<b>57</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) were prepared in analogy to the reactions outlined in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of 5-Mono- or Disubstituted 3-Ethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic Acids and 1-(3-Ethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)ethanones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>t</i></sup>BuLi, THF, EtI, −100 to −70 °C, 2–18 h, 31–85%; (b) MeLi, diethyl ether, 20–30 °C, 1–2 h, 33–66%; (c) H<sub>2</sub>SO<sub>4</sub>, rt, 24 h, 70%, then 1 bar of H<sub>2</sub>, Pd/C, EA, rt, 24 h, quantitative;<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> (d) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 24 h; (e) oxalyl chloride, DCM or CHCl<sub>3</sub>, 0–30 °C, 1–18 h; (f) (1) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, rt, 1 h; (2) NaOEt, EtOH, 65–75 °C, 18 h; (3) 2 N aqueous LiOH or NaOH, H<sub>2</sub>O, 70 °C, 2–3 h; 23–47% (over steps d, e, f, b); (g) (1) Ph<sub>3</sub>PMeBr, NaH, toluene, DMSO, rt, 1 h, quantitative (crude);<a onclick="showRef(event, 'ref92 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref94">(92, 94)</a> (2) Et<sub>2</sub>Zn, CH<sub>2</sub>I<sub>2</sub>, toluene, −40 °C to rt, 18 h, then TFA, H<sub>2</sub>O, rt, 30 min, 90% (crude);<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> (h) (1) piperidine, ethanol, 85 °C, 24 h, then NaOAc, HOAc, 85 °C, 24 h, 63%; (2) 1 atm of H<sub>2</sub>, Pd/C, EA, rt, 90 min, 97%.<a onclick="showRef(event, 'ref91 ref95'); return false;" href="javascript:void(0);" class="ref ref91 ref95">(91, 95)</a>.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 24 h, 60–65%; (b) oxalyl chloride, CHCl<sub>3</sub>, rt, 30 min, 88% crude; (c) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, 30 °C, 2 h, 46%; (d) 1 N aqueous NaOH, EtOH, 70 °C, 1 h, 98%; (e) <sup><i>t</i></sup>BuLi, EtI, THF, −100 to −80 °C, 8 h, 50%; (f) <i>N</i>,<i>O</i>-dimethylhydroxylamine HCl, TBTU, Hünig’s base, DMF, rt, 3 h, 92%; (g) 2 N aqueous HCl, THF, 40 °C, 2 h, 96%; (h) NaBH<sub>4</sub>, MeOH, rt, 1 h, quantitative crude; (i) MeMgBr, THF, rt, 18 h, 82%; (j) MeMgBr, THF, rt, 3 h, 40–45%; (k) HNMe<sub>2</sub>, NaBH(OAc)<sub>3</sub>, EtOH, rt, 18 h, 50–66%; (l) MeMgBr, THF, rt, 3 h, 80% to quantitative (crude).</p></p></figure><div class="NLM_p">Synthesis of alkylated thiophene-2-carboxylic acids <b>94</b>, <b>96</b>, <b>97</b>, and <b>99</b>–<b>102</b>, which were used to prepare the target compounds <b>81</b>–<b>90</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), is shown in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Formylation of isopentyl methyl ketone <b>91</b> using ethyl formate under basic conditions furnished enol <b>92</b> (or tautomer) which was treated with oxalyl chloride at room temperature to give vinyl chloride <b>93</b>. Reacting <b>93</b> with ethyl mercaptoacetate in the presence of a base furnished 4-isobutyl-3-methylthiophene-2-carboxylic acid <b>94</b>. Conversely, if ketone <b>91</b> was formylated under Vilsmeyer conditions, the isomeric vinyl chloride <b>95</b> was obtained. Treating this material with ethyl mercaptoacetate delivered 4-isobutyl-5-methylthiophene-2-carboxylic acid <b>96</b> which could be further alkylated using <i>tert</i>-butyllithium followed by methyl iodide to give the 3,5-dimethyl substituted thiophene derivative <b>97</b>. Finally, alkylation of thiophene-2-carboxylic acid <b>98</b> using LDA or <i>tert</i>-butyllithium and an alkyl halide to give the 5-alkylated thiophene-2-carboxylic acids <b>99</b>–<b>102</b> was performed following literature procedures.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The target compounds <b>81</b>–<b>90</b> were then prepared in analogy to the pathway shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div><div class="NLM_p">The target compounds <b>4</b> and <b>80</b> were prepared starting from thiophenecarboxylic acids <b>97</b> and <b>102</b>, respectively, in analogy to the pathways outlined in Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of Thiophene-2-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, 0 °C to rt, 15 h, 66%; (b) oxalyl chloride, CHCl<sub>3</sub>, rt, 2 h, quantitative crude; (c) (1) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, rt, 15 h; (2) NaOEt, EtOH, 85 °C, 1 h; (3) 2 N aqueous LiOH, EtOH, rt, 48 h, 28–41%; (d) POCl<sub>3</sub>, DMF, 0 °C, 30 min, rt, 3 h, quantitative crude; (e) <sup><i>t</i></sup>BuLi, THF, MeI, −78 °C, 2 h, 65%; (f) LDA or <sup><i>t</i></sup>BuLi, THF, alkyl iodide or bromide, −78 °C, 2 h, 15–68%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro SAR Discussion</h3><div class="NLM_p">For the following discussion, the compounds’ potencies were assessed using a GTPγS assay with membranes from CHO cells expressing either the recombinant S1P<sub>1</sub> or S1P<sub>3</sub> receptor. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> compiles a first set of compounds wherein the polar side chain attached to the phenyl ring has been varied. As already observed in the 3-carene derived series,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> a large variety of polar side chains was tolerated at the phenyl ring and the relative potency order was preserved between the two series. In general, the cyclohexane fused thiophene derivatives were slightly less potent on both S1P<sub>1</sub> and S1P<sub>3</sub>.</div><div class="NLM_p">Thus, while both glycerol derivatives <b>24</b> and <b>25</b> reached single digit nanomolar activity with several-hundred-fold selectivity against S1P<sub>3</sub>, the phenol <b>21</b> and the ethylene and propylene glycol derivatives <b>22</b> and <b>23</b> showed a slightly reduced affinity for S1P<sub>1</sub>. The amine <b>26</b> was more potent on S1P<sub>1</sub> when compared to its alcohol analogue <b>22</b>. The opposite trend was observed when the (racemic) amine <b>29</b> was compared to the corresponding glycerol analogues <b>24</b> and <b>25</b>. Adding a hydroxyethyl chain to amines <b>26</b> and <b>29</b> (compounds <b>27</b>, <b>28</b>, <b>30</b>) reduced the compound’s affinity for S1P<sub>1</sub>. On the other hand, masking the basic nitrogen in compound <b>30</b> by forming glycolamide <b>3</b> improved the compound’s affinity for S1P<sub>1</sub> and S1P<sub>3</sub> significantly. Interestingly, compounds <b>31</b> and <b>32</b> combining a basic nitrogen with a carboxylic acid in their side chain again showed high affinity for the S1P<sub>1</sub> receptor and maintained good selectivity against S1P<sub>3</sub>. The much shorter propanoic acid side chain in <b>33</b> led to a reduced potency on both receptors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Polar Side Chains in the 4-Position of the Phenyl Ring<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>. EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. All compounds with EC<sub>50</sub> ≤ 1 μM behaved as full agonists on S1P<sub>1</sub> and S1P<sub>3</sub> (<i>E</i><sub>max</sub> > 85%). For compounds with EC<sub>50</sub> > 1 μM it was not possible to determine whether or not they are full agonists because no activity plateau was reached at the highest compound concentration tested (10 μM). For details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">For comparison, for structure see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the 3-Substituent at the 4,5,6,7-Tetrahydrobenzo[<i>c</i>]thiophene<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0015.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">propanone</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>1</sub> [nM]</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>3</sub> [nM]</th><th class="colsep0 rowsep0" align="center">oxadiazole</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>1</sub> [nM]</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>3</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">5270</td><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">314</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">4418</td><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">141</td><td class="colsep0 rowsep0" align="left"><b>42</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl</td><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">242</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">3910</td><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">83</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>. EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. All compounds with EC<sub>50</sub> ≤ 1 μM behaved as full agonists on S1P<sub>1</sub> and S1P<sub>3</sub> (<i>E</i><sub>max</sub> > 85%). For compounds with EC<sub>50</sub> > 1 μM it was not possible to determine whether or not they are full agonists because no activity plateau was reached at the highest compound concentration tested (10 μM). For details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Compound not prepared.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Pure (<i>S</i>)-enantiomer only. Studies on earlier series and close analogues of compounds discussed in this account (cf. compounds <b>23</b> and <b>24</b>) showed only little differences between the two enantiomers with respect to S1P receptor affinity.</p></div></div></div><div class="NLM_p">In contrast to the carene derivatives, the 4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene series allowed for easy synthetic access to a variety of scaffolds with different 3-substituents (benzo[<i>c</i>]thiophene numbering). Therefore, the influence of the 3-substituent could be studied in more detail. The SAR is illustrated with a set of compounds incorporating a “glycolamide” side chain and includes propanone (<b>34</b>–<b>39</b>) or oxadiazole (<b>40</b>–<b>44</b>) linked derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In general, both linkers led to potent S1P<sub>1</sub> agonists. The propanone linked compounds were consistently more selective against S1P<sub>3</sub>. In both linker series, the 3-unsubstituted compounds (<b>34</b> and <b>40</b>) showed high affinity and more than 100-fold selectivity for the S1P<sub>1</sub> receptor. In the propanone linked series, increasing the size of the 3-substituent from hydrogen to an <i>n</i>-propyl group had little effect on the S1P<sub>1</sub> receptor affinity while the potency on S1P<sub>3</sub> increased steadily. The affinity profile of the trifluoromethyl derivative <b>38</b> resembled the one of the ethyl analogue <b>36</b>, while the methoxythiophene <b>39</b> showed almost identical potencies as the methyl analogue <b>35</b>. The oxadiazole derivatives, too, gained potency on S1P<sub>3</sub> with increasing chain length of the 3-substituent. But they lost potency on S1P<sub>1</sub> in going from <b>40</b> to <b>43</b> making the <i>n</i>-propyl derivative <b>43</b> the least selective compound of this set. As before, the affinity profile of the methoxythiophene <b>44</b> was very similar to the one of the methyl analogue <b>41</b>.</div><div class="NLM_p">Several 4-substituted cyclohexanones are either commercially available or easily accessible by short syntheses. Using these cyclohexanones as starting materials in our standard thiophene synthesis allowed for a rapid assembly of a collection of 4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene scaffolds with a variety of substituents in position 5. Compounds with either a propanone or an oxadiazole linker were prepared. For the following SAR discussion propapone derivatives with a glycerol side chain and oxadiazoles incorporating a glycolamide side chain have been compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. As already seen with the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the propanone linked derivatives were clearly more selective against S1P<sub>3</sub>. In the propanone series, removal of the two 5-methyl groups (compound <b>45</b>) led to a clear loss in affinity for S1P<sub>1</sub>, while the same modification in the oxadiazole linked series (compound <b>54</b>) slightly improved the compound’s potency on S1P<sub>1</sub>. The various 5-substituents showed little difference on the S1P<sub>1</sub> receptor affinity of propanones <b>46</b>–<b>50</b> and oxadiazoles <b>42</b> and <b>55</b>–<b>57</b>. On the other hand, the affinity for the S1P<sub>3</sub> receptor increased with increasing size of the substituents in position 5. As a consequence, the two diethyl substituted compounds <b>47</b> and <b>55</b> are the least selective representatives of the propanone and the oxadiazole series, respectively. Interestingly, forming a ring between the two alkyl groups in position 5 clearly improved the selectivity against S1P<sub>3</sub> (compare <b>48</b> with <b>46</b>, <b>56</b> with <b>42</b>, <b>49</b> with <b>47</b>, and <b>57</b> with <b>55</b>), and the cyclopropyl derivative <b>48</b> was the most selective example of the propanone series. In the oxadiazole series, the cyclopropyl derivative <b>56</b> was clearly more selective than its dimethyl analogue <b>42</b> but did not reach the selectivity of the unsubstituted compound <b>54</b>. An alcohol function (compounds <b>51</b> and <b>52</b>) or a dimethylamino group (compound <b>53</b>) in position 5 of the tetrahydrobenzo[<i>c</i>]thiophene scaffold was obviously not tolerated.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of the Substitutent at the Cyclohexane Ring<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>. EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. All compounds with EC<sub>50</sub> ≤ 1 μM behaved as full agonists on S1P<sub>1</sub> and S1P<sub>3</sub> (<i>E</i><sub>max</sub> > 85%). For compounds with EC<sub>50</sub> > 1 μM it was not possible to determine whether or not they are full agonists because no activity plateau was reached at the highest compound concentration tested (10 μM). For details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Compound not prepared.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">As an approximately 1:1 mixture of epimers.</p></div></div><div></div></div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Simplifying the bicyclo[3.1.0]hexane fused thiophene head.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Knowing that opening of the bicyclo[3.1.0]hexane system (as in <b>2</b>) to a cyclohexane yielded highly potent and selective S1P<sub>1</sub> agonists, we then studied further simplifications of the cyclohexane fused thiophene moiety. We therefore prepared a series of compounds wherein the cyclohexane ring was opened (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The compounds compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> illustrate our findings. In the propanone linked series (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), the carene derivative <b>2</b> and the cyclohexane fused thiophene <b>3</b> showed a nearly identical affinity profile for S1P<sub>1</sub> and S1P<sub>3</sub>. Also the 4-isobutyl-3,5-dimethylthiophene <b>4</b> was almost identical in potency on S1P<sub>1</sub>. This compound, however, was clearly more selective against S1P<sub>3</sub> when compared to its (bi)cyclic analogues <b>2</b> and <b>3</b>. Interestingly, moving the isobutyl substituent to position 5 and omitting additional methyl groups at the thiophene head to give compound <b>80</b> reduced the compound’s affinity for S1P<sub>1</sub> only slightly and increased the potency on S1P<sub>3</sub>. In the oxadiazole linked series (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), the bicyclo[3.1.0]hexane <b>81</b> and the cyclohexane <b>82</b> were highly potent on S1P<sub>1</sub>. The exact ring-opened analogue of cyclohexane <b>82</b>, compound <b>83</b>, was slightly less active on both receptors than compound <b>82</b>. Replacing the ethyl group in R<sub>3</sub> by a methyl group (<b>84</b>) or a hydrogen (<b>86</b>) restored the compound’s affinity for S1P<sub>1</sub> and reduced the potency on S1P<sub>3.</sub> On the other hand, omitting the 5-methyl group (R<sub>1</sub>) in <b>84</b> to give compound <b>85</b> not only enhanced the potency on S1P<sub>1</sub> but also significantly improved the selectivity against S1P<sub>3</sub>, a trend already observed in the cyclohexane fused thiophene series (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). On the other hand, removing the 3-methyl group in <b>84</b> to give <b>86</b> had a less pronounced effect on the compound’s affinity profile. In contrast to the observations with the two propanone derivatives <b>80</b> and <b>4</b>, the 5-isobutylthiophene <b>87</b> retained the potency on S1P<sub>1</sub> and lost affinity for S1P<sub>3</sub> when compared to the 4-isobutylthiophene <b>86</b>. While the 5-<i>n</i>-butyl and the 5-ethyl analogues <b>88</b> and <b>90</b>, respectively, were both less potent on S1P<sub>1</sub> and S1P<sub>3</sub>, the 5-<i>n</i>-propyl substituted thiophene <b>89</b> is comparable to <b>87</b> on S1P<sub>1</sub> but more selective against S1P<sub>3</sub>. In brief, the data on the oxadiazoles in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> illustrate that while the S1P<sub>1</sub> receptor tolerates a large variety of alkyl substituted thiophene heads, the S1P<sub>3</sub> receptor is clearly more susceptible to changes in this part of the molecule. This is most impressively demonstrated by comparing the cyclohexane fused thiophene derivative <b>82</b> with the 5-propyl substituted analogue <b>89</b>. The large structural difference between these two compounds has no effect on S1P<sub>1</sub> affinity but evokes an 80-fold potency shift on S1P<sub>3</sub>. The EC<sub>50</sub> values for the propanone derivatives compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> confirm earlier observations that in this series the affinity toward the S1P<sub>3</sub> receptor is consistently lower than in the oxadiazole series.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Substitution Pattern around the Thiophene Ring in the Propanone Series<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0018.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0019.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>. EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. All compounds with EC<sub>50</sub> ≤ 1 μM behaved as full agonists on S1P<sub>1</sub> and S1P<sub>3</sub> (<i>E</i><sub>max</sub> > 85%). For compounds with EC<sub>50</sub> > 1 μM it was not possible to determine whether or not they are full agonists because no activity plateau was reached at the highest compound concentration tested (10 μM). For details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Compound represents a 1:1 mixture of epimers with respect to polar side chain.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Compound represents racemate.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of Substitution Pattern around the Thiophene Ring in the Oxadiazole Series<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0020.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0021.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>. EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. All compounds with EC<sub>50</sub> ≤ 1 μM behaved as full agonists on S1P<sub>1</sub> and S1P<sub>3</sub> (<i>E</i><sub>max</sub> > 85%). For compounds with EC<sub>50</sub> > 1 μM it was not possible to determine whether or not they are full agonists because no activity plateau was reached at the highest compound concentration tested (10 μM). For details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Compound represents 1:1 mixture of epimers at polar side chain.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Racemic compound.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Lymphocyte counts in Wistar rats receiving 10 mg/kg compound po.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">+30% at 96 h.</p></div><div class="footnote" id="t5fn6"><sup>Table f</sup><p class="last">–73% at 72 h, −7% at 144 h.</p></div><div class="footnote" id="t5fn7"><sup>Table g</sup><p class="last">After administration of 3 mg/kg.</p></div><div class="footnote" id="t5fn8"><sup>Table h</sup><p class="last">+14% at 72 h.</p></div><div class="footnote" id="t5fn9"><sup>Table i</sup><p class="last">In vivo data of pure (<i>S</i>)-enantiomer.</p></div></div><div></div></div><div class="NLM_p">The similarity of the various thiophene headgroups becomes apparent when the X-ray crystal structures of the corresponding thiophene-2-carboxylic acids <b>103</b>, <b>9</b>, and <b>97</b> are superimposed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The substituents decorating the three thiophene-2-carboxylic acids assume conformations that overlap considerably suggesting overall very similar steric demands and space filling properties of these thiophene derivatives. While <b>103</b> comprises literally no degree of rotational freedom, cyclohexane <b>9</b> is more flexible because the ring pucker in <b>9</b> could switch, leading to a minor change in space filling. In <b>97</b> two preferred orientations of the isobutyl side chain (above or below the thiophene plane) are conceivable; however, the two neighboring methyl groups constrain its free rotation.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures (a) and superposition of the X-ray structures (b, c) of the three thiophene-2-carboxylic acids <b>103</b> (red), <b>9</b> (yellow), and <b>97</b> (blue) using the thiophene ring as the anchor unit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Studies</h3><div class="NLM_p">In the course of establishing the SAR on the S1P<sub>1</sub> and S1P<sub>3</sub> receptor, we also studied the DMPK properties of selected compounds. In vitro metabolic stability data showed a clear difference between the propanone and the oxadiazole linked compounds, and we anticipated that the propanone linked derivatives would be clearly inferior with respect to pharmacokinetics (PK) and in particular pharmacodynamics (PD). We therefore selected compound <b>36</b> as the most potent representative of the propanone series and its oxadiazole analogue <b>42</b> to illustrate the typical PK and PD behavior of the two subseries. In vitro and in vivo PK data of the two compounds are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. In rat liver microsomes and hepatocytes propanone <b>36</b> showed a much higher in vitro clearance than oxadiazole <b>42</b>. Similarly, a marked difference in in vivo clearance was observed between the two compounds upon iv administration of 1 mg/kg to Wistar rats. As both compounds had a comparable volume of distribution (<i>V</i><sub>ss</sub>), plasma concentrations of compound <b>36</b> dropped with a half-life (<i>t</i><sub>1/2</sub>) of 1.7 h while compound <b>42</b> showed a half-life of 21 h. The high clearance observed with propanone <b>36</b> results in low exposure (<i>C</i><sub>max</sub>, AUC<sub>0–24h</sub>) after oral dosing (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat PK Data of Propanone <b>36</b> and Oxadiazole <b>42</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>36</b></th><th class="colsep0 rowsep0" align="center"><b>42</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Experiment: In Vitro</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intrinsic clearance, rat microsomes [(μL/min)/mg]</td><td class="colsep0 rowsep0" align="left">>1250</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat hepatocytes [(μL/min)/10<sup>6</sup> cells]</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Experiment: In Vivo, 1 mg/kg iv</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clearance in vivo [(mL/min)/kg]</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> [L/kg]</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> in vivo [h]</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Experiment: In Vivo, 10 mg/kg po</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–24h</sub> [ng·h/mL]</td><td class="colsep0 rowsep0" align="left">276</td><td class="colsep0 rowsep0" align="left">28100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> [ng/mL]</td><td class="colsep0 rowsep0" align="left">141</td><td class="colsep0 rowsep0" align="left">1450</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> [h]</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability <i>F</i> [%]</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>33<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">PK parameters obtained in Wistar rats after oral administration of 10 mg/kg and iv administration of 1 mg/kg of either <b>36</b> or <b>42</b>; for details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Bioavailability cannot be determined accurately, as sampling time was up to 24 h only.</p></div></div></div><div class="NLM_p">At this point, we decided to compare the pharmacodynamic behavior of compounds <b>36</b> and <b>42</b> with their respective PK profile. Hence, the compounds were administered at a dose of 10 mg/kg to male Wistar rats and the blood lymphocyte count (LC) was measured shortly before and 3, 6, and 24 h after compound administration. A LC reduction of ≥60% was considered to be the maximal effect (plateau) to be observed under the conditions of the experiment.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The different pharmacokinetic properties of the two compounds clearly reflected their pharmacodynamic behavior (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). While the highly potent propanone <b>36</b> maximally reduced LC at 3 and 6 h (plasma concentrations of 32 and 10 ng/mL, respectively) and showed complete recovery of the LC at 24 h (plasma concentratoin of <1.5 ng/mL) after compound administration, the less potent oxadiazole <b>42</b> showed maximal LC reduction for at least 24 h (plasma concentration at 24 h of 530 ng/mL) and a still significant effect on LC after 3 and 6 days (plasma concentrations of 236 and 66 ng/mL, respectively) because of significantly higher plasma concentrations.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Lymphocyte counts measured after administration of 10 mg/kg of either ketone <b>36</b> (A) or oxadiazole <b>42</b> (B) to male Wistar rats. Note the different range of the time axis for the two graphs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In two recent studies, compounds that did not produce a sustained 24 h maximal LC reduction after single dose administration have been shown to be efficacious in the mouse EAE model of multiple sclerosis, suggesting that sustained maximal LC reduction is not mandatory to obtain in vivo efficacy in this model.<a onclick="showRef(event, 'ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref97 ref98">(97, 98)</a> On the other hand, in clinical studies transient heart rate reduction after oral dosing of (selective) S1P<sub>1</sub> receptor agonists has been observed.<a onclick="showRef(event, 'ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60 ref61">(58-61)</a> Model studies in guinea pigs suggested that the S1P<sub>1</sub> receptor is rapidly desensitized upon activation by a S1P<sub>1</sub> receptor agonist and sustained plasma concentrations of the agonist protect the animal from second dose effects on heart rate.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> A sustained 24 h plasma exposure, and as a consequence a sustained LC count reduction in the rat, therefore appeared desirable from a compound safety and efficacy perspective. Bearing this in mind, we studied the in vivo efficacy of the oxadiazole derivatives <b>81</b>–<b>90</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) at an oral dose of 10 mg/kg. All compounds showed a rapid onset of action, and with the exception of compound <b>83</b>, all compounds reached maximal LC reduction 3 h after compound administration. The duration of action, however, varied significantly between the various thiophene derivatives. While compound <b>81</b> maximally reduced LC for at least 24 h and complete recovery of LC was observed at 96 h, cyclohexane derivative <b>82</b> fully sequestered circulating lymphocytes for at least 72 h and LC recovery was seen after 168 h only. The 4-isobutyl substituted thiophenes <b>84</b>, <b>85</b>, and <b>86</b> maximally reduced LC for at least 24 h. Rapid reversibility of the LC reduction could be observed when compound <b>85</b> was administered at a lower dose of 3 mg/kg. At this dose, LC was maximally reduced at 6 h but was already close to baseline values 24 h after compound administration.</div><div class="NLM_p">In the series of the 5-alkylthiophenes <b>87</b>–<b>90</b>, only the isobutyl derivative <b>87</b> was able to maximally sequester blood lymphocytes for 24 h. The <i>n</i>-butyl (<b>88</b>), the <i>n</i>-propyl (<b>89</b>), and the ethyl (<b>90</b>) thiophenes all showed complete recovery of LC 24 h after compound administration. This observation could be rationalized on the basis of the compounds’ plasma exposures. For instance, while the isopropylthiophene <b>87</b> showed plasma concentrations of 1010, 680, and 23 ng/mL at 3, 6, and 24 h after oral administration, respectively, the concentrations of the ethyl analogue <b>90</b> were 490, 190, and <2 ng/mL at these time points.</div><div class="NLM_p">Lymphocytes leave lymph nodes by migrating along a gradient of S1P that exists between plasma and lymph. Synthetic S1P<sub>1</sub> receptor agonists lead to S1P<sub>1</sub> receptor internalization and thus abolish the lymphocyte’s ability to sense the S1P gradient and to leave the lymph node. The concentration of the synthetic S1P<sub>1</sub> agonist in lymph can be expected to influence the agonist’s pharmacodynamic behavior.<a onclick="showRef(event, 'ref11 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref11 ref42 ref43">(11, 42, 43)</a> We thus extended the above rat PK studies and measured the concentration of compound <b>42</b> in mesenteric lymph fluid that was collected over periods of 20 min at several time points after oral administration of 10 mg/kg compound <b>42</b>. In the middle of each lymph collection period, a plasma sample was drawn as well. The compound concentrations summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> demonstrate that for the first few hours the concentration of compound <b>42</b> in mesenteric lymph fluid exceeded the one in plasma by far, indicating that there is significant lymphatic transport of the compound after oral dosing. The compound was quickly absorbed into mesenteric lymph, reaching a concentration of nearly 6000 ng/mL at 1 h after administration. Plasma concentrations increased much more slowly and reached a significantly lower <i>C</i><sub>max</sub>. Compound concentrations in plasma and mesenteric lymph were equal at 24 h after compound administration, suggesting equilibration of the compound between the two compartments. As a consequence of the rapid and pronounced lymphatic transport of compound <b>42</b>, the exposure (AUC<sub>0–<i>t</i></sub>) in mesenteric lymph was significantly higher than in plasma. Although our experimental setup does not allow calculation of the fraction of the dose that undergoes lymphatic transport, lymphatic exposure and thus lymphatic transport are significant. The high lymph exposure of compound <b>42</b> may contribute to the compound’s in vivo efficacy.</div><div class="NLM_p">Compound concentrations in lymph fluids are not determined regularly. However, it is generally accepted that lipophilicity is a clear driver of lymphatic transport.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100, 101)</a> The high lipophilicity (log <i>D</i> = 4.3) of compound <b>42</b> and its lipid-like structure may thus explain its propensity for high lymphatic transport. Prompted by this interesting observation, the lymphatic route of absorption was studied for a few closely related analogues of amide <b>42</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, EC<sub>50</sub> values on S1P<sub>1</sub> and S1P<sub>3</sub> are given for completeness). Not surprisingly, the more lipophilic diol <b>104</b> (log <i>D</i> = 5.4) showed a very similar behavior. The compound was rapidly absorbed into mesenteric lymph, reaching a <i>C</i><sub>max</sub> that is remarkably higher than in plasma. Mesenteric lymph exposure was again significantly higher than plasma exposure. Despite their ionic/zwitter ionic nature, the acid <b>105</b> and the amino acid <b>106</b> appear rather lipophilic (log <i>D</i> of 3.6 and 4.9, respectively) and showed significant lymphatic transport as well.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Concentration of Compound <b>42</b> in Plasma and Mesenteric Lymph after Oral Administration of 10 mg/kg to Wistar Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><b>42</b> concentration  [ng/mL]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sample time<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a>[h]</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">mesenteric lymph</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">44.4</td><td class="colsep0 rowsep0" align="left">5790</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">58.1</td><td class="colsep0 rowsep0" align="left">4340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">4600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">132</td><td class="colsep0 rowsep0" align="left">8090</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">911</td><td class="colsep0 rowsep0" align="left">4590</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">24.8</td><td class="colsep0 rowsep0" align="left">680</td><td class="colsep0 rowsep0" align="left">684</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Mean of collection interval given for mesenteric lymph.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Mesenteric Lymph and Plasma Exposure after Oral Administration of 10 mg/kg of Compounds <b>42</b>, <b>104</b>, <b>105</b>, and <b>106</b> to Male Wistar Rats</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0022.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0023.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>. EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. All compounds behaved as full agonists on S1P<sub>1</sub> and S1P<sub>3</sub> (<i>E</i><sub>max</sub> > 85%). For details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t8fn2"><sup>Table b</sup><p class="last"><i>t</i><sub>max</sub> given in parentheses.</p></div><div class="footnote" id="t8fn3"><sup>Table c</sup><p class="last">0–<i>t</i> = from 0 h to last quantifiable measurement (<i>t</i> = 24 h except for <b>104</b>, <i>t</i> = 6.4 h).</p></div></div><div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By replacing the bicyclo[3.1.0]hexane by a cyclohexane or an isobutyl group, we were able to reduce the structural complexity and rigidity of our S1P<sub>1</sub> agonists such as <b>2</b> without compromising their in vitro potency and in vivo efficacy. For these novel thiophene derivatives the SARs of the polar side chain and the linker between the thiophene and the phenyl ring bearing the polar side chain were similar to those previously reported for the bicyclo[3.1.0]hexane fused thiophene series.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The easier and much more versatile access to the current thiophene headgroups, however, allowed detailed SAR studies that were not available for the (+)-3-carene derived bicyclo[3.1.0]hexane fused thiophenes. For instance, the influence of the substituent in position 5 of the thiophene as well as of the two methyl groups attached to the cyclohexane ring could be studied easily. In the cyclohexane fused thiophene series, the 5-substituent strongly influenced the compound’s affinity for the S1P<sub>3</sub> receptor. With increasing length of this alkyl chain the compounds became less selective for the S1P<sub>1</sub> receptor. For instance, attaching an <i>n</i>-propyl group to position 5 of the thiophene head furnished dual S1P<sub>1</sub>/S1P<sub>3</sub> receptor agonists (e.g., <b>43</b>). The affinity for the S1P<sub>3</sub> receptor also increased with increasing size of the substituents attached to the cyclohexane ring, and the two diethyl substituted compounds <b>47</b> and <b>55</b> were the least selective representatives in the propanone and the oxadiazole series, respectively. These observations illustrate that the S1P<sub>1</sub> receptor is rather tolerant, while the S1P<sub>3</sub> receptor is much more sensitive toward changes in size and shape of the thiophene headgroup. As observed earlier,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> the linker between the thiophene head and the phenyl ring bearing the polar side chain further influenced the compound’s selectivity against the S1P<sub>3</sub> receptor. In general, the oxadiazole linked compounds were more potent on S1P<sub>3</sub> and thus less selective for S1P<sub>1</sub> than their propanone linked analogues. On the other hand, the oxadiazole derivatives usually showed lower in vitro and in vivo clearance and as a consequence a higher efficacy in sequestering lymphocytes from circulation. Several oxadiazole derivatives (e.g., <b>42</b>, <b>81</b>, <b>82</b>, and <b>84</b>–<b>87</b>) maximally reduced LC for at least 24 h after oral dosing of 10 mg/kg to Wistar rats. Among these, compounds <b>85</b> and <b>87</b> appear particularly interesting, as they incorporate a simple alkyl substituted thiophene head and combine high affinity and selectivity for S1P<sub>1</sub> with sustained maximal LC reduction.</div><div class="NLM_p last">Finally, we discovered that lymphatic transport is a significant route of absorption for several of the compounds discussed in this study. Compounds that undergo lymphatic transport may offer several advantages. First, although these compounds may ultimately end up in the systemic circulation, they avoid hepatic first pass metabolism. Lymphatic transport may therefore positively influence the bioavailability of a compound.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100, 101)</a> Second, lymphatic transport may also offer opportunities for a tissue targeted approach wherein plasma exposure is minimal. The PKC inhibitor sotrastaurin, for instance, showed superior immunosuppressor efficacy in vivo when compared to a structurally close analogue reaching similar plasma exposure but lacking significant lymphatic absorption.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Mesenteric lymph concentrations of compounds <b>42</b> and <b>104</b>–<b>106</b> exceeded those in plasma significantly. These compounds may therefore be particularly useful in diseases where mesenteric lymph represents the target compartment. This may indeed be the case for autoimmune diseases affecting the gastrointestinal tract such as ulcerative colitis or Crohn’s disease. More detailed studies to understand the correlation between tissue specific pharmacokinetic behavior and efficacy in relevant disease models are certainly warranted for the compounds described above.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div class="NLM_p">All reagents and solvents were used as purchased from commercial sources (Sigma-Aldrich Switzerland, Lancaster Synthesis GmbH, Germany, Acros Organics USA). Moisture sensitive reactions were carried out under an argon atmosphere. Progress of the reactions was followed either by thin-layer chromatography (TLC) analysis (Merck, 0.2 mm silica gel 60 F<sub>254</sub> on glass plates) or by LC–MS. LC–MS parameters were the following: Finnigan MSQ Plus or MSQ surveyor (Dionex, Switzerland), with HP 1100 binary pump and DAD (Agilent, Switzerland); column Zorbax SB-AQ, 3.5 μm, 120 Å, 4.6 mm × 50 mm (Agilent) or Zorbax extended C18, 1.8 μm, 4.6 mm × 20 mm (Agilent); gradient, 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid, within 1 min; flow, 4.5 mL/min; 40 °C; <i>t</i><sub>R</sub> is given in min; UV detection at 230, 254, and 280 nm. LC–MS analysis was done on a Waters Acquity UPLC system equipped with an ACQ-PDA detector, an ACQ-ESL detector, and an ACQ-SQ detector; column ACQUITY UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm; gradient, 2–98% acetonitrile containing 0.045% formic acid in water containing 0.05% formic acid over 1.8 min; flow, 1.2 mL/min; 60 °C.</div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> HPLC Using Chiral Stationary Phase</h4><div class="NLM_p last">Hardware from UltiMate instrument series (Dionex) and parameters were the following: HPG-3200SD binary pump, WPS-3000 autosampler, TCC-3200 thermostated column compartment, DAD-3000 detector, SRD-3400 degasser, ValveMate 2 (Gilson) solvent valves; column, solvent, and retention time (<i>t</i><sub>R</sub>) as indicated, DEA = diethylamine, TFA = trifluoroacetic acid, at 25 °C, flow 1 mL/min. No racemization was observed during the synthesis of the target compounds. LC–HRMS parameters were the following: analytical pump, Waters Acquity Binary Solvent Manager; MS, SYNAPT G2MS, source temperature 150 °C; desolvatation temperature 400 °C; desolvatation gas flow 400 L/h; cone gas flow, 10 L/h; extraction cone, 4 RF; lens, 0.1 V; sampling cone, 30; capillary, 1.5 kV; high resolution mode; gain, 1.0; MS function, 0.2 s per scan; 120–1000 amu in full scan, centroid mode; lock spray, leucine enkephalin 2 ng/mL (556.2771 Da); scan time 0.2 s with interval of 10 s and average of five scans; DAD, Acquity UPLC PDA detector; column: Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm from Waters, thermostated in the Acquity UPLC column manager at 60 °C. Eluents were the following: water + 0.05% formic acid; B, acetonitrile + 0.05% formic acid. Gradient was 2–98% B over 3.0 min. Flow was 0.6 mL/min. Detection was with UV 214 nm and MS. <i>t</i><sub>R</sub> is given in min.</div></div><div id="secs" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> NMR Spectroscopy</h4><div class="NLM_p last">Equipment used was Varian Oxford for <sup>1</sup>H (300 MHz) or <sup>13</sup>C (75 MHz) or Bruker Avance II, 400 MHz UltraShield, for <sup>1</sup>H (400 MHz) and <sup>13</sup>C (100 MHz). Chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS), and multiplicities are given as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), h (hextet), hept (heptuplet), m (multiplet), or br (broad). Coupling constants are given in Hz. Several compounds have been prepared in a combinatorial library format on a 15–50 mmol scale. For those compounds <sup>1</sup>H NMR spectra were acquired using nondeuterated 10 mM DMSO stock solutions submitted for biological testing.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The solvent and water signal were suppressed by irradiation at 2.54 and 3.54 ppm, respectively. As a consequence, signal integrals close to those frequencies are not always accurate. The numbers of protons given in the description represent observed values.</div></div><div id="secu" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Compound Purification</h4><div class="NLM_p last">Compounds were purified by flash column chromatography (CC) on silica gel 60 (Fluka Sigma-Aldrich, Switzerland) or by preparative HPLC (Waters XBridge Prep C18, 5 μm, OBD, 19 mm × 50 mm, or Waters X-terra RP18, 19 mm × 50 mm, 5 μm, gradient of acetonitrile in water containing 0.4% of formic acid, flow of 75 mL/min) or by MPLC (Labomatic MD-80-100 pump, linear UVIS-201 detector, column 350 mm × 18 mm, Labogel-RP-18-5s-100, gradient of 10% methanol in water to 100% methanol).</div></div><div id="secv" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> X-ray Diffraction</h4><div class="NLM_p last">To determine the molecular structure of thiophenecarboxylic acids <b>9</b>, <b>97</b>, and <b>103</b>, a crystal of the compound was mounted on a Bruker Nonius diffractometer equipped with a CCD detector and reflections were measured using monochromatic Mo Kα radiation. The structure was solved by direct methods using SIR92. Refinement was performed with CRYSTALS. Full matrix least-squares refinement was performed with anisotropic temperature factors for all atoms except hydrogen which were included at calculated positions with isotropic temperature factors. Coordinates, anisotropic temperature factors, bond lengths, and bond angles have been deposited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, United Kingdom, <a href="http://www.ccdc.cam.ac.uk/" class="extLink">http://www.ccdc.cam.ac.uk/</a>, under the following deposition numbers: 972174 (<b>9</b>), 972173 (<b>97</b>), 972175 (<b>103</b>).</div></div><div id="secw" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Purity</h4><div class="NLM_p last">The purity of all target compounds was assessed using the two independent LC–MS methods described above: (1) a Zorbax SB-AQ, 5 μm, 120 Å, 4.6 mm × 50 mm (Agilent) column, eluting with a gradient of 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid, within 1 min, flow of 4.5 mL/min, and (2) an ACQUITY UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column, eluting with a gradient of 2–98% acetonitrile containing 0.045% formic acid in water containing 0.05% formic acid over 1.8 min, flow of 1.2 mL/min. In addition, important compounds were analyzed by LC–HRMS as described above. Purity and identity of the target compounds were further corroborated by NMR spectroscopy, and chiral integrity was proven by HPLC using chiral stationary phases. No racemization/epimerization was observed during the synthesis of the target compounds. According to these LC–MS analyses, final compounds showed a purity of ≥95% (UV at 230 and at 214 nm).</div></div></div><div id="secm" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> In Vitro Potency Assessment</h3><div class="NLM_p last">Data (EC<sub>50</sub>) are given as geometric means (<i>X</i><sub>geo</sub>) with geometric standard deviation (σ<sub>g</sub>). The upper and lower 95% confidence limits are calculated as <i>X</i><sub>geo</sub>σ<sub>g</sub><sup>2</sup> and <i>X</i><sub>geo</sub>/σ<sub>g</sub><sup>2</sup>, respectively (results not shown).</div></div><div id="secx" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> GTPγS Binding Assays</h3><div class="NLM_p last">GTPγS binding assays were performed in 96-well polypropylene microtiter plates in a final volume of 200 μL. Membrane preparations of CHO cells expressing recombinant human S1P<sub>1</sub> or S1P<sub>3</sub> receptors were used. Assay conditions were 20 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.1% fatty acid free BSA, 1 or 3 μM GDP (for S1P<sub>1</sub> or S1P<sub>3</sub>, respectively), 2.5% DMSO, and 50 pM <sup>35</sup>S-GTPγS. Test compounds were dissolved and diluted and preincubated with the membranes, in the absence of <sup>35</sup>S-GTPγS, in 150 μL of assay buffer at room temperature for 30 min. After addition of 50 μL of <sup>35</sup>S-GTPγS in assay buffer, the reaction mixture was incubated for 1 h at room temperature. The assay was terminated by filtration of the reaction mixture through a multiscreen GF/C plate, prewetted with ice-cold 50 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.4% fatty acid free BSA, using a cell harvester. The filter plates were then washed with ice-cold 10 mM Na<sub>2</sub>HPO<sub>4</sub>/NaH<sub>2</sub>PO<sub>4</sub> (70%/30%, w/w) containing 0.1% fatty acid free BSA. Then the plates were dried at 50 °C and sealed. An amount of 25 μL of MicroScint20 was added, and membrane-bound <sup>35</sup>S-GTPγS was determined on the TopCount. Specific <sup>35</sup>S-GTPγS binding was determined by subtracting nonspecific binding (the signal obtained in the absence of agonist) from maximal binding (the signal obtained with 10 μM S1P). The EC<sub>50</sub> of a test compound is the concentration of a compound inducing 50% of specific binding.</div></div><div id="secy" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Metabolic Stability in Liver Microsomes and Hepatocytes</h3><div class="NLM_p last">Glucose 6-phosphate (disodium salt) and NADP were purchased from Sigma (Buchs, Switzerland). Glucose 6-phosphate dehydrogenase was supplied by Boehringer Mannheim (Rotkreuz, Switzerland). All other chemicals and solvents used throughout this study were of the highest commercially available quality. Liver microsomal preparations from humans (pool of 48 donors), male Wistar rat (pool of 4 animals), and Beagle dog (pool of several animals) were purchased from Becton Dickinson (Basel, Switzerland). They were employed at a microsomal protein concentration of 0.5 mg/mL. The NADPH-regenerating system used for the microsomal incubations was prepared as a 10-fold concentrated stock solution and kept at −20 °C. It consisted of 11 mM NADP, 100 mM glucose 6-phosphate, and 50 mM MgCl<sub>2</sub> in 0.1 M phosphate buffer (pH 7.4). An amount of 20 UI/mL glucose 6-phosphate dehydrogenase was added before use. Incubations of compounds were performed at a single concentration of 1 μM in a total reaction volume of 1 mL at 37 °C in an Eppendorf thermomixer at 450 rpm. The reaction was initiated by addition of the NADPH-regenerating system (100 μL) containing the glucose 6-phosphate dehydrogenase and terminated after appropriate time periods up to 15 min by addition of ice-cold methanol (100 μL) to aliquots (100 μL) of the reaction mixture. The samples were centrifuged at 3220<i>g</i> for 20 min at 4 °C, and an aliquot (10 μL) of the supernatant was submitted to LC–MS–MS analysis. The total concentration of DMSO in the assay did not exceed 0.1%. Male rat hepatocytes were prepared following the standard two-step collagenase perfusion method.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Freshly prepared hepatocytes were cultured in phenol red-free William’s medium E supplemented with 10% fetal calf serum, 0.7 μM insulin, 10.000 UI/mL penicillin, and 10 mg/mL streptomycin (preincubation medium). Freshly isolated rat hepatocytes were centrifuged at 50<i>g</i> for 4 min at 4 °C and resuspended in preincubation medium, and the cell number and initial viability were determined using the erythrosine exclusion test. Cell viabilities below 85% were rejected for use. After a second centrifugation step, cells were resuspended in preincubation medium at a nominal density of 5.0 × 10<sup>5</sup> viable cells/mL. Aliquots (400 μL) of this suspension were dispensed into collagen-coated 24-well plates and incubated at 37 °C for a period of about 3 h in a humidified atmosphere containing 5% CO<sub>2</sub>. At the end of the preincubation period, the medium was removed from each well and replaced with 200 μL of prewarmed (37 °C) incubation medium containing compounds at a final concentration of 1 μM. Duplicate wells were sampled at 0, 0.5, 1, 2, 4, and 24 h by addition of 200 μL of methanol containing 0.3% SDS, and the entire well content was transferred into cryovials. Samples were stored frozen at −20 °C pending analysis. Compound disappearance was monitored by LC–MS–MS (MRM). Intrinsic clearances were determined by initial first order disappearance rates according to Obach et al.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Pharmacokinetics in the Rat</h3><div class="NLM_p">Male Wistar rats (RCC Ltd., Biotechnology and Animal Breeding Division, Füllinsdorf, Switzerland) were used for pharmacokinetic experiments after an acclimatization period of at least 7 days after delivery. The body weight of the rats was about 250 g at the day of the experiment. Two days prior to dosing, rats were anesthetized via inhalation by the gas anesthetic isoflurane. Buprenorphine was dosed as analgesic at 0.03 mg/kg sc half an hour before the operation. Catheters were implanted into the jugular vein and carotid artery under aseptic conditions to allow for multiple serial blood sampling. Animals foreseen for oral dosing did not undergo surgery, and blood samples were taken sublingually under light anesthesia with isoflurane. Compounds were administered intravenously as a 5 min infusion via the jugular vein at a dose of 1 mg/kg body weight formulated as solutions in an aqueous mixed micellar vehicle based on phospholipids and bile acids. Oral administration at a dose of 10 mg/kg was performed by gavage. For that, the compounds were dissolved in DMSO. This solution was added to a stirred solution of succinylated gelatin (7.5%) in water. The resulting milky suspension contained 5% of DMSO. Serial blood samples of 0.25 mL each were taken predose and at 30 min and 1, 2, 3, 4, 6, 8, and 24 h postdose into vials containing EDTA as anticoagulant. For the iv applications, additional samples were obtained 2, 10, and 20 min after the end of infusion. Plasma was separated by centrifugation and stored at −20 °C. By use of 1.25 μL of plasma on column, lower and upper limits of quantification were 1.52 and 1.52 ng/mL and 3300 and 10 000 ng/mL for compounds <b>36</b> and <b>42</b>, respectively. Pharmacokinetic parameters were estimated with the WinNonlin software (Pharsight Corporation, Mountain View, CA, USA) using noncompartmental analysis.</div><div class="NLM_p">For lymph sampling, rats were put under anesthesia by 150 mg/kg thiobutobarbital sodium salt, ip, at selected times after oral dosing and a catheter was inserted into the thoracic lymph duct after a laparotomy. The mesenteric lymph was collected for at least 10 min. Also a blood sample was taken at the mean time of the lymph collection period. At the end of the sampling period rats were euthanized with pentobarbital (iv or ip). All animals had free access to food and water during the entire duration of the experiments. Plasma and lymph samples from the rat were analyzed after protein precipitation with methanol and centrifugation at 3220<i>g</i> for 20 min at 4 °C using liquid chromatography coupled to mass spectrometry (LC–MS–MS) using appropriate calibration curves, internal standards (close analogues), and bioanalytical quality controls.</div><div class="NLM_p last">In vivo efficacy of the target compounds was assessed by measuring the circulating lymphocytes after oral administration of 1–10 mg/kg of a target compound to normotensive male Wistar rats. The animals were housed in climate-controlled conditions with a 12 h light/dark cycle and had free access to normal rat chow and drinking water. Blood was collected before and 3, 6, and 24 h after drug administration. Full blood was subjected to hematology using Beckman Coulter Ac·T 5diff CP (Beckman Coulter International SA, Nyon, Switzerland). The effect on lymphocyte count (% LC) was calculated for each animal as the difference between LC at a given time point and the predose value (=100%). All data are presented as the mean ± SEM. Statistical analyses were performed by analysis of variance (ANOVA) using Statistica (StatSoft) and the Student–Newman–Keuls procedure for multiple comparisons. Because of interindividual variability and the circadian rhythm of the number of circulating lymphocytes, a compound showing relative changes in the range of −20% to +40% is considered inactive. A lymphocyte count reduction in the range of −60% to −75% represents the maximal effect to be observed under the conditions of the experiment. The null hypothesis was rejected when <i>p</i> < 0.05. For formulation, the compounds were dissolved in DMSO. This solution was added to a stirred solution of succinylated gelatin (7.5%) in water. The resulting milky suspension containing a final concentration of 5% of DMSO was administred to the animals by gavage. A mixture of 95% of succinylated gelatin (7.5%) in water and 5% of DMSO served as vehicle.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5,5-Dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic Acid (<b>8</b>)</h3><div class="NLM_p">(a) To a solution of 4,4-dimethylcyclohex-2-enone (50 g, 403 mmol) in EA (230 mL) a suspension of Pd/C (2.5 g, 10% Pd) in EA is added. The suspension is stirred at room temperature for 2 h under 1 bar of H<sub>2</sub>. The catalyst is filtered off and the solvent of the filtrate is carefully evaporated to give 4,4-dimethyl-cyclohexanone <b>5</b> (50 g, 98%) as a colorless oil which slowly crystallizes. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.34 (t, <i>J</i> = 6.4 Hz, 4 H), 1.66 (t, <i>J</i> = 6.4 Hz, 4 H), 1.09 (s, 6 H).</div><div class="NLM_p">(b) To an ice-cold solution of potassium <i>tert</i>-butylate (24.5 g, 109 mmol, 50% solution in <i>tert</i>-butanol) in THF (700 mL), ethyl formate (120 mL, 123 mmol) is slowly added. The mixture is stirred at room temperature for 30 min before a solution of <b>5</b> (50 g, 396 mmol) in ethyl formate (50 mL) and THF (70 mL) is added over a period of 20 min. Upon complete addition, stirring is continued at 15–20 °C for 30 min. The orange suspension is poured onto 10% aqueous citric acid solution (200 mL) and brine (200 mL) and extracted with EA (2 × 200 mL). The organic extracts are washed with 0.2 N aqueous NaOH and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness to give 5,5-dimethyl-2-oxocyclohexanecarbaldehyde <b>6</b> (52 g, 85%) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.89 min, [M + 1 + CH<sub>3</sub>CN]<sup>+</sup> = 196.15. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 14.42 (d, <i>J</i> = 2.1 Hz, 1 H), 8.59 (d, <i>J</i> = 1.8 Hz, 1 H), 2.40 (t, <i>J</i> = 6.8 Hz, 2 H), 2.14 (s, 2 H), 1.50 (t, <i>J</i> = 6.8 Hz, 2 H), 1.01 (s, 6 H).</div><div class="NLM_p">(c) To a solution of <b>6</b> (51 g, 331 mmol) in chloroform (250 mL), oxalyl chloride (40 mL, 465 mmol) is rapidly added. Gas evolution is observed, and the mixture becomes warm (35 °C). The mixture is cooled with a water bath to 20–25 °C. After the mixture was stirred for 1 h, ice followed by 3 N aqueous NaOH (100 mL) is added carefully. Again, gas formation is observed. The mixture is stirred for 45 min until gas evolution has ceased. The organic phase is separated, and the aqueous phase is extracted once more with chloroform. The combined organic extracts are washed with water and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent is removed in vacuo to give crude 2-chloromethylene-4,4-dimethylcyclohexanone <b>7</b> (50 g, 87%) as a brown oil. LC–MS: <i>t</i><sub>R</sub> = 0.96 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.15 (t, <i>J</i> = 2.1 Hz, 1 H), 2.47 (t, <i>J</i> = 7.0 Hz, 2 H), 2.43 (s, 2 H), 1.71 (t, <i>J</i> = 7.0 Hz, 2 H), 1.06 (s, 6 H).</div><div class="NLM_p last">(d) To a part (300 mL) of a freshly prepared solution of sodium (21 g, 875 mmol) in ethanol (500 mL), mercaptoacetic acid ethyl ester (50 mL) is added. The resulting solution is added over a period of 10 min to a solution of <b>7</b> (50 g, 290 mmol) in THF (170 mL). The mixture becomes warm (50 °C). Upon complete addition, the remaining part of the freshly prepared solution of sodium in ethanol (200 mL) is added to the reaction mixture. The mixture is stirred at room temperature for 15 min before 1 N aqueous LiOH solution (300 mL) is added. The solution is refluxed for 3 h, then stirred at room temperature for 16 h. The THF and ethanol are removed under reduced pressure, and the remaining dark solution is extracted with heptane/EA 3:1 (2 × 200 mL). The aqueous phase is acidified by adding citric acid (30 g) and 2 N aqueous HCl (200 mL) and then extracted three times with EA. The combined organic extracts are washed three times with saturated aqueous NaHCO<sub>3</sub> solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The resulting dark brown oil is dissolved in acetonitrile at 60 °C and crystallized at 5 °C. The crystals are collected, washed with acetonitrile, and dried to give <b>8</b> (31 g, 51%) as a slightly gray powder. LC–MS: <i>t</i><sub>R</sub> = 0.95 min, [M + 1 + CH<sub>3</sub>CN]<sup>+</sup> = 252.18. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.15 (s, 1 H), 3.05 (t, <i>J</i> = 7.0 Hz, 2 H), 2.47 (s, 2 H), 1.58 (t, <i>J</i> = 7.0 Hz, 2 H), 0.97 (s, 6 H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3,5,5-Trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic Acid (<b>9</b>)</h3><div class="NLM_p last">At −78 °C a solution of <b>8</b> (5 g, 23.8 mmol) in THF is treated with <i>tert</i>-butyllithium (41 mL, 1.5 M in pentane). The mixture is stirred at −78 °C for 15 min before methyl iodide (17.1 g, 120 mmol) is added dropwise. Stirring is continued at −78 °C for 30 min. The mixture is warmed to room temperature, diluted with water (400 mL), acidified with 10% aqueous citric acid solution, and extracted three times with EA. The combined organic extracts are dried over MgSO<sub>4</sub> and evaporated. The remaining solid is suspended in heptane/diethyl ether, filtered, and dried under HV to give <b>9</b> (4.01 g, 75%) as a beige powder. LC–MS: <i>t</i><sub>R</sub> = 0.97 min, [M + 1] = 225.13. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.49 (s br, 1 H), 2.87 (t, <i>J</i> = 6.7 Hz, 2 H), 2.26 (s, 5 H), 1.45 (t, <i>J</i> = 6.7 Hz, 2 H), 0.91 (s, 6 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 164.0, 145.4, 139.1, 136.4, 122.7, 38.3, 35.3, 29.6, 28.1, 24.2, 13.4. Crystals suitable for single crystal X-ray structure analysis were obtained by crystallizing <b>9</b> from acetonitrile. Crystals of <b>9</b> (C<sub>12</sub>H<sub>16</sub>O<sub>2</sub>S, formula weight 224.09) formed in the triclinic space group <i>P</i>1̅. A total of 12 337 reflections was measured at 293 K. Results were the following: molecules/unit cell <i>Z</i> = 2, cell dimensions <i>a</i> = 6.6024(6) Å, <i>b</i> = 8.6950(8) Å, <i>c</i> = 9.8154(10) Å, α = 96.056(7)°, β = 96.461(7)°, γ = 94.944(6)°; calculated density of 1.34 g cm<sup>–3</sup>. The final <i>R</i>-factor of 0.031 was obtained for 2416 observed reflections (<i>I</i> > 3σ(<i>I</i>)). CCDC code is 972174.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-Ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic Acid (<b>10</b>)</h3><div class="NLM_p last">To a cooled solution (−78 °C) of <b>8</b> (960 mg, 4.57 mmol) in THF (19 mL), <i>tert</i>-butyllithium (8 mL, 1.5 M solution in pentane) is added. The mixture is stirred at −78 °C for 10 min before ethyl iodide (3.80 g, 24.37 mmol) is added. The reaction mixture is stirred at −78 °C for 3 h. Water/methanol 1:1 (8 mL) followed by 10% aqueous citric acid solution is added, and the mixture is extracted with EA. The combined organic extracts are washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The remaining solid is suspended in acetonitrile (6 mL), heated to 60 °C, cooled to room temperature, filtered, and dried to give <b>10</b> (640 mg, 50%) as a slightly beige solid. LC–MS: <i>t</i><sub>R</sub> = 1.01 min, [M + 1 + CH<sub>3</sub>CN] = 280.10. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.48 (s br, 1 H), 2.87 (t, <i>J</i> = 6.8 Hz, 2 H), 2.66 (q, <i>J</i> = 7.5 Hz, 2 H), 2.27 (s, 2 H), 1.46 (t, <i>J</i> = 6.7 Hz, 2 H), 1.15 (t, <i>J</i> = 7.5 Hz, 3 H), 0.91 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 168.6, 149.23, 149.21, 134.6, 121.4, 40.8, 35.3, 29.5, 28.0, 21.9, 21.5, 14.7.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(3,5,5-Trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)ethanone (<b>14</b>)</h3><div class="NLM_p last">To a suspension of <b>9</b> (4.10 g, 18.28 mmol) in diethyl ether (300 mL), methyllithium (23 mL, 1.6 M solution in diethyl ether) is slowly added at room temperature. The reaction mixture becomes clear, yellow, and slightly warm (26 °C) and is stirred for 15 min before it is quenched with water. The organic layer is separated, washed once more with water, dried over MgSO<sub>4</sub>, and evaporated. The crude product is purified by CC on silica gel, eluting with heptane/EA 4:1 to give <b>14</b> (2.80 g, 69%) as a pale yellow crystalline solid. LC–MS: <i>t</i><sub>R</sub> = 0.97 min, [M + 1] = 223.26. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 3.00 (t, <i>J</i> = 7.0 Hz, 2 H), 2.43 (s, 3 H), 2.31 (s, 3 H), 2.26 (s, 2 H), 1.51 (t, <i>J</i> = 7.0 Hz, 2 H), 0.95 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 190.6, 145.6, 140.0, 137.3, 131.7, 38.6, 35.4, 29.4, 27.9, 25.2, 13.5.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-Isobutyl-3-methylthiophene-2-carboxylic Acid (<b>94</b>)</h3><div class="NLM_p">(a) To a solution of KO<sup><i>t</i></sup>Bu (50 g, 446 mmol) in THF (400 mL) is added during 30 min ethyl formate (92 g, 1.25 mol). Strong gas evolution occurs. The mixture is cooled during the addition with a water bath at 10 °C. After complete addition, the mixture is stirred until the gas evolution ceases (15 min). The mixture is cooled with ice at 0 °C, and a mixture of 5-methyl-2-hexanone <b>91</b> (34.25 g, 300 mmol) and ethyl formate (41 g, 0.55 mol) is added slowly during 30 min. The mixture is stirred for 15 h, diluted with EA (500 mL), and washed with 1 N aqueous HCl (100 mL), 1 M aqueous NaH<sub>2</sub>PO<sub>4</sub> solution (100 mL), and brine (100 mL). The organic extract is dried (MgSO<sub>4</sub>), filtered, and evaporated to give crude 4-hydroxy-3-isobutylbut-3-en-2-one <b>92</b> (28 g, 66%) which is used without further purification. LC–MS: <i>t</i><sub>R</sub> = 0.80 min, [M + 1] = 143.39. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.99 (d, <i>J</i> = 6.4 Hz, 1 H), 2.11 (s, 3 H), 2.00 (d, <i>J</i> = 7.2 Hz, 2 H), 1.60 (hept, <i>J</i> = 7.0 Hz, 1 H), 0.89 (d, <i>J</i> = 6.6 Hz, 6 H).</div><div class="NLM_p">(b) To a solution of <b>92</b> (28 g, 197 mmol) in chloroform (350 mL) a solution of oxalyl chloride (44.3 g, 349 mmol) in chloroform (50 mL) is added slowly during 5 min. The resulting dark brown mixture is stirred at room temperature for 2 h before it is cooled to 0 °C and treated with ice (100 g) followed by 1 N aqueous NaOH (100 mL). When the quite violent gas evolution ceases, the phases are separated (the still acidic aqueous phase is discarded). The organic phase is washed with 1 N aqueous NaOH (3 × 75 mL) and 1 N aqueous NaH<sub>2</sub>PO<sub>4</sub> (75 mL), dried (MgSO<sub>4</sub>), filtered, and evaporated to give crude 4-chloro-3-isobutylbut-3-en-2-one <b>93</b> (31.6 g, quantitative) as a dark brown oil. LC–MS: <i>t</i><sub>R</sub> = 0.97 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.29 (s, 1 H), 2.36 (d, <i>J</i> = 7.3 Hz, 2 H), 2.31 (s, 3 H), 1.81 (hept, <i>J</i> = 6.8 Hz, 1 H), 0.87 (d, <i>J</i> = 6.7 Hz, 6 H).</div><div class="NLM_p last">(c) KO<sup><i>t</i></sup>Bu (44.2 g, 394 mmol) is added portionwise to ethanol (200 mL). The mixture is stirred for 30 min at 20 °C to dissolve all KO<sup><i>t</i></sup>Bu. Mercaptoacetic acid ethyl ester (47.3 g, 394 mmol) is added, and the temperature is maintained at 20 °C. This solution is slowly added at 20 °C to a solution of the crude <b>93</b> (31.6 g, 197 mmol) in THF (350 mL). The mixture is stirred at room temperature for 15 h before sodium ethylate (13.4 g, 197 mmol) is added, and stirring is continued at reflux for 1 h. The mixture is cooled to room temperature, and the solvents are evaporated on a rotavap. The residue is diluted with diethyl ether (500 mL), washed with 1 M aqueous NaH<sub>2</sub>PO<sub>4</sub> (200 mL), 1 N aqueous NaOH (2 × 100 mL), saturated aqueous NaHCO<sub>3</sub> (35 mL) containing 10% aqueous NaOCl (15 mL), and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The resulting residue (36.3 g) is dissolved in EtOH (250 mL). 2 N aqueous LiOH (100 mL) is added, and the mixture is stirred at room temperature for 48 h before it is extracted with diethyl ether (1 × 400 mL, 2 × 150 mL). The organic extracts are washed with 1 N aqueous NaOH (3 × 100 mL). The aqueous extracts are carefully acidified with 25% aqueous HCl and then extracted with DCM (3 × 150 mL). The combined DCM extracts are dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product is purified by crystallization from acetonitrile (150 mL) at 4 °C to give <b>94</b> (16.0 g, 41%) as a beige-brown crystalline powder. LC–MS: <i>t</i><sub>R</sub> = 0.95 min. <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 7.21 (s, 1 H), 2.43 (s, 3 H), 2.42 (d, <i>J</i> = 7.0 Hz, 2 H), 1.83 (nonet, <i>J</i> = 7.0 Hz, 1 H), 0.92 (d, <i>J</i> = 7.0 Hz, 6 H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-Isobutyl-5-methylthiophene-2-carboxylic Acid (<b>96</b>)</h3><div class="NLM_p">(a) Phosphorus oxychloride (53.7 g, 350 mmol) is slowly added to DMF (60 mL) stirred at 5 °C. Upon complete addition, the clear solution is stirred for further 30 min at 5 °C before 5-methyl-2-hexanone <b>91</b> (20 g, 175 mmol) is added dropwise. The yellow solution is stirred for 30 min at 0 °C, then for 90 min at room temperature. The mixture becomes warm (40 °C), and a thick suspension forms. The mixture is cooled to 25 °C, and stirring is continued for 1 h before it is poured into an aqueous solution of NaOAc (80 g)/ice mixture. The mixture is extracted twice with diethyl ether. The organic extracts are washed with water, combined, dried over MgSO<sub>4</sub>, filtered, and evaporated to give crude 3-chloro-2-isobutylbut-2-enal <b>95</b> (35.4 g, quantitative) as a 2:3 mixture of <i>E</i>/<i>Z</i> isomers as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.97 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ major isomer 10.02 (s, 1 H), 2.60 (s, 3 H), 2.33 (d, <i>J</i> = 7.3 Hz, 2 H), 1.82 (hept, <i>J</i> = 7.0 Hz, 1 H), 0.87 (d, <i>J</i> = 6.7 Hz, 6 H); δ minor isomer 10.22 (s, 1 H), 2.38 (s, 3 H), 2.20 (d, <i>J</i> = 7.3 Hz, 2 H), 1.69 (hept, <i>J</i> = 6.4 Hz, 1 H), 0.86 (d, <i>J</i> = 6.7 Hz, 6 H).</div><div class="NLM_p last">(b) Sodium (10.7 g, 467 mmol) is dissolved in ethanol (500 mL), and the resulting solution is diluted with THF (100 mL) before mercaptoacetic acid ethyl ester (33.7 g, 280 mmol) dissolved in THF (70 mL) is slowly added at 5 °C. The mixture is stirred at room temperature for 1 h before a solution of <b>95</b> (30 g, 187 mmol) in THF (100 mL) is slowly added at 8 °C. The resulting yellow suspension is stirred at room temperature for 16 h. The reaction mixture is diluted with diethyl ether (500 mL) and is washed with dilute aqueous NaOCl solution followed by aqueous 1 N HCl and water. The organic extract is dried over MgSO<sub>4</sub>, filtered, and evaporated. The remaining orange oil is dissolved in ethanol (150 mL), and 2 N aqueous LiOH (50 mL) is added. The mixture is stirred for 16 h at 50 °C, acidified with 2 N aqueous HCl, and extracted with EA. The organic extract is dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product is recrystallized from EA/heptane to give <b>96</b> (10.5 g, 28%) as colorless crystals. LC–MS: <i>t</i><sub>R</sub> = 0.92 min, [M + 1 + CH<sub>3</sub>CN] = 240.16. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.59 (s, 1 H), 2.40–2.37 (m, 5 H), 1.84 (hept, <i>J</i> = 7.0 Hz, 1 H), 0.90 (d, <i>J</i> = 7.0 Hz, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 167.8, 144.0, 139.3, 137.4, 127.4, 37.3, 29.6, 22.4, 14.0.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Isobutyl-3,5-dimethylthiophene-2-carboxylic Acid (<b>97</b>)</h3><div class="NLM_p last">Under argon, a solution of <b>96</b> (2.00 g, 10.1 mmol) in THF (150 mL) is allowed to stand over 3 Å molecular sieves for 30 min before it is transferred to the reaction vessel. The solution is cooled to −78 °C, and <sup><i>t</i></sup>BuLi (20.2 mL of 1.5 M solution in pentane) is added. Upon complete addition, stirring is continued at −78 °C for 45 min before MeI (7.16 g, 50.4 mmol) is added. Stirring is continued at −70 °C for 30 min. The mixture is allowed to warm to room temperature. The reaction is quenched by adding 10% aqueous citric acid solution and water. The mixture is extracted three times with EtOAc (3 × 200 mL). The organic extracts are combined, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product is purified by column chromatography on silica gel, eluting with heptane/EtOAc 4:1 to give <b>97</b> (1.40 g, 65%) as a white solid. LC–MS: <i>t</i><sub>R</sub> = 0.97 min, [M + 1 + CH<sub>3</sub>CN] = 254.26. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.46 (s, 3 H), 2.39 (s, 3 H), 2.36 (d, <i>J</i> = 7.0 Hz, 2 H), 1.78 (hept, <i>J</i> = 7.0 Hz, 1 H), 0.91 (d, <i>J</i> = 7.0 Hz, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 168.7, 148.0, 142.3, 139.9, 122.2, 36.0, 29.2, 22.5, 14.9, 14.5. Crystals suitable for single crystal X-ray structure analysis were obtained by crystallizing <b>97</b> by the isothermal distillation method<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106, 107)</a> using EA as solvent and hexane as the precipitating agent. Crystals of <b>97</b> (C<sub>11</sub>H<sub>16</sub>O<sub>2</sub>S, formula weight 212.09) formed in the monoclinic space group <i>C</i>2/<i>c</i>, and 13 680 reflections were measured at 293 K. Results were the following: molecules/unit cell <i>Z</i> = 8, cell dimensions <i>a</i> = 15.852(3) Å, <i>b</i> = 7.0898(10) Å, <i>c</i> = 20.177(3) Å, α = 90°, β = 93.945(16)°, γ = 90°; calculated density of 1.24 g cm<sup>–3</sup>. The final <i>R</i>-factor of 0.035 was obtained for 2450 observed reflections (<i>I</i> > 3σ(<i>I</i>)). CCDC code is 972173.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Isobutylthiophene-2-carboxylic Acid (<b>102</b>)</h3><div class="NLM_p last">To a solution of thiophene-2-carboxylic acid <b>98</b> (4.16 g, 32.1 mmol) in THF (200 mL) <i>tert</i>-butyllithium (49 mL, 1.7 M solution in pentane, 83.6 mmol) is slowly added at −78 °C. The mixture is stirred at −78 °C for 30 min before isobutyl bromide (22.7 g, 160.7 mmol) is carefully added. The mixture is stirred at −78 °C for 5 h, then at room temperature for 16 h. The reaction is quenched by the addition of water (400 mL). The mixture is acidified and extracted with EA. The organic extract is dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product is purified by MPLC on reverse phase silica gel to give <b>102</b> (1.67 g, 28%) as a brownish oil. LC–MS: <i>t</i><sub>R</sub> = 0.91 min. <sup>1</sup> H NMR (CDCl<sub>3</sub>): δ 7.73 (d, <i>J</i> = 3.8 Hz, 1 H), 6.80 (d, <i>J</i> = 3.8 Hz, 1 H), 2.72 (d, <i>J</i> = 7.0 Hz, 2 H), 1.94 (hept, <i>J</i> = 6.7 Hz, 1H), 0.96 (d, <i>J</i> = 6.7 Hz, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 168.0, 154.5, 135.2, 130.3, 126.4, 39.8, 30.7, 22.2.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>rac</i>-<i>N</i>-(3-(2,6-Dimethyl-4-(3-oxo-3-(3,5,5-trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)propyl)phenoxy)-2-hydroxypropyl)-2-hydroxyacetamide (<b>3</b>)</h3><div class="NLM_p last">A solution of glycolic acid (61 mg, 0.806 mmol), TBTU (224 mg, 0.698 mmol), and Hünig’s base (278 mg, 2.15 mmol) in DCM (5 mL) is stirred at room temperature for 10 min before a solution of <b>29</b> (231 mg, 0.537 mmol) in DCM (5 mL) is added. The mixture is stirred at room temperature for 1 h. Another portion of glycolic acid (61 mg, 0.806 mmol) and TBTU (100 mg, 0.311 mmol) is added, and stirring is continued for 2 h. The mixture is diluted with DCM and washed with saturated aqueous NaHCO<sub>3</sub> solution. The washing is extracted back two times with DCM. The organic extracts are combined, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product is purified on preparative TLC plates using DCM containing 5% of methanol to give <b>3</b> (143 mg, 55%) as a colorless foam. LC–MS: <i>t</i><sub>R</sub> = 1.00 min, [M + 1]<sup>+</sup> = 488.17. HPLC with chiral stationary phase (Chiralpak IA 250 mm × 4.6 mm i.d., 5 μm; 90% heptane containing 0.05% DEA, 10% ethanol containing 0.05% DEA): <i>t</i><sub>R</sub> = 19.7 min, 48%, <i>t</i><sub>R</sub> = 22.0 min, 52%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.97 (t br, <i>J</i> = 5.0 Hz, 1 H), 6.87 (s, 2 H), 4.08–4.15 (m, 1 H), 4.15 (s, 2 H), 3.69–3.84 (m, 3 H), 3.40–3.52 (m, 1 H), 2.97–3.08 (m, 4 H), 2.86–2.96 (m, 2 H), 2.33 (s, 3 H), 2.28 (s, 2 H), 2.24 (s, 6 H), 1.53 (t, <i>J</i> = 6.7 Hz, 2 H), 0.97 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 192.3, 172.9, 153.2, 146.0, 139.9, 137.3, 137.1, 131.0, 130.5, 129.0, 73.4, 70.2, 62.2, 43.5, 42.3, 38.6, 35.4, 30.0, 29.5, 27.9, 25.3, 16.3, 13.5. LC–HRMS: <i>t</i><sub>R</sub> = 2.08 min, [M + H]/<i>z</i> = 488.2471, found = 488.2470.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(4-Hydroxy-3,5-dimethyl-phenyl)-1-(3,5,5-trimethyl-4,5,6,7-tetrahydro-benzo[c]thiophen-1-yl)-propan-1-one (<b>21</b>)</h3><div class="NLM_p">(a) A solution of 1-(3,5,5-trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)ethanone <b>14</b> (1.35 g, 6.07 mmol) and 4-hydroxy-3,5-dimethylbenzaldehyde (1.09 g, 7.29 mmol) in ethanol (20 mL) and 5 N HCl in isopropanol (10 mL) is stirred at room temperature for 100 min. The dark solution is diluted with diethyl ether (300 mL), washed with water followed by a 1:1 mixture of 1 N aqueous NaOH and saturated aqueous NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and evaporated. The crude product is purified by CC on silica gel, eluting with heptane/EA 7:3 to give 3-(4-hydroxy-3,5-dimethylphenyl)-1-(3,5,5-trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)propenone (1.86 g, 87%) as a yellow-orange solid. LC–MS: <i>t</i><sub>R</sub> = 1.15 min, [M + 1] = 355.26. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.65 (d, <i>J</i> = 15.2 Hz, 1 H), 7.26 (s, 2 H), 7.13 (d, <i>J</i> = 15.2 Hz, 1 H), 5.04 (s, 1 H), 3.15 (t, <i>J</i> = 6.4 Hz, 2 H), 2.37 (s, 3 H), 2.31 (s, 2 H), 2.28 (s, 6 H), 1.56 (t, <i>J</i> = 6.4 Hz, 2 H), 0.99 (s, 6 H).</div><div class="NLM_p last">(b) A solution of 3-(4-hydroxy-3,5-dimethylphenyl)-1-(3,5,5-trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)propenone (1.86 g, 5.25 mmol) in THF (50 mL) and ethanol (50 mL) is treated with Pd/C (400 mg, 10% Pd), and the resulting slurry is stirred at room temperature for 5 h under 1.5 bar of H<sub>2</sub>. The catalyst is filtered off, and the solvent of the filtrate is evaporated. The crude product is purified by CC on silica gel, eluting with heptane/EA 1:1 to give <b>21</b> (1.80 g, 96%) as a pale red foam. LC–MS: <i>t</i><sub>R</sub> = 1.15 min, [M + 1] = 357.27. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.85 (s, 2 H), 4.53 (s, 1 H), 3.07–2.98 (m, 4 H), 2.94–2.86 (m, 2 H), 2.33 (s, 3 H), 2.28 (s, 2 H), 2.22 (s, 6 H), 1.53 (t, <i>J</i> = 7.0 Hz, 2 H), 0.97 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 192.5, 150.5, 145.9, 139.7, 137.3, 132.9, 131.1, 128.5, 123.0, 43.9, 38.6, 35.5, 30.0, 29.5, 27.9, 25.3, 16.0, 13.5.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>rac</i>-3-[4-(3-Amino-2-hydroxypropoxy)-3,5-dimethylphenyl]-1-(3,5,5-trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)propan-1-one (<b>29</b>)</h3><div class="NLM_p">(a) To a solution of <b>21</b> (420 mg, 1.18 mmol) in isopropanol (15 mL) and 3 N aqueous NaOH (6 mL) <i>rac</i>-epichlorohydrin (545 mg, 5.89 mmol) is added. The mixture is stirred at room temperature for 20 h before it is diluted with diethyl ether (150 mL) and washed with saturated NaHCO<sub>3</sub> solution (50 mL). The washing is extracted back with diethyl ether (150 mL). The combined organic extracts are dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product is purified by column chromatography on silica gel, eluting with heptane/EtOAc 4:1 to give <i>rac</i>-3-(3,5-dimethyl-4-(oxiran-2-ylmethoxy)phenyl)-1-(3,5,5-trimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)propan-1-one (443 mg, 91%) as an almost colorless oil. LC–MS: <i>t</i><sub>R</sub> = 1.19 min, [M + 1]<sup>+</sup> = 413.36. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.87 (s, 2 H), 4.00 (dd, <i>J</i><sub>1</sub> = 11.1 Hz, <i>J</i><sub>2</sub> = 3.3 Hz, 1 H), 3.73 (dd, <i>J</i><sub>1</sub> = 11.1 Hz, <i>J</i><sub>2</sub> = 5.9 Hz, 1 H), 3.31–3.39 (m, 1 H), 2.98–3.08 (m, 4 H), 2.85–2.96 (m, 3 H), 2.70 (dd, <i>J</i><sub>1</sub> = 4.9 Hz, <i>J</i><sub>2</sub> = 2.6 Hz, 1 H), 2.33 (s, 3 H), 2.28 (s, 2 H), 2.26 (s, 6 H), 1.53 (t, <i>J</i> = 6.7 Hz, 2 H), 0.97 (s, 6 H).</div><div class="NLM_p last">(b) A solution of the above epoxide (443 mg, 1.07 mmol) in 7 N NH<sub>3</sub> in methanol (15 mL) is stirred at 65 °C for 18 h in a sealed vessel. The mixture is concentrated and dried to give <b>29</b> (443 mg, 96%) as a pale yellow foam. LC–MS: <i>t</i><sub>R</sub> = 0.89 min, [M + 1]<sup>+</sup> = 430.33. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, solvent suppression): δ 6.87 (s, 2 H), 3.90–3.97 (m, 1 H), 3.63–3.65 (m, 1 H), 2.87–2.93 (m, 2 H), 2.73–2.82 (m, 2 H), 2.30 (s, 3 H), 2.27 (s, 2 H), 2.17 (s, 6 H-), 1.43–1.50 (m, 2 H), 0.92 (s, 6 H).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>rac</i>-<i>N</i>-(3-{2-Ethyl-4-[3-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-3-oxopropyl]-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>36</b>)</h3><div class="NLM_p last"><b>36</b> was prepared in analogy to <b>3</b> using <b>15</b>, giving a beige foam. LC–MS: <i>t</i><sub>R</sub> = 1.05 min, [M + 1] = 516.42. HPLC with chiral stationary phase (Chiralpak IE 250 mm × 4.6 mm i.d., 5 μm; 70% heptane containing 0.05% DEA, 30% ethanol containing 0.05% DEA): <i>t</i><sub>R</sub> = 11.0 min, 50%, <i>t</i><sub>R</sub> = 11.8 min, 50%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.86–6.95 (m, 3 H), 4.16 (s, 2 H), 4.09–4.15 (m, 1 H), 3.69–3.84 (m, 3 H), 3.40–3.52 (m, 1 H), 3.20 (s br, 1 H), 3.00–3.10 (m, 4 H), 2.90–2.98 (m, 2 H), 2.72 (q, <i>J</i> = 7.6 Hz, 2 H), 2.61 (q, <i>J</i> = 7.5 Hz, 2 H), 2.30 (s, 2 H), 2.25 (s, 3 H), 1.54 (t, <i>J</i> = 7.0 Hz, 2 H), 1.26 (t, <i>J</i> = 7.6 Hz, 3 H), 1.21 (t, <i>J</i> = 7.8 Hz, 3 H), 0.97 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 192.4, 172.8, 152.7, 147.6, 146.1, 137.4, 136.6, 136.4, 130.9, 130.5, 129.0, 127.2, 74.0, 70.2, 62.2, 43.5, 42.2, 38.6, 35.6, 30.2, 29.5, 27.9, 25.3, 22.9, 21.7, 16.4, 15.0, 14.9. LC–HRMS: <i>t</i><sub>R</sub> = 2.25 min, [M + H]/<i>z</i> = 516.2784, found = 516.2787.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-((<i>S</i>)-3-{2-Ethyl-4-[5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)[1,2,4]oxadiazol-3-yl]-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>42</b>)</h3><div class="NLM_p">(a) To a solution of <b>10</b> (2.00 g, 8.39 mmol) in DMF (25 mL) Hünig’s base (2.17 g, 16.8 mmol) followed by TBTU (2.96 g, 9.23 mmol) is added. The mixture is stirred at room temperature for 10 min before 3-ethyl-4,<i>N</i>-dihydroxy-5-methylbenzamidine (1.63 g, 8.39 mmol, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) is added. Stirring is continued at room temperature for 18 h. The mixture is diluted with EA and washed with water. The organic extract is dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue is dissolved in dioxane (20 mL) and stirred under reflux for 20 h. The mixture is cooled to room temperature and concentrated, and the crude product is purified by CC on silica gel, eluting with heptane/EA 9:1 to give 2-ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenol (2.36 g, 71%) as a yellow solid. LC–MS: <i>t</i><sub>R</sub> = 1.16 min, [M + 1] = 396.16. <sup>1</sup>H NMR (CDCl<sub>3</sub>: δ 7.82 (s, 2 H), 7.28 (s, 1 H), 4.99 (s, 1 H), 3.17 (t, <i>J</i> = 6.8 Hz, 2 H), 2.80 (q, <i>J</i> = 7.5 Hz, 2 H), 2.72 (q, <i>J</i> = 7.6 Hz, 2 H), 2.38 (s, 2 H), 2.35 (s, 3 H), 1.66 (t, <i>J</i> = 6.7 Hz, 2 H), 1.33 (t, <i>J</i> = 7.5 Hz, 3 H), 1.32 (t, <i>J</i> = 7.3 Hz, 3 H).</div><div class="NLM_p last">(b) The title compound is then prepared from the above phenol following the procedures described for compounds <b>3</b> and <b>29</b>, giving a white solid. LC–MS: <i>t</i><sub>R</sub> = 1.05 min, [M + 1] = 528.23. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.85 (s, 1 H), 7.84 (s, 1 H), 7.08 (t br, <i>J</i> = 5.8 Hz, 1 H), 4.18–4.24 (m, 3 H), 3.90 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 4.6 Hz, 1 H), 3.76–3.86 (m, 2 H), 3.48–3.56 (m, 1 H), 3.16 (t, <i>J</i> = 6.7 Hz, 2 H), 2.80 (q, <i>J</i> = 7.5 Hz, 3 H), 2.74 (q, <i>J</i> = 7.5 Hz, 2 H), 2.38 (s, 5 H), 1.66 (t, <i>J</i> = 6.7 Hz, 2 H), 1.33 (t, <i>J</i> = 7.5 Hz, 3 H), 1.31 (t, <i>J</i> = 7.5 Hz, 3 H), 1.04 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 173.3, 172.2, 168.0, 157.0, 147.7, 144.7, 137.4, 135.7, 131.4, 128.4, 126.7, 123.1, 115.2, 74.1, 70.1, 62.2, 42.3, 38.5, 35.4, 29.6, 27.9, 24.3, 22.9, 21.6, 16.5, 14.91, 14.87. LC–HRMS: <i>t</i><sub>R</sub> = 2.47 min, [M + H]/<i>z</i> = 528.2532, found = 528.2523.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>rac</i>-2-Hydroxy-<i>N</i>-(2-hydroxy-3-{4-[5-(5-isobutylthiophen-2-yl)[1,2,4]oxadiazol-3-yl]-2,6-dimethylphenoxy}propyl)acetamide (<b>87</b>)</h3><div class="NLM_p last"><b>87</b> was prepared in analogy to <b>42</b> using <b>102</b>, giving a white solid. LC–MS: <i>t</i><sub>R</sub> = 1.01 min, [M + 1] = 460.18. <sup>1</sup>H NMR δ: 7.83 (s, 2 H), 7.80 (d, <i>J</i> = 3.7 Hz, 1 H), 7.00 (t br, <i>J</i> = 6.5 Hz, 1 H), 6.90 (d, <i>J</i> = 3.7 Hz, 1 H), 4.17–4.25 (m, 3 H), 3.90 (dd, <i>J</i><sub>1</sub> = 9.5 Hz, <i>J</i><sub>2</sub> = 4.5 Hz, 1 H), 3.83 (dd, <i>J</i><sub>1</sub> = 9.5 Hz, <i>J</i><sub>2</sub> = 6.3 Hz, 1 H), 3.76–3.83 (m, 1 H), 3.48–3.57 (m, 1 H), 2.79 (d, <i>J</i> = 7.1 Hz, 2 H), 2.37 (s, 6 H), 1.93–2.05 (m, 1 H), 1.01 (d, <i>J</i> = 6.6 Hz, 6 H). LC–HRMS: <i>t</i><sub>R</sub> = 1.45 min, [M + H]/<i>z</i> = 460.1906, found = 460.1909.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>S</i>)-3-(2-Ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)propane-1,2-diol (<b>104</b>)</h3><div class="NLM_p last">To a solution of 3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic acid <b>10</b> (200 mg, 0.839 mmol) in DMF (5 mL) DIPEA (217 mg, 1.68 mmol) followed by TBTU (296 mg, 0.923 mmol) is added. The mixture is stirred at room temperature for 10 min before (<i>R</i>)-4-(2,2-dimethyl[1,3]dioxolan-4-ylmethoxy)-3-ethyl-<i>N</i>-hydroxy-5-methylbenzamidine (259 mg, 0.839 mmol) is added. Stirring is continued at room temperature for 1 h. The mixture is diluted with EA (100 mL), washed with water (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated. The remaining residue is dissolved in dioxane (10 mL), and the mixture is stirred at 80 °C for 18 h, then at 100 °C for 48 h. The mixture is concentrated, and the crude product is purified on preparative TLC plates using heptane/EA 9:1 to give (<i>R</i>)-3-(4-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-3-ethyl-5-methylphenyl)-5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazole (217 mg, 51%) as a pale beige resin. LC–MS: <i>t</i><sub>R</sub> = 1.25 min, [M + 1] = 511.27. This material is dissolved in 4 M HCl in dioxane (10 mL), and the mixture is stirred at room temperature for 18 h. The solvent is removed in vacuo and the crude product is purified by preparative HPLC to give the title compound <b>104</b> (160 mg, 80%). LC–MS: <i>t</i><sub>R</sub> = 1.10 min, [M + 1] = 471.28. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.86 (s, 1 H), 7.85 (s, 1 H), 4.13–4.20 (m, 1 H), 3.82–3.99 (m, 4 H), 3.17 (t, <i>J</i> = 6.7 Hz, 2 H), 2.80 (q, <i>J</i> = 7.5 Hz, 2 H), 2.76 (q, <i>J</i> = 7.8 Hz, 2 H), 2.40 (s, 3 H), 2.38 (s, 2 H), 2.10 (s br, 1 H), 1.67 (t, <i>J</i> = 6.7 Hz, 2 H), 1.34 (t, <i>J</i> = 7.8 Hz, 3 H), 1.32 (t, <i>J</i> = 7.0 Hz, 3 H), 1.05 (s, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 172.2, 168.1, 157.0, 147.7, 144.6, 137.5, 135.7, 131.5, 128.4, 126.7, 123.2, 115.2, 73.9, 71.0, 63.8, 38.5, 35.5, 29.6, 27.9, 24.3, 22.9, 21.6, 16.4, 14.9. LC–HRMS: <i>t</i><sub>R</sub> = 1.80 min, [M + H]/<i>z</i> = 471.2318, found = 471.2315.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(2-Ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenyl)propanoic Acid (<b>105</b>)</h3><div class="NLM_p last">To a solution of 3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic acid <b>10</b> (2.00 g, 8.39 mmol) in DMF (20 mL) DIPEA (3.25 g, 25.2 mmol) followed by TBTU (2.83 g, 8.81 mmol) is added. The mixture is stirred at room temperature for 5 min before 3-[2-ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methylphenyl]propanoic acid (2.10 g, 8.39 mmol, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) is added. Stirring is continued at room temperature for 2 h. Water (50 mL) and saturated aqueous NaHCO<sub>3</sub> solution (50 mL) are added, and the mixture is extracted twice with EA (2 × 100 mL). The organic extracts are combined, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue is dissolved in dioxane (50 mL), and the mixture is stirred at 80 °C for 18 h. The solvent is evaporated and the crude product is purified by preparative HPLC to give the title compound <b>105</b> (2.85 g, 75%) as a white solid. LC–MS: <i>t</i><sub>R</sub> = 1.14 min, [M + 1] = 453.13. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.28 (s br, 1 H), 7.69 (s, 1 H), 7.69 (s, 1 H), 3.07 (t, <i>J</i> = 6.6 Hz, 2 H), 2.90–2.96 (m, 2 H), 2.80 (q, <i>J</i> = 7.4 Hz, 2 H), 2.72 (q, <i>J</i> = 7.5 Hz, 2 H), 2.36–2.42 (m, 7 H), 1.62 (t, <i>J</i> = 6.6 Hz, 2 H), 1.25 (t, <i>J</i> = 7.5 Hz, 3 H), 1.22 (t, <i>J</i> = 7.5 Hz, 3 H), 0.99 (s, 6 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 174.2, 171.9, 168.1, 148.2, 144.9, 143.3, 141.2, 137.7, 136.3, 127.0, 125.3, 124.4, 114.6, 38.2, 35.1, 34.0, 29.7, 28.0, 25.7, 24.6, 24.3, 21.4, 19.9, 16.1, 15.2. LC–HRMS: <i>t</i><sub>R</sub> = 1.85 min, [M + H]/<i>z</i> = 453.2212, found = 453.2209.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-((2-(2-Ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)ethyl)amino)propanoic Acid (<b>106</b>)</h3><div class="NLM_p">(a) To a solution of 2-ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenol (1.60 g, 4.03 mmol) in isopropanol (100 mL) and 3 M aqueous NaOH (40 mL) 2-bromoethanol (2.02 g, 16.1 mmol) is added, and the mixture is stirred at 65 °C for 18 h. Another portion of 2-bromoethanol (2.02 g, 16.1 mmol) is added, and stirring is continued at 65 °C for 48 h. The mixture is diluted with EA (250 mL) and washed with water (100 mL). The organic extract is dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product is purified by CC on silica gel, eluting with heptane/EA to give 2-(2-ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)ethanol (1.15 g, 65%) as a beige oil. LC–MS: <i>t</i><sub>R</sub> = 1.15 min, [M + 1] = 440.94.</div><div class="NLM_p last">(b) To a solution of 2-(2-ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)ethanol (1.10 g, 2.50 mmol) in DCM triethylamine (354 mg, 3.50 mmol) is added. The mixture is cooled to 0 °C before methanesulfonyl chloride (343 mg, 3.00 mmol) is added. The mixture is stirred at 0 °C for 1 h, then at room temperature for 2 h before it is diluted with DCM (50 mL), washed with H<sub>2</sub>O (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give a crude mesylate intermediate (1.46 g, quantitative). LC–MS: <i>t</i><sub>R</sub> = 1.14 min, [M + 1] = 511.99. This material is added to a solution of β-alanine methyl ester obtained by filtering a solution of the corresponding hydrochloride salt (471 mg, 3.37 mmol) in acetonitrile over Dowex Marathon ion-exchange resin (4 g, OH form). Triethylamine (49 mg, 0.482 mmol) is added, and the mixture is stirred at 80 °C for 96 h in a sealed vessel. The mixture is concentrated and the crude product is purified by preparative HPLC to give methyl 3-((2-(2-ethyl-4-(5-(3-ethyl-5,5-dimethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)-6-methylphenoxy)ethyl)amino)propanoate which is dissolved in THF (5 mL), methanol (4 mL), and 3 M aqueous NaOH (1 mL). The mixture is stirred at room temperature for 8 h. The mixture is diluted with water acidified with aqueous HCl and extracted twice with DCM (2 × 50 mL). The organic extracts are washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated, and dried to give the title compound <b>106</b> (115 mg, 47%) as a colorless resin. LC–MS: <i>t</i><sub>R</sub> = 0.92 min, [M + 1] = 512.05. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.41 (s br, 2 H), 7.78 (s, 1 H), 7.74 (s, 1 H), 4.26 (t, <i>J</i> = 4.8 Hz, 2 H), 3.44–3.61 (m, 4 H), 3.08–3.20 (m, 4 H), 2.79 (q, <i>J</i> = 7.5 Hz, 2 H), 2.71 (q, <i>J</i> = 7.4 Hz, 2 H), 2.37–2.44 (m, 2 H), 2.36 (s, 2 H), 2.35 (s, 3 H), 1.65 (t, <i>J</i> = 6.8 Hz, 2 H), 1.32 (t, <i>J</i> = 7.5 Hz, 3 H), 1.29 (t, <i>J</i> = 8.0 Hz, 3 H), 1.04 (s, 6 H). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.76 (s, 2 H), 4.09 (t, <i>J</i> = 4.5 Hz, 2 H), 3.27 (t, <i>J</i> = 7.0 Hz, 2 H), 3.06 (t, <i>J</i> = 6.5 Hz, 2 H), 2.70–2.84 (m, 6 H), 2.38 (s, 5 H), 1.61 (t, <i>J</i> = 6.5 Hz, 2 H), 1.25 (t, <i>J</i> = 7.5 Hz, 3 H), 1.24 (t, <i>J</i> = 7.5 Hz, 3 H), 0.99 (s, 6 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 172.4, 172.0, 167.8, 157.3, 148.3, 145.1, 138.1, 136.4, 132.4, 128.3, 126.4, 122.9, 114.5, 68.3, 47.4, 43.6, 38.2, 35.1, 30.9, 29.7, 28.0, 24.3, 22.6, 21.4, 16.7, 15.3, 15.2. LC–HRMS: <i>t</i><sub>R</sub> = 1.35 min, [M + H]/<i>z</i> = 512.2583, found = 512.2584.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/jm401456d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details on the synthesis and characterization of all target compounds and intermediates not described in the main text. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401456d/suppl_file/jm401456d_si_001.pdf">jm401456d_si_001.pdf (602.16 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401456d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin H. Bolli</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9d4d8cbcdd0d797dbd6d5d5d0f9d8dacddcd5d0d6d797dad6d4"><span class="__cf_email__" data-cfemail="5835392a2c3136763a3734343118393b2c3d34313736763b3735">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Velker</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claus Müller</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Mathys</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magdalena Birker</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Bravo</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bur</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben de Kanter</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Hess</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Kohl</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Lehmann</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Solange Meyer</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Nayler</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Rey</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Scherz</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beat Steiner</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d350e5041-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors gratefully acknowledge their colleagues Stefan Abele, Céline Bortolamiol, Maxime Boucher, Stéphane Delahaye, Patrick Dörrwächter, Fabienne Drouet, Alexandre Flock, Julien Grimont, Hakim Hadana, Julie Hoerner, Benedikt Hofstetter, Heidemarie Kletzl, François LeGoff, Claire Maciejasz, Céline Mangold, Katalin Menyhart, Matthias Merrettig, Christine Metzger, Michel Rauser, Gunther Schmidt, Christine Seeger, Jürgen Seifert, Virginie Sippel, Mireille Tena Stern, Marco Tschanz, Gaby von Aesch, Daniel Wanner, Aude Weigel, and Rolf Wüst for the excellent work done and Martine Clozel and Thomas Weller for support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i50" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i50"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i51" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i51"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">BuLi</td><td class="NLM_def"><p class="first last">butyllithium</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarbocylate</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">HV</td><td class="NLM_def"><p class="first last">high vacuum</p></td></tr><tr><td class="NLM_term">LC</td><td class="NLM_def"><p class="first last">lymphocyte count</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropylamide</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 107 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verin, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersto, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrest, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span> </span><span class="NLM_article-title">Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1165%2Fajrcmb.24.6.4323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11415936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVWhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=711-719&author=F.+Liuauthor=A.+D.+Verinauthor=P.+Wangauthor=R.+Dayauthor=R.+P.+Werstoauthor=F.+J.+Chrestauthor=D.+K.+Englishauthor=J.+G.+N.+Garcia&title=Differential+regulation+of+sphingosine-1-phosphate-+and+VEGF-induced+endothelial+cell+chemotaxis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis: involvement of Giα2-linked Rho kinase activity</span></div><div class="casAuthors">Liu, Feng; Verin, Alexander D.; Wang, Peiyi; Day, Regina; Wersto, Robert P.; Chrest, Francis J.; English, Denis K.; Garcia, Joe G. N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">711-719</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">The authors compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor.  S1P-induced endothelial cell migration was max. at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/mL) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase).  Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification.  These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling.  Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/neg. Rho, or the addn. of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration.  Conversely, pharmacol. inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3' kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration.  Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration.  These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-assocd. kinase and p38 MAP kinase activation.  The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdSiUsOQr0MrVg90H21EOLACvtfcHk0lira6k1n43D8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVWhsbc%253D&md5=57d11f81a89e65e37a4a05db38386606</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.24.6.4323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.24.6.4323%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DVerin%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DDay%26aufirst%3DR.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DChrest%26aufirst%3DF.%2BJ.%26aulast%3DEnglish%26aufirst%3DD.%2BK.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26atitle%3DDifferential%2520regulation%2520of%2520sphingosine-1-phosphate-%2520and%2520VEGF-induced%2520endothelial%2520cell%2520chemotaxis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2001%26volume%3D24%26spage%3D711%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase, sphingosine-1-phosphate, and apoptosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1585</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1585&publication_year=2002&pages=193-201&author=M.+Maceykaauthor=S.+G.+Payneauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+kinase%2C+sphingosine-1-phosphate%2C+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DPayne%26aufirst%3DS.%2BG.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252C%2520sphingosine-1-phosphate%252C%2520and%2520apoptosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1585%26spage%3D193%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Graeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1874</span><span class="NLM_x">–</span> <span class="NLM_lpage">1878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1874-1878&author=M.+Graelerauthor=E.+J.+Goetzl&title=Activation-regulated+expression+and+chemotactic+function+of+sphingosine+1-phosphate+receptors+in+mouse+splenic+T+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraeler%26aufirst%3DM.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DActivation-regulated%2520expression%2520and%2520chemotactic%2520function%2520of%2520sphingosine%25201-phosphate%2520receptors%2520in%2520mouse%2520splenic%2520T%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2002%26volume%3D16%26spage%3D1874%26epage%3D1878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dorsam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroogy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voice, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P<sub>1</sub> G protein-coupled receptor</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3500</span><span class="NLM_x">–</span> <span class="NLM_lpage">3507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2003&pages=3500-3507&author=G.+Dorsamauthor=M.+H.+Graelerauthor=C.+Seroogyauthor=Y.+Kongauthor=J.+K.+Voiceauthor=E.+J.+Goetzl&title=Transduction+of+multiple+effects+of+sphingosine+1-phosphate+%28S1P%29+on+T+cell+functions+by+the+S1P1+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDorsam%26aufirst%3DG.%26aulast%3DGraeler%26aufirst%3DM.%2BH.%26aulast%3DSeroogy%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DVoice%26aufirst%3DJ.%2BK.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DTransduction%2520of%2520multiple%2520effects%2520of%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520on%2520T%2520cell%2520functions%2520by%2520the%2520S1P1%2520G%2520protein-coupled%2520receptor%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D171%26spage%3D3500%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Sphingolipids in cell signalling: their function as receptor ligands, second messengers, and raft constituents</span> <span class="citation_source-journal">Curr. Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.2174%2F157339506775471929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=101-118&author=T.+Baumrukerauthor=A.+Billich&title=Sphingolipids+in+cell+signalling%3A+their+function+as+receptor+ligands%2C+second+messengers%2C+and+raft+constituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in cell signaling: their function as receptor ligands, second messengers, and raft constituents</span></div><div class="casAuthors">Baumruker, Thomas; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Current Immunology Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-118</span>CODEN:
                <span class="NLM_cas:coden">CIRUBM</span>;
        ISSN:<span class="NLM_cas:issn">1573-3955</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids have lately been recognized as important signaling mols. with an unexpected multitude of actions and mechanisms.  While we are currently just uncovering the tip of the iceberg, the available data give us an unprecedented understanding of how membrane rearrangements translate into the generation of intracellular lipid signaling mols. and further into secreted bioactive lipids.  Furthermore, new concepts such as the rheostat of sphingolipids show that fundamental principles in signaling also do apply to this class of mols.  The plethora of sphingolipids as well as sphingolipid modifying enzymes seem to comprise many novel, attractive, and pharmaceutically exploitable targets beyond sphingolipidoses, in applications ranging from autoimmune diseases and neurodegenerative conditions to cancer.  In this review, we summarize the mechanistic triad of action of sphingolipids as membrane/raft components, intracellular signaling mols., and secreted mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfFRnNDDtK57Vg90H21EOLACvtfcHk0lhcpA3SPNroDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGks7g%253D&md5=9d05be8584cab71d6671ff33079a7b50</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F157339506775471929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157339506775471929%26sid%3Dliteratum%253Aachs%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DSphingolipids%2520in%2520cell%2520signalling%253A%2520their%2520function%2520as%2520receptor%2520ligands%252C%2520second%2520messengers%252C%2520and%2520raft%2520constituents%26jtitle%3DCurr.%2520Immunol.%2520Rev.%26date%3D2006%26volume%3D2%26spage%3D101%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsutake, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.plipres.2007.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17449104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksleksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=126-144&author=A.+Kiharaauthor=S.+Mitsutakeauthor=Y.+Mizutaniauthor=Y.+Igarashi&title=Metabolism+and+biological+functions+of+two+phosphorylated+sphingolipids%2C+sphingosine+1-phosphate+and+ceramide+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate</span></div><div class="casAuthors">Kihara, Akio; Mitsutake, Susumu; Mizutani, Yukiko; Igarashi, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-144</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are major lipid constituents of the eukaryotic plasma membrane.  Without certain sphingolipids, cells and/or embryos cannot survive, indicating that sphingolipids possess important physiol. functions that are not substituted for by other lipids.  One such role may be signaling.  Recent studies have revealed that some sphingolipid metabolites, such as long-chain bases (LCBs; sphingosine (Sph) in mammals), long-chain base 1-phosphates (LCBPs; sphingosine 1-phosphate (S1P) in mammals), ceramide (Cer), and ceramide 1-phosphate (C1P), act as signaling mols.  The addn. of phosphate groups to LCB/Sph and Cer generates LCBP/S1P and C1P, resp.  These phospholipids exhibit completely different functions than those of their precursors.  In this review, we describe recent advances in understanding the functions of LCBP/S1P and C1P in mammals and in the yeast Saccharomyces cerevisiae.  Since LCB/Sph, LCBP/S1P, Cer, and C1P are mutually convertible, regulation of not only the total amt. of the each lipid but also of the overall balance in cellular levels is important.  Therefore, we describe in detail their metabolic pathways, as well as the genes involved in each reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR2VCpyhKRq7Vg90H21EOLACvtfcHk0lhcpA3SPNroDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksleksbY%253D&md5=e34947eaf24710a0c332884f05d1085e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2007.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2007.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DA.%26aulast%3DMitsutake%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DY.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DMetabolism%2520and%2520biological%2520functions%2520of%2520two%2520phosphorylated%2520sphingolipids%252C%2520sphingosine%25201-phosphate%2520and%2520ceramide%25201-phosphate%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2007%26volume%3D46%26spage%3D126%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.pharmthera.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17561264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=84-105&author=V.+Brinkmann&title=Sphingosine+1-phosphate+receptors+in+health+and+disease%3A+mechanistic+insights+from+gene+deletion+studies+and+reverse+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-105</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid that is critically involved in the embryonic development of the cardiovascular and central nervous systems.  In the adult, S1P can produce cytoskeletal re-arrangements in many cell types to regulate immune cell trafficking, vascular homeostasis and cell communication in the central nervous system.  S1P is contained in body fluids and tissues at different concns., and excessive prodn. of the pleiotropic mediator at inflammatory sites may participate in various pathol. conditions.  Gene deletion studies and reverse pharmacol. (techniques aiming to identify both ligands and function of receptors) provided evidence that many effects of S1P are mediated via five G-protein-coupled S1P receptor subtypes, and novel therapeutic strategies based on interaction with these receptors are being initiated.  The prototype S1P receptor modulator, FTY720 (fingolimod), targets four of the five S1P receptor subtypes and may act at several levels to modulate lymphocyte trafficking via lymphocytic and endothelial S1P1 and, perhaps, other inflammatory processes through addnl. S1P receptor subtypes.  A recently completed Phase II clin. trial suggested that the drug may provide an effective treatment of relapsing-remitting multiple sclerosis.  FTY720 is currently being evaluated in larger-scale, longer-term, Phase III studies.  This review provides an overview on S1P activities and S1P receptor function in health and disease, and summarizes the clin. experience with FTY720 in transplantation and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbwKhZo2vLrVg90H21EOLACvtfcHk0lhao_8qhqFt8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D&md5=cacdb374439270734f34a0ca4771ca3d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DSphingosine%25201-phosphate%2520receptors%2520in%2520health%2520and%2520disease%253A%2520mechanistic%2520insights%2520from%2520gene%2520deletion%2520studies%2520and%2520reverse%2520pharmacology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D84%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hisano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawahara, A.</span><span> </span><span class="NLM_article-title">The functional roles of S1P in immunity</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1093%2Fjb%2Fmvs090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A280%3ADC%252BC38bhsVakug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2012&pages=305-311&author=Y.+Hisanoauthor=T.+Nishiauthor=A.+Kawahara&title=The+functional+roles+of+S1P+in+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The functional roles of S1P in immunity</span></div><div class="casAuthors">Hisano Yu; Nishi Tsuyoshi; Kawahara Atsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The lipid mediator sphingosine-1-phosphate (S1P) is generated within cells from sphingosine by two sphingosine kinases (SPHK1 and SPHK2).  Intracellularly synthesized S1P is released into the extracellular fluid by S1P transporters, including SPNS2.  Released S1P binds specifically to the G protein-coupled S1P receptors (S1PR1/S1P(1)-S1PR5/S1P(5)), which activate a diverse range of downstream signalling pathways.  Recent studies have proposed that one of the central physiological functions of intercellular S1P signalling is in lymphocyte trafficking in vivo because genetic disruption of SPHK1/2, SPNS2 or S1PR1/S1P(1) in mice induces a lymphopenia phenotype.  In this review, we discuss the current understanding of intercellular S1P signalling in the context of immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTNG8hBgzHx79KldV63DuefW6udTcc2eY9gR0amQUr67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bhsVakug%253D%253D&md5=0518eb05299bad2c3c7ee19c2df05f03</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvs090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvs090%26sid%3Dliteratum%253Aachs%26aulast%3DHisano%26aufirst%3DY.%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DKawahara%26aufirst%3DA.%26atitle%3DThe%2520functional%2520roles%2520of%2520S1P%2520in%2520immunity%26jtitle%3DJ.%2520Biochem.%26date%3D2012%26volume%3D152%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=265-269&author=J.+Chunauthor=E.+J.+Goetzlauthor=T.+Hlaauthor=Y.+Igarashiauthor=K.+R.+Lynchauthor=W.+Moolenaarauthor=S.+Pyneauthor=G.+Tigyi&title=International+Union+of+Pharmacology.+XXXIV.+Lysophospholipid+receptor+nomenclature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMoolenaar%26aufirst%3DW.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXXIV.%2520Lysophospholipid%2520receptor%2520nomenclature%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D265%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ishii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptors: signaling and biology</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1146%2Fannurev.biochem.73.011303.073731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15189145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=321-354&author=I.+Ishiiauthor=N.+Fukushimaauthor=X.+Yeauthor=J.+Chun&title=Lysophospholipid+receptors%3A+signaling+and+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptors: Signaling and biology</span></div><div class="casAuthors">Ishii, Isao; Fukushima, Nobuyuki; Ye, Xiaoqin; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321-354</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophospholipids (LPs), such as lysophosphatidic acid and sphingosine 1-phosphate, are membrane-derived bioactive lipid mediators.  LPs can affect fundamental cellular functions, which include proliferation, differentiation, survival, migration, adhesion, invasion, and morphogenesis.  These functions influence many biol. processes that include neurogenesis, angiogenesis, wound healing, immunity, and carcinogenesis.  In recent years, identification of multiple cognate G protein-coupled receptors has provided a mechanistic framework for understanding how LPs play such diverse roles.  Generation of LP receptor-null animals has allowed rigorous examn. of receptor-mediated physiol. functions in vivo and has identified new functions for LP receptor signaling.  Efforts to develop LP receptor subtype-specific agonists/antagonists are in progress and raise expectations for a growing collection of chem. tools and potential therapeutic compds.  The rapidly expanding literature on the LP receptors is herein reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJpFGxhumTLVg90H21EOLACvtfcHk0lhao_8qhqFt8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslags7g%253D&md5=0bb52f19cf0e1ec7f19bc8aa3f0b01a5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073731%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DI.%26aulast%3DFukushima%26aufirst%3DN.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520receptors%253A%2520signaling%2520and%2520biology%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D321%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnri1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15999095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=560-570&author=H.+Rosenauthor=E.+J.+Goetzl&title=Sphingosine+1-phosphate+and+its+receptors%3A+an+autocrine+and+paracrine+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span></div><div class="casAuthors">Rosen, Hugh; Goetzl, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a biol. active lysophospholipid that transmits signals through a family of G-protein-coupled receptors to control cellular differentiation and survival, as well as the vital functions of several types of immune cell.  In this Review article, the authors discuss recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles.  In an autocrine manner, through interactions with different G-protein-coupled receptors, S1P also enhances optimal mast-cell migration and release of pro-inflammatory mediators in allergic reactions.  S1P-S1P-receptor regulatory systems might therefore be novel targets for the therapy of diverse immunol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-Zo0R14YILVg90H21EOLACvtfcHk0lgoGbZ-6AdzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D&md5=b680f6c9e29d407579ab7f056209d853</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnri1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1650%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520its%2520receptors%253A%2520an%2520autocrine%2520and%2520paracrine%2520network%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D560%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Meyer-zu-Heringdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobs, K. H.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2006&pages=923-940&author=D.+Meyer-zu-Heringdorfauthor=K.+H.+Jakobs&title=Lysophospholipid+receptors%3A+signalling%2C+pharmacology+and+regulation+by+lysophospholipid+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer-zu-Heringdorf%26aufirst%3DD.%26aulast%3DJakobs%26aufirst%3DK.%2BH.%26atitle%3DLysophospholipid%2520receptors%253A%2520signalling%252C%2520pharmacology%2520and%2520regulation%2520by%2520lysophospholipid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1768%26spage%3D923%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gardell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubi, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Emerging medicinal roles for lysophospholipid signaling</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.molmed.2005.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16406843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=65-75&author=S.+E.+Gardellauthor=A.+E.+Dubiauthor=J.+Chun&title=Emerging+medicinal+roles+for+lysophospholipid+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging medicinal roles for lysophospholipid signaling</span></div><div class="casAuthors">Gardell, Shannon E.; Dubin, Adrienne E.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The two lysophospholipids (LPs) lysophosphatidic acid and sphingosine 1-phosphate (S1P) regulate diverse biol. processes.  Over the past decade, it has become clear that medically relevant LP activities are mediated by specific G protein-coupled receptors, implicating them in the etiol. of a growing no. of disorders.  A new class of LP agonists shows promise for drug therapy: the exptl. drug FTY720 is phosphorylated in vivo to produce a potent S1P receptor agonist (FTY720-P) and is currently in Phase III clin. trials for kidney transplantation and Phase II for multiple sclerosis.  Recent genetic and pharmacol. studies on LP signaling in animal disease models have identified new areas in which interventions in LP signaling might provide novel therapeutic approaches for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjqDlFdQXDbVg90H21EOLACvtfcHk0lgoGbZ-6AdzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaku7Y%253D&md5=f82bde20b880c86f6bf660ae73c9a0ec</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2005.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2005.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGardell%26aufirst%3DS.%2BE.%26aulast%3DDubi%26aufirst%3DA.%2BE.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DEmerging%2520medicinal%2520roles%2520for%2520lysophospholipid%2520signaling%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D65%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangeer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.cellsig.2008.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18694820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=7-13&author=T.+Okadaauthor=T.+Kajimotoauthor=S.+Jahangeerauthor=S.+Nakamura&title=Sphingosine+kinase%2Fsphingosine+1-phosphate+signalling+in+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span></div><div class="casAuthors">Okada, Taro; Kajimoto, Taketoshi; Jahangeer, Saleem; Nakamura, Shun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids were once regarded as inert structural components of cell membranes.  Now these metabolites are generally believed to be important bioactive mols. that control a wide repertoire of cellular processes such as proliferation and survival of cells.  Along with these ubiquitous cell functions obsd. in many peripheral tissues sphingolipid metabolites, esp. sphingosine 1-phosphate, exert important neuron-specific functions such as regulation of neurotransmitter release.  This review summarizes physiol. and pathol. roles of sphingolipid metabolites emphasizing the role of sphingosine 1-phosphate in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvd7-soq4atbVg90H21EOLACvtfcHk0lgoGbZ-6AdzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI&md5=99538d7efb7f9866723a691e4d05f877</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2008.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2008.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKajimoto%26aufirst%3DT.%26aulast%3DJahangeer%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520signalling%2520in%2520central%2520nervous%2520system%26jtitle%3DCell.%2520Signalling%26date%3D2009%26volume%3D21%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in neural signalling and function</span> <span class="citation_source-journal">Acta Paediatr., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=40-43&author=S.+Milstienauthor=D.+Gudeauthor=S.+Spiegel&title=Sphingosine+1-phosphate+in+neural+signalling+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520in%2520neural%2520signalling%2520and%2520function%26jtitle%3DActa%2520Paediatr.%252C%2520Suppl.%26date%3D2007%26volume%3D96%26spage%3D40%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.coph.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16563863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=244-250&author=V.+Brinkmannauthor=T.+Baumruker&title=Pulmonary+and+vascular+pharmacology+of+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span></div><div class="casAuthors">Brinkmann, Volker; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-250</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Dysregulation of vasomotor tone, endothelial barrier function and immune cell trafficking are central to the pathol. of many lung diseases, including acute lung injury, adult respiratory distress syndrome, chronic obstructive pulmonary disease and asthma.  There is increasing evidence that the serum sphingolipid sphingosine 1-phosphate and its G-protein-coupled receptors are pivotal not only in the regulation of lymphocyte migration, but also in the maintenance of vascular homeostasis and the preservation of permeability barriers that sep. discrete compartments in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogmZxjsblpVLVg90H21EOLACvtfcHk0ljz4iAAXTu0eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D&md5=6e55263d754e331bcfa5d82ddc3eed7a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPulmonary%2520and%2520vascular%2520pharmacology%2520of%2520sphingosine%25201-phosphate%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D244%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Uhlig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulbins, E.</span><span> </span><span class="NLM_article-title">Sphingolipids in the lungs</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1164%2Frccm.200804-595SO" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18755926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2008&pages=1100-1114&author=S.+Uhligauthor=E.+Gulbins&title=Sphingolipids+in+the+lungs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in the lungs</span></div><div class="casAuthors">Uhlig, Stefan; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1100-1114</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  Sphingolipids such as sphingosine-1-phosphate (S1P), ceramide, or sphingomyelin are essential constituents of plasma membranes and regulate many (patho)physiol. cellular responses inducing apoptosis and cell survival, vascular permeability, mast cell activation, and airway smooth muscle functions.  The complexity of sphingolipid biol. is generated by a great variety of compds., diverse receptors, and often antagonistic functions of different sphingolipids.  For instance, apoptosis is promoted by ceramide and prevented by S1P, and pulmonary vascular permeability is increased by S1P2/3 receptors and by ceramide, whereas S1P1 receptors stabilize barrier integrity.  Several enzymes of the sphingolipid metab. respond to external stimuli such as sphingomyelinase isoenzymes that are activated by many stress stimuli and the sphingosine kinase isoenzymes that are activated by allergens.  The past years have provided increasing evidence that these processes contribute to pulmonary disorders including asthma, chronic obstructive pulmonary disease, acute lung injury, and cystic fibrosis.  Sphingolipid metab. offers several novel therapeutic targets for the treatment of lung diseases such as emphysema, asthma, cystic fibrosis, respiratory tract infection, sepsis, and acute lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1c1qpC7wtVLVg90H21EOLACvtfcHk0ljz4iAAXTu0eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D&md5=b10c3ec2970d660c9f4acd57657ae380</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1164%2Frccm.200804-595SO&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200804-595SO%26sid%3Dliteratum%253Aachs%26aulast%3DUhlig%26aufirst%3DS.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DSphingolipids%2520in%2520the%2520lungs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2008%26volume%3D178%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Augé, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nègre-Salvayre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvayre, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span> </span><span class="NLM_article-title">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FS0163-7827%2800%2900007-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=10799716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=207-229&author=N.+Aug%C3%A9author=A.+N%C3%A8gre-Salvayreauthor=R.+Salvayreauthor=T.+Levade&title=Sphingomyelin+metabolites+in+vascular+cell+signaling+and+atherogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span></div><div class="casAuthors">Auge, Nathalie; Negre-Salvayre, Anne; Salvayre, Robert; Levade, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-229</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 186 refs.  The atherosclerotic lesion most probably develops through a no. of cellular events which implicate all vascular cell types and include synthesis of extracellular proteins, cell proliferation, differentiation and death.  Sphingolipids and sphingolipid metabolizing enzymes may play important roles in atherogenesis, not only because of lipoprotein alterations but also by mediating a no. of cellular events which are believed to be crucial in the development of the vascular lesions such as proliferation or cell death.  Exogenous sphingolipids may mediate various biol. effects such as apoptosis, mitogenesis or differentiation depending on the cell type.  Moreover, several mols. present in the atherogenic lesion, such as oxidized LDL, growth factors or cytokines, which activate intracellular signaling pathways leading to vascular cell modifications, can stimulate sphingomyelin hydrolysis and generation of ceramide (and other metabolites as sphingosine-1-phosphate).  Here we review the potential implication of the sphingomyelin/ceramide cycle in vascular cell signaling related to atherosclerosis, and more generally the role of sphingolipids in the events obsd. during the atherosclerotic process as cell differentiation, migration, adhesion, retraction, proliferation and death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR0eHtIWIEnrVg90H21EOLACvtfcHk0ljz4iAAXTu0eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D&md5=bc3809c124061cac95443445af340377</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0163-7827%2800%2900007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7827%252800%252900007-2%26sid%3Dliteratum%253Aachs%26aulast%3DAug%25C3%25A9%26aufirst%3DN.%26aulast%3DN%25C3%25A8gre-Salvayre%26aufirst%3DA.%26aulast%3DSalvayre%26aufirst%3DR.%26aulast%3DLevade%26aufirst%3DT.%26atitle%3DSphingomyelin%2520metabolites%2520in%2520vascular%2520cell%2520signaling%2520and%2520atherogenesis%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2000%26volume%3D39%26spage%3D207%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span> </span><span class="NLM_article-title">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fsj.bjp.0705934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15504747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=666-684&author=A.+E.+Alewijnseauthor=S.+L.+M.+Petersauthor=M.+C.+Michel&title=Cardiovascular+effects+of+sphingosine-1-phosphate+and+other+sphingomyelin+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.; Michel, Martin C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-684</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Upon various stimuli, cells metabolize sphingomyelin from the cellular plasma membrane to form sphingosylphosphorylcholine (SPC) or ceramide.  The latter can be further metabolized to sphingosine and then sphingosine-1-phosphate (S1P).  Apart from local formation, S1P and SPC are major constituents of blood plasma.  All four sphingomyelin metabolites (SMM) can act upon intracellular targets, and at least S1P and probably also SPC can addnl. act upon G-protein-coupled receptors.  While the mol. identity of the SPC receptors remains unclear, several subtypes of S1P receptors have been cloned and their distribution in cardiovascular tissues is described.  In the heart SMM can alter intracellular Ca2+ release, particularly via the ryanodine receptor, and conductance of various ion channels in the plasma membrane, particularly IK(Ach).  While the various SMM differ somewhat in their effects, the above alterations of ion homeostasis result in reduced cardiac function in most cases, and ceramide and/or sphingosine may be the mediators of the neg. inotropic effects of tumor necrosis factor.  In the vasculature, SMM mainly act as acute vasoconstrictors in most vessels, but ceramide can be a vasodilator.  SMM-induced vasoconstriction involves mobilization of Ca2+ from intracellular stores, influx of extracellular Ca2+ via L-type channels and activation of a rho-kinase.  Extended exposure to SMM, particularly S1P, promotes several stages of the angiogenic process like endothelial cell activation, migration, proliferation, tube formation and vascular maturation.  The authors propose that SMM are an important class of endogenous modulators of cardiovascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm47o1k_ITeLVg90H21EOLACvtfcHk0ljz4iAAXTu0eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN&md5=b1f804471e653a56ad6794fd5092803f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705934%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26atitle%3DCardiovascular%2520effects%2520of%2520sphingosine-1-phosphate%2520and%2520other%2520sphingomyelin%2520metabolites%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D666%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McVerry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span> </span><span class="NLM_article-title">In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.cellsig.2004.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15494205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=131-139&author=B.+J.+McVerryauthor=J.+G.+N.+Garcia&title=In+vitro+and+in+vivo+modulation+of+vascular+barrier+integrity+by+sphingosine+1-phosphate%3A+mechanistic+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights</span></div><div class="casAuthors">McVerry, Bryan J.; Garcia, Joe G. N.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P), a biol. active lipid growth factor, induces robust endothelial cell activation resulting in cellular locomotion, vascular maturation and angiogenesis.  Recent work by our lab. has demonstrated S1P to enhance the cellular barrier function of the vascular endothelium.  S1P-induced modulation of vascular permeability is effected through profound cytoskeletal reorganization initiated by cell surface receptor-mediated G protein activation and downstream signaling via the Rho family of small GTPases.  The details of the downstream signaling mechanism remain an active area of in vitro investigation.  Translational investigation suggests a profound impact of S1P administration in the modulation of edema formation in disease state manifest as acute inflammatory lung injury in which increased vascular permeability is a hallmark feature.  These data support an exciting potential therapeutic role for S1P in vascular barrier enhancement necessary for the treatment of critically ill patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4F51YD2iELLVg90H21EOLACvtfcHk0lgVbvbXwyqgww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D&md5=4d45ffb844dbe0853e55fb0a92a9b409</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DMcVerry%26aufirst%3DB.%2BJ.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520modulation%2520of%2520vascular%2520barrier%2520integrity%2520by%2520sphingosine%25201-phosphate%253A%2520mechanistic%2520insights%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yatomi, Y.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular disease</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.2174%2F138161206775474404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16472149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=575-587&author=Y.+Yatomi&title=Sphingosine+1-phosphate+in+vascular+biology%3A+possible+therapeutic+strategies+to+control+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases</span></div><div class="casAuthors">Yatomi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-587</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Blood platelets are very unique in that they store sphingosine 1-phosphate (Sph-1-P) abundantly (possibly due to the existence of highly active sphingosine kinase and a lack of Sph-1-P lyase) and release this bioactive lipid extracellularly upon stimulation.  Vascular endothelial cells (ECs) and smooth muscle cells (SMCs) respond dramatically to this platelet-derived bioactive lipid mainly through a family of G protein-coupled Sph-1-P receptors named S1P1, 2, 3, 4, and 5, originally referred to as EDG-1, 5, 3, 6, and 8, resp.  In fact, the importance of Sph-1-P in platelet-vascular cell interactions has been revealed in a no. of recent reports.  Through interaction with ECs, Sph-1-P can mediate physiol. wound healing processes such as vascular repair, although this important bioactive lipid can become atherogenic and thrombogenic, and cause or aggravate cardiovascular diseases esp. under certain pathol. conditions.  Sph-1-P induces vasoconstriction through interaction with SMCs.  It is likely that regulation of Sph-1-P biol. activities is important for the therapeutical purpose to control vascular disorders.  Particularly, the development of specific S1P receptor agonists or antagonists seems a reasonable strategy to selectively regulate the bioactivity of Sph-1-P, considering that a great diversity of Sph-1-P actions has been reported and that this diversity depends mainly on the S1P receptor subtype involved.  In this review, I will summarize recent findings on possible roles of Sph-1-P in vascular biol. and its therapeutical implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTzHZO1dz1pLVg90H21EOLACvtfcHk0lgVbvbXwyqgww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D&md5=8aaf620c15964f6b5a4db05df0f9c042</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F138161206775474404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474404%26sid%3Dliteratum%253Aachs%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DSphingosine%25201-phosphate%2520in%2520vascular%2520biology%253A%2520possible%2520therapeutic%2520strategies%2520to%2520control%2520vascular%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D575%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span> </span><span class="NLM_article-title">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.it.2007.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17276731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=102-107&author=H.+Rosenauthor=M.+G.+Sannaauthor=S.+M.+Cahalanauthor=P.+J.+Gonzalez-Cabrera&title=Tipping+the+gatekeeper%3A+S1P+regulation+of+endothelial+barrier+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span></div><div class="casAuthors">Rosen, Hugh; Sanna, M. Germana; Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The lysophospholipid sphingosine 1-phosphate (S1P) is a pleiotropic signaling lipid present constitutively in plasma, and secreted locally at elevated concns. at sites of inflammation.  S1P maintains essential variable homeostatic functions in addn. to inducing pathophysiol. through the activation of five specific high-affinity G-protein-coupled receptors.  Therefore, S1P can function as an extracellular rheostat regulating tonic and acutely evoked functions.  Although S1P receptors can regulate lymphoid development and lymphocyte trafficking, and different opinions exist on the roles of receptor agonism and functional antagonism in regulating lymphocyte recirculation, this personal perspective highlights the pivotal control points regulated by constitutive and induced S1P receptor tone at vascular endothelial and lymphatic endothelial barriers, through which S1P agonism impacts on both innate and adaptive immunity.  The authors also emphasize how specific, proof-of-concept chem. tools complement genetic approaches by enabling reversible perturbation of the S1P-S1P1 receptor axis and, thus, clarifying in vivo mechanisms in the absence of developmental compensations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5AFhhSUSlLVg90H21EOLACvtfcHk0lgVbvbXwyqgww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D&md5=2ccb920fd60591f904189b7e69597a99</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2007.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2007.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26atitle%3DTipping%2520the%2520gatekeeper%253A%2520S1P%2520regulation%2520of%2520endothelial%2520barrier%2520function%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26spage%3D102%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulders, A. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongsma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Vascular effects of sphingolipids</span> <span class="citation_source-journal">Acta Paediatr., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=44-48&author=M.+C.+Michelauthor=A.+C.+M.+Muldersauthor=M.+Jongsmaauthor=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Vascular+effects+of+sphingolipids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DMulders%26aufirst%3DA.%2BC.%2BM.%26aulast%3DJongsma%26aufirst%3DM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DVascular%2520effects%2520of%2520sphingolipids%26jtitle%3DActa%2520Paediatr.%252C%2520Suppl.%26date%3D2007%26volume%3D96%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Sphingolipid signalling in the cardiovascular system: good, bad or both?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.ejphar.2008.02.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18420192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2008&pages=292-302&author=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Sphingolipid+signalling+in+the+cardiovascular+system%3A+good%2C+bad+or+both%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipid signalling in the cardiovascular system: Good, bad or both?</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">292-302</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are biol. active lipids that play important roles in various cellular processes and the sphingomyelin metabolites ceramide, sphingosine and sphingosine-1-phosphate can act as signaling mols. in most cell types.  With the recent development of the immunosuppressant drug FTY720 (Fingolimod) which after phosphorylation in vivo acts as a sphingosine-1-phosphate receptor agonist, research on the role of sphingolipids in the immune and other organ systems was triggered enormously.  Since it was reported that FTY720 induced a modest, but significant transient decrease in heart rate in animals and humans, the question was raised which pharmacol. properties of drugs targeting sphingolipid signaling will affect cardiovascular function in vivo.  The answer to this question will most likely also indicate what type of drug could be used to treat cardiovascular disease.  The latter is becoming increasingly important because of the increasing population carrying characteristics of the metabolic syndrome.  This syndrome is, amongst others, characterized by obesity, hypertension, atherosclerosis and diabetes.  As such, individuals with this syndrome are at increased risk of heart disease.  Now numerous studies have investigated sphingolipid effects in the cardiovascular system, can we speculate whether certain sphingolipids under specific conditions are good, bad or maybe both.  In this review we will give a brief overview of the pathophysiol. role of sphingolipids in cardiovascular disease.  In addn., we will try to answer how drugs that target sphingolipid signaling will potentially influence cardiovascular function and whether these drugs would be useful to treat cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrn1VPopZK7Vg90H21EOLACvtfcHk0lgGeW8yL-hdLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D&md5=259b21af9aa684253974c6772861c859</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DSphingolipid%2520signalling%2520in%2520the%2520cardiovascular%2520system%253A%2520good%252C%2520bad%2520or%2520both%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D585%26spage%3D292%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate-specific G protein-coupled receptors as novel therapeutic targets for atherosclerosis</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=117-137&author=Y.+Okamotoauthor=F.+Wangauthor=K.+Yoshiokaauthor=N.+Takuwaauthor=Y.+Takuwa&title=Sphingosine-1-phosphate-specific+G+protein-coupled+receptors+as+novel+therapeutic+targets+for+atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DTakuwa%26aufirst%3DN.%26aulast%3DTakuwa%26aufirst%3DY.%26atitle%3DSphingosine-1-phosphate-specific%2520G%2520protein-coupled%2520receptors%2520as%2520novel%2520therapeutic%2520targets%2520for%2520atherosclerosis%26jtitle%3DPharmaceuticals%26date%3D2011%26volume%3D4%26spage%3D117%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lucke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">Endothelial functions of sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1159%2F000315109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=20502008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=87-96&author=S.+Luckeauthor=B.+Levkau&title=Endothelial+functions+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial Functions of Sphingosine-1-phosphate</span></div><div class="casAuthors">Lucke, Susann; Levkau, Bodo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The biol. active sphingolipid sphingosine-1-phosphate (S1P) plays key functions in the immune, inflammatory, and cardiovascular systems.  In the vasculature, S1P and its receptors are involved in vessel morphogenesis and angiogenesis during embryonic development and in the adult organism both under normal and pathol. conditions.  Via its actions on endothelial and smooth muscle cells, S1P regulates arterial tone, vascular permeability, and tissue perfusion.  Elevated local S1P levels during inflammation induce endothelial adhesion mols., recruit inflammatory cells, and activate dendritic cells.  At the same time, S1P activates a neg. feedback loop that consecutively seals endothelial cell-cell contacts, decreases vascular leakage, and inhibits cytokine-induced leukocyte adhesion.  Thus S1P dets. not only the build-up, magnitude, and duration of an inflammatory reaction but also the pace of its resoln.  This review focuses on the role S1P plays in endothelial function, its receptors and signalling pathways, and the role its major carrier high-d. lipoproteins (HDL) play in its bioavailability and transport.  We will also discuss the potential of interfering with S1P-S1P receptor interactions for the treatment of endothelial disorders and vascular pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgsnbdFMWkH7Vg90H21EOLACvtfcHk0lgGeW8yL-hdLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D&md5=7cb409784dfea08b42abaa924e5b3bff</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1159%2F000315109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315109%26sid%3Dliteratum%253Aachs%26aulast%3DLucke%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3DEndothelial%2520functions%2520of%2520sphingosine-1-phosphate%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Oskeritzian, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.pharmthera.2007.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17669501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=390-399&author=C.+A.+Oskeritzianauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+in+allergic+responses%2C+asthma+and+anaphylaxis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span></div><div class="casAuthors">Oskeritzian, Carole A.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-399</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in many cellular processes, acting not only as an extracellular ligand to its specific G protein-coupled receptors, but also as a putative intracellular messenger with yet unidentified targets.  Mast cells are tissue-dwelling pivotal early effectors of allergic responses, which produce and secrete S1P that can bind to its receptors present on mast cells to influence their activation and functions.  In this review, we will first discuss the current knowledge of S1P prodn. by two isoenzymes of sphingosine kinase (SphK).  Mechanisms of SphK activation will be discussed, with an emphasis on exptl. approaches developed to study their differential activation and biol. roles in the context of mast cells.  The relevance of mast cells in the etiol. of allergic disorders, asthma and anaphylaxis is well established.  In this review, this concept will be revisited, focusing on the contribution of S1P prodn. and secretion to the symptoms assocd. with dysregulated inflammatory responses.  To conclude, counteracting the proinflammatory effects of S1P could be envisioned as a therapeutic strategy to treat allergic disorders, exacerbated airway inflammation, and anaphylactic reactions, and various options will be discussed, such as the development of pharmacol. tools to inhibit SphKs, S1P neutralizing monoclonal antibody, and S1P receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU658KZB9wzbVg90H21EOLACvtfcHk0lgGeW8yL-hdLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL&md5=6ca77f4bc8322527e1d6ad3db24b6244</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DOskeritzian%26aufirst%3DC.%2BA.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520in%2520allergic%2520responses%252C%2520asthma%2520and%2520anaphylaxis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D390%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rivera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span> </span><span class="NLM_article-title">The alliance of sphingosine-1-phosphate and its receptors in immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnri2400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18787560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=753-763&author=J.+Riveraauthor=R.+L.+Proiaauthor=A.+Olivera&title=The+alliance+of+sphingosine-1-phosphate+and+its+receptors+in+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The alliance of sphingosine-1-phosphate and its receptors in immunity</span></div><div class="casAuthors">Rivera, Juan; Proia, Richard L.; Olivera, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">753-763</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a biol. active metabolite of plasma membrane sphingolipids that is essential for immune cell trafficking.  Its concn. is increased in many inflammatory conditions, such as asthma and autoimmunity.  Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5).  Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogShP9St3JD7Vg90H21EOLACvtfcHk0lgTlqOOlIiiTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI&md5=27e4cbfcd2f91fb1ff9cab462f0e44b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnri2400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2400%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DOlivera%26aufirst%3DA.%26atitle%3DThe%2520alliance%2520of%2520sphingosine-1-phosphate%2520and%2520its%2520receptors%2520in%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D753%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauschen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier-Schellersheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, R. N.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=524-528&author=M.+Ishiiauthor=J.+G.+Egenauthor=F.+Klauschenauthor=M.+Meier-Schellersheimauthor=Y.+Saekiauthor=J.+Vacherauthor=R.+L.+Proiaauthor=R.+N.+Germain&title=Sphingosine-1-phosphate+mobilizes+osteoclast+precursors+and+regulates+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DEgen%26aufirst%3DJ.%2BG.%26aulast%3DKlauschen%26aufirst%3DF.%26aulast%3DMeier-Schellersheim%26aufirst%3DM.%26aulast%3DSaeki%26aufirst%3DY.%26aulast%3DVacher%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DGermain%26aufirst%3DR.%2BN.%26atitle%3DSphingosine-1-phosphate%2520mobilizes%2520osteoclast%2520precursors%2520and%2520regulates%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D524%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span> </span><span class="NLM_article-title">New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1893-1900&author=A.+Huwilerauthor=J.+Pfeilschifter&title=New+players+on+the+center+stage%3A+sphingosine+1-phosphate+and+its+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26atitle%3DNew%2520players%2520on%2520the%2520center%2520stage%253A%2520sphingosine%25201-phosphate%2520and%2520its%2520receptors%2520as%2520drug%2520targets%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1893%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate signalling in cancer</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1042%2FBST20110602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22260672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=94-100&author=N.+J.+Pyneauthor=F.+Tonelliauthor=K.+G.+Limauthor=J.+S.+Longauthor=J.+Edwardsauthor=S.+Pyne&title=Sphingosine+1-phosphate+signalling+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate signalling in cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Tonelli, Francesca; Lim, Keng Gat; Long, Jaclyn S.; Edwards, Joanne; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an increasing body of evidence demonstrating a crit. role for the bioactive lipid S1P (sphingosine 1-phosphate) in cancer.  S1P is synthesized and metabolized by a no. of enzymes, including sphingosine kinase, S1P lyase and S1P phosphatases.  S1P binds to cell-surface G-protein-coupled receptors (S1P1-S1P5) to elicit cell responses and can also regulate, by direct binding, a no. of intracellular targets such as HDAC (histone deacetylase) 1/2 to induce epigenetic regulation.  S1P is involved in cancer progression including cell transformation/oncogenesis, cell survival/apoptosis, cell migration/metastasis and tumor microenvironment neovascularization.  In the present paper, we describe our research findings regarding the correlation of sphingosine kinase 1 and S1P receptor expression in tumors with clin. outcome and we define some of the mol. mechanisms underlying the involvement of sphingosine kinase 1 and S1P receptors in the formation of a cancer cell migratory phenotype.  The role of sphingosine kinase 1 in the acquisition of chemotherapeutic resistance and the interaction of S1P receptors with oncogenes such as HER2 is also reviewed.  We also discuss novel aspects of the use of small-mol. inhibitors of sphingosine kinase 1 in terms of allosterism, ubiquitin-proteasomal degrdn. of sphingosine kinase 1 and anticancer activity.  Finally, we describe how S1P receptor-modulating agents abrogate S1P receptor-receptor tyrosine kinase interactions, with potential to inhibit growth-factor-dependent cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryryplFV-76bVg90H21EOLACvtfcHk0lgTlqOOlIiiTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D&md5=e0f90be10095c1d682345caaf8cce2c0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1042%2FBST20110602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110602%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BS.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520signalling%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikumar, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate signaling and its role in disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.tcb.2011.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22001186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=50-60&author=M.+Maceykaauthor=K.+B.+Harikumarauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+signaling+and+its+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate signaling and its role in disease</span></div><div class="casAuthors">Maceyka, Michael; Harikumar, Kuzhuvelil B.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) is now recognized as a crit. regulator of many physiol. and pathophysiol. processes, including cancer, atherosclerosis, diabetes and osteoporosis.  S1P is produced in cells by two sphingosine kinase isoenzymes, SphK1 and SphK2.  Many cells secrete S1P, which can then act in an autocrine or paracrine manner.  Most of the known actions of S1P are mediated by a family of five specific G protein-coupled receptors.  More recently, it was shown that S1P also has important intracellular targets involved in inflammation, cancer and Alzheimer's disease.  This suggests that S1P actions are much more complex than previously thought, with important ramifications for development of therapeutics.  This review highlights recent advances in our understanding of the mechanisms of action of S1P and its roles in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0UHcgnAzcArVg90H21EOLACvtfcHk0lgTlqOOlIiiTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D&md5=93baaa54059ffec593c9e0092716f02e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2011.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2011.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520signaling%2520and%2520its%2520role%2520in%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2012%26volume%3D22%26spage%3D50%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=853-856&author=K.+Adachiauthor=T.+Koharaauthor=N.+Nakaoauthor=M.+Aritaauthor=K.+Chibaauthor=T.+Mishinaauthor=S.+Sasakiauthor=T.+Fujita&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+2-substituted-2-amino-1%2C3-propanediols%3A+discovery+of+a+novel+immunosuppressant%2C+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DNakao%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25202-substituted-2-amino-1%252C3-propanediols%253A%2520discovery%2520of%2520a%2520novel%2520immunosuppressant%252C%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D853%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masubuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span> </span><span class="NLM_article-title">FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">5037</span><span class="NLM_x">–</span> <span class="NLM_lpage">5044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=9590253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=5037-5044&author=K.+Chibaauthor=Y.+Yanagawaauthor=Y.+Masubuchiauthor=H.+Kataokaauthor=T.+Kawaguchiauthor=M.+Ohtsukiauthor=Y.+Hoshino&title=FTY720%2C+a+novel+immunosuppressant%2C+induces+sequestration+of+circulating+mature+lymphocytes+by+acceleration+of+lymphocyte+homing+in+rats.+I.+FTY720+selectively+decreases+the+number+of+circulating+mature+lymphocytes+by+acceleration+of+lymphocyte+homing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing</span></div><div class="casAuthors">Chiba, Kenji; Yanagawa, Yoshiki; Masubuchi, Yumi; Kataoka, Hirotoshi; Kawaguchi, Takafumi; Ohtsuki, Makio; Hoshino, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5037-5044</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">FTY720, given i.v. or orally at 0.03 mg/kg or more, prolonged skin allograft survival in a dose-dependent manner and showed more potent immunosuppressive activity than cyclosporin A (CsA) or tacrolimus (FK506) in MHC-incompatible rat strains of WKAH donors and F344 recipients.  However, unlike CsA or FK506, FTY720 up to 1000 nM did not affect IL-2 prodn. in allogeneic MLC.  Within 3-24 h after a single oral administration of FTY720 at 0.1-1 mg/kg, the no. of lymphocytes in the rats was markedly decreased in the peripheral blood and thoracic duct lymph and partially in spleen.  By contrast, the no. of lymphocytes in peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN), and Peyer's patches (PP) was increased at the same time.  I.v. transfusion of calcein-labeled rat lymphocytes into rats revealed that FTY720 accelerated lymphocyte homing to PLN, MLN, and PP, dose dependently.  Since FTY720-induced lymphocyte homing was completely blocked by simultaneous treatment of the calcein-labeled lymphocytes with mAbs against CD62L, CD49d, and CD11a before the transfusion, the acceleration of lymphocyte homing by FTY720 appears to be mediated by lymphocyte-homing receptors.  Thus, FTY720 sequesters circulating mature lymphocytes into PLN, MLN, and PP by acceleration of lymphocyte homing and thereby decreases the no. of lymphocytes in peripheral blood, thoracic duct lymph, and spleen.  Based on these observations, sequestration of circulating mature-lymphocytes is presumed to be a main mechanism of the immunosuppressive activity of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeImxxYccaHrVg90H21EOLACvtfcHk0ljkTzoiO1UUmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D&md5=db7da181424c790a0fb07c0dc60badae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DYanagawa%26aufirst%3DY.%26aulast%3DMasubuchi%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DOhtsuki%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DY.%26atitle%3DFTY720%252C%2520a%2520novel%2520immunosuppressant%252C%2520induces%2520sequestration%2520of%2520circulating%2520mature%2520lymphocytes%2520by%2520acceleration%2520of%2520lymphocyte%2520homing%2520in%2520rats.%2520I.%2520FTY720%2520selectively%2520decreases%2520the%2520number%2520of%2520circulating%2520mature%2520lymphocytes%2520by%2520acceleration%2520of%2520lymphocyte%2520homing%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D160%26spage%3D5037%26epage%3D5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Pinschewer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochsenbein, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odermatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengartner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinkernagel, R. M.</span><span> </span><span class="NLM_article-title">FTY720 immunosupression impairs effector T cell peripheral homing without affecting induction, expansion, and memory</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">5761</span><span class="NLM_x">–</span> <span class="NLM_lpage">5770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=5761-5770&author=D.+D.+Pinschewerauthor=A.+F.+Ochsenbeinauthor=B.+Odermattauthor=V.+Brinkmannauthor=H.+Hengartnerauthor=R.+M.+Zinkernagel&title=FTY720+immunosupression+impairs+effector+T+cell+peripheral+homing+without+affecting+induction%2C+expansion%2C+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinschewer%26aufirst%3DD.%2BD.%26aulast%3DOchsenbein%26aufirst%3DA.%2BF.%26aulast%3DOdermatt%26aufirst%3DB.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DHengartner%26aufirst%3DH.%26aulast%3DZinkernagel%26aufirst%3DR.%2BM.%26atitle%3DFTY720%2520immunosupression%2520impairs%2520effector%2520T%2520cell%2520peripheral%2520homing%2520without%2520affecting%2520induction%252C%2520expansion%252C%2520and%2520memory%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D5761%26epage%3D5770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinschewer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span> </span><span class="NLM_article-title">FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FS0041-1345%2800%2902126-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11266942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2htbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=530-531&author=V.+Brinkmannauthor=S.+Chenauthor=L.+Fengauthor=D.+Pinschewerauthor=Z.+Nikolovaauthor=R.+Hof&title=FTY720+alters+lymphocyte+homing+and+protects+allografts+without+inducing+general+immunosuppression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression</span></div><div class="casAuthors">Brinkmann, V.; Chen, S.; Feng, L.; Pinschewer, D.; Nikolova, Z.; Hof, R.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">530-531</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 12 refs.  The novel immunomodulator, FTY720, prolongs with remarkable potency the survival of allografted kidney, heart, liver, small bowel, and skin in animal models including nonhuman primates, and prevents the development of coronary artery disease and graft-vs.-host-disease (GVHD).  It interferes with the responsiveness of lymphocytes to chemokines, suppressing lymphocyte recirculation to the periphery and infiltration of T cells into grafted organs without impairment of immune responses to systemic viral infection.  Several expts. conducted on the efficiency of FTY720 are presented.  Topics covered include modulation of chemokine-driven lymphocyte migration; impairment of T-and B-cell function; and safety pharmacol. and clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-qZW0gPJe7Vg90H21EOLACvtfcHk0ljkTzoiO1UUmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2htbk%253D&md5=5692b6e5068ce7595c8f80d09aff82b7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2800%2902126-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252800%252902126-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DPinschewer%26aufirst%3DD.%26aulast%3DNikolova%26aufirst%3DZ.%26aulast%3DHof%26aufirst%3DR.%26atitle%3DFTY720%2520alters%2520lymphocyte%2520homing%2520and%2520protects%2520allografts%2520without%2520inducing%2520general%2520immunosuppression%26jtitle%3DTransplant.%2520Proc.%26date%3D2001%26volume%3D33%26spage%3D530%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lgoJw9ffhhKgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornancin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dévay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechtcheriakova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">47408</span><span class="NLM_x">–</span> <span class="NLM_lpage">47415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1074%2Fjbc.M307687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=13129923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=47408-47415&author=A.+Billichauthor=F.+Bornancinauthor=P.+D%C3%A9vayauthor=D.+Mechtcheriakovaauthor=N.+Urtzauthor=T.+Baumruker&title=Phosphorylation+of+the+immunomodulatory+drug+FTY720+by+sphingosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span></div><div class="casAuthors">Billich, Andreas; Bornancin, Frederic; Devay, Piroska; Mechtcheriakova, Diana; Urtz, Nicole; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">47408-47415</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The immunomodulatory drug FTY720 is phosphorylated in vivo, and the resulting FTY720 phosphate as a ligand for sphingosine-1-phosphate receptors is responsible for the unique biol. effects of the compd.  So far, phosphorylation of FTY720 by murine sphingosine kinase (SPHK) 1a had been documented.  We found that, while FTY720 is also phosphorylated by human SPHK1, the human type 2 isoform phosphorylates the drug 30-fold more efficiently, because of a lower Km of FTY720 for SPHK2.  Similarly, murine SPHK2 was more efficient than SPHK1a.  Among splice variants of the human SPHKs, an N-terminally extended SPHK2 isoform was even more active than SPHK2 itself.  Further SPHK superfamily members, namely ceramide kinase and a "SPHK-like" protein, failed to phosphorylate sphingosine and FTY720.  Thus, only SPHK1 and 2 appear to be capable of phosphorylating FTY720.  Using selective assay conditions, SPHK1 and 2 activities in murine tissues were measured.  While activity of SPHK2 toward sphingosine was generally lower than of SPHK1, FTY720 phosphorylation was higher under conditions favoring SPHK2.  In human endothelial cells, while activity of SPHK1 toward sphingosine was 2-fold higher than of SPHK2, FTY720 phosphorylation was 7-fold faster under SPHK2 assay conditions.  Finally, FTY720 was poorly phosphorylated in human blood as compared with rodent blood, in line with the low activity of SPHK1 and in particular of SPHK2 in human blood.  To conclude, both SPHK1 and 2 are capable of phosphorylating FTY720, but SPHK2 is quant. more important than SPHK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5e-dVWnBT7Vg90H21EOLACvtfcHk0lgoJw9ffhhKgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D&md5=26820503680682863dc76a69ea02fc7e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307687200%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DD%25C3%25A9vay%26aufirst%3DP.%26aulast%3DMechtcheriakova%26aufirst%3DD.%26aulast%3DUrtz%26aufirst%3DN.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPhosphorylation%2520of%2520the%2520immunomodulatory%2520drug%2520FTY720%2520by%2520sphingosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D47408%26epage%3D47415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P<sub>2</sub> and S1P<sub>3</sub> receptors and Smad-independent signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14839</span><span class="NLM_x">–</span> <span class="NLM_lpage">14851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=14839-14851&author=K.+Sobelauthor=K.+Menyhartauthor=N.+Killerauthor=B.+Renaultauthor=Y.+Bauerauthor=R.+Studerauthor=B.+Steinerauthor=M.+H.+Bolliauthor=O.+Naylerauthor=J.+Gatfield&title=Sphingosine-1-phosphate+%28S1P%29+receptor+agonists+mediate+pro-fibrotic+responses+in+normal+human+lung+fibroblasts+via+S1P2+and+S1P3+receptors+and+Smad-independent+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobel%26aufirst%3DK.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DKiller%26aufirst%3DN.%26aulast%3DRenault%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DY.%26aulast%3DStuder%26aufirst%3DR.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DGatfield%26aufirst%3DJ.%26atitle%3DSphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonists%2520mediate%2520pro-fibrotic%2520responses%2520in%2520normal%2520human%2520lung%2520fibroblasts%2520via%2520S1P2%2520and%2520S1P3%2520receptors%2520and%2520Smad-independent%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D14839%26epage%3D14851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, J.</span><span> </span><span class="NLM_article-title">The vascular S1P gradient: cellular sources and biological significance</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=477-482&author=T.+Hlaauthor=K.+Venkataramanauthor=J.+Michaud&title=The+vascular+S1P+gradient%3A+cellular+sources+and+biological+significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DVenkataraman%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DJ.%26atitle%3DThe%2520vascular%2520S1P%2520gradient%253A%2520cellular%2520sources%2520and%2520biological%2520significance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1781%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Finding a way out: lymphocyte egress from lymphoid organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fni1545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18026082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1295-1301&author=S.+R.+Schwabauthor=J.+G.+Cyster&title=Finding+a+way+out%3A+lymphocyte+egress+from+lymphoid+organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a way out: lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Schwab, Susan R.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1301</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function.  The discovery that a small-mol. inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs.  S1P exists in higher concns. in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit.  Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes.  In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites.  We relate this model to work examg. the effects of S1P receptor agonists on endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWY-Rk111SmLVg90H21EOLACvtfcHk0ljrukrejUYA8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J&md5=ccf7ef06130d3ebd218707ac92618f36</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fni1545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1545%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DFinding%2520a%2520way%2520out%253A%2520lymphocyte%2520egress%2520from%2520lymphoid%2520organs%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1295%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Pappu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regard, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=295-298&author=R.+Pappuauthor=S.+R.+Schwabauthor=I.+Cornelissenauthor=J.+P.+Pereiraauthor=J.+B.+Regardauthor=Y.+Xuauthor=E.+Camererauthor=Y.-W.+Zhengauthor=Y.+Huangauthor=J.+G.+Cysterauthor=S.+R.+Coughlin&title=Promotion+of+lymphocyte+egress+into+blood+and+lymph+by+distinct+sources+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPappu%26aufirst%3DR.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCornelissen%26aufirst%3DI.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DRegard%26aufirst%3DJ.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DY.-W.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DPromotion%2520of%2520lymphocyte%2520egress%2520into%2520blood%2520and%2520lymph%2520by%2520distinct%2520sources%2520of%2520sphingosine-1-phosphate%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D295%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goitsuka, R.</span><span> </span><span class="NLM_article-title">Lymphopenia induced by a novel selective S1P<sub>1</sub> antagonist structurally unrelated to S1P</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1821</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1821&publication_year=2012&pages=600-606&author=Y.+Fujiiauthor=H.+Ohtakeauthor=N.+Onoauthor=T.+Haraauthor=T.+Sakuraiauthor=S.+Takahashiauthor=T.+Takayamaauthor=Y.+Fukasawaauthor=F.+Shiozawaauthor=N.+Tsukaharaauthor=T.+Hirayamaauthor=Y.+Igarashiauthor=R.+Goitsuka&title=Lymphopenia+induced+by+a+novel+selective+S1P1+antagonist+structurally+unrelated+to+S1P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTakayama%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DY.%26aulast%3DShiozawa%26aufirst%3DF.%26aulast%3DTsukahara%26aufirst%3DN.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DGoitsuka%26aufirst%3DR.%26atitle%3DLymphopenia%2520induced%2520by%2520a%2520novel%2520selective%2520S1P1%2520antagonist%2520structurally%2520unrelated%2520to%2520S1P%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1821%26spage%3D600%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Quancard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollbuck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berst, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehlmayer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seuwen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersperger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassilana, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigaud, M.</span><span> </span><span class="NLM_article-title">A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.chembiol.2012.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22999882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2ktbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1142-1151&author=J.+Quancardauthor=B.+Bollbuckauthor=P.+Janserauthor=D.+Angstauthor=F.+Berstauthor=P.+Buehlmayerauthor=M.+Streiffauthor=C.+Beerliauthor=V.+Brinkmannauthor=D.+Gueriniauthor=P.+A.+Smithauthor=T.+J.+Seabrookauthor=M.+Traebertauthor=K.+Seuwenauthor=R.+Herspergerauthor=C.+Brunsauthor=F.+Bassilanaauthor=M.+Bigaud&title=A+potent+and+selective+S1P1+antagonist+with+efficacy+in+experimental+autoimmune+encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis</span></div><div class="casAuthors">Quancard, Jean; Bollbuck, Birgit; Janser, Philipp; Angst, Daniela; Berst, Frederic; Buehlmayer, Peter; Streiff, Markus; Beerli, Christian; Brinkmann, Volker; Guerini, Danilo; Smith, Paul A.; Seabrook, Timothy J.; Traebert, Martin; Seuwen, Klaus; Hersperger, Rene; Bruns, Christian; Bassilana, Frederic; Bigaud, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1142-1151</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lymphocyte trafficking is critically regulated by the Sphingosine 1-phosphate receptor-1 (S1P1), a G protein-coupled receptor that has been highlighted as a promising therapeutic target in autoimmunity.  Fingolimod (FTY720, Gilenya) is a S1P1 receptor agonist that has recently been approved for the treatment of multiple sclerosis (MS).  Here, we report the discovery of NIBR-0213, a potent and selective S1P1 antagonist that induces long-lasting redn. of peripheral blood lymphocyte counts after oral dosing.  NIBR-0213 showed comparable therapeutic efficacy to fingolimod in exptl. autoimmune encephalomyelitis (EAE), a model of human MS.  These data provide convincing evidence that S1P1 antagonists are effective in EAE.  In addn., the profile of NIBR-0213 makes it an attractive candidate to further study the consequences of S1P1 receptor antagonism and to differentiate the effects from those of S1P1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbbNhwIy5fA7Vg90H21EOLACvtfcHk0ljrukrejUYA8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2ktbbK&md5=7cf4d66d138fa7f316ac971508e45058</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DBollbuck%26aufirst%3DB.%26aulast%3DJanser%26aufirst%3DP.%26aulast%3DAngst%26aufirst%3DD.%26aulast%3DBerst%26aufirst%3DF.%26aulast%3DBuehlmayer%26aufirst%3DP.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DP.%2BA.%26aulast%3DSeabrook%26aufirst%3DT.%2BJ.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DSeuwen%26aufirst%3DK.%26aulast%3DHersperger%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DBassilana%26aufirst%3DF.%26aulast%3DBigaud%26aufirst%3DM.%26atitle%3DA%2520potent%2520and%2520selective%2520S1P1%2520antagonist%2520with%2520efficacy%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1142%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the sphingosine 1-phosphate receptor, S1P<sub>1</sub>, on T-cells controls thymic emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+sphingosine+1-phosphate+receptor%2C+S1P1%2C+on+T-cells+controls+thymic+emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520controls%2520thymic%2520emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprak, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3351</span><span class="NLM_x">–</span> <span class="NLM_lpage">3355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3351-3355&author=J.+J.+Haleauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=G.+C.+Kooauthor=S.+L.+Koprakauthor=J.+J.+Jacksonauthor=H.+Rosenauthor=S.+Mandala&title=Potent+S1P+receptor+agonists+replicate+the+pharmacologic+actions+of+the+novel+immune+modulator+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DKoprak%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DJ.%2BJ.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DPotent%2520S1P%2520receptor%2520agonists%2520replicate%2520the%2520pharmacologic%2520actions%2520of%2520the%2520novel%2520immune%2520modulator%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3351%26epage%3D3355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.chembiol.2005.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15975516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=703-715&author=E.+Joauthor=M.+G.+Sannaauthor=P.+J.+Gonzalez-Cabreraauthor=S.+Thangadaauthor=G.+Tigyiauthor=D.+A.+Osborneauthor=T.+Hlaauthor=A.+L.+Parrillauthor=H.+Rosen&title=S1P1-selective+in+vivo-active+agonists+from+high-throughput+screening%3A+off-the-shelf+chemical+probes+of+receptor+interactions%2C+signaling%2C+and+fate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">S1P1-Selective In Vivo-Active Agonists from High- Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate</span></div><div class="casAuthors">Jo, Euijung; Sanna, M. Germana; Gonzalez-Cabrera, Pedro J.; Thangada, Shobha; Tigyi, Gabor; Osborne, Daniel A.; Hla, Timothy; Parrill, Abby L.; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">703-715</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The essential role of the sphingosine 1-phosphate (S1P) receptor S1P1 in regulating lymphocyte trafficking was demonstrated with the S1P1-selective nanomolar agonist, SEW2871.  Despite its lack of charged headgroup, the tetraarom. compd. SEW2871 binds and activates S1P1 through a combination of hydrophobic and ion-dipole interactions.  Both S1P and SEW2871 activated ERK, Akt, and Rac signaling pathways and induced S1P1 internalization and recycling, unlike FTY720-phosphate, which induces receptor degrdn.  Agonism with receptor recycling is sufficient for alteration of lymphocyte trafficking by S1P and SEW2871.  S1P1 modeling and mutagenesis studies revealed that residues binding the S1P headgroup are required for kinase activation by both S1P and SEW2871.  Therefore, SEW2871 recapitulates the action of S1P in all the signaling pathways examd. and overlaps in interactions with key headgroup binding receptor residues, presumably replacing salt-bridge interactions with ion-dipole interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2m1otCJEz8LVg90H21EOLACvtfcHk0liqGqOu6kWW1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D&md5=31a1a616e98d96ba6d9dfbb0a38ed39c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DOsborne%26aufirst%3DD.%2BA.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P1-selective%2520in%2520vivo-active%2520agonists%2520from%2520high-throughput%2520screening%253A%2520off-the-shelf%2520chemical%2520probes%2520of%2520receptor%2520interactions%252C%2520signaling%252C%2520and%2520fate%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D703%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fni1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16273098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1228-1235&author=S.+H.+Weiauthor=H.+Rosenauthor=M.+P.+Matheuauthor=M.+G.+Sannaauthor=S.-K.+Wangauthor=E.+Joauthor=C.-H.+Wongauthor=I.+Parkerauthor=M.+D.+Cahalan&title=Sphingosine+1-phosphate+type+1+receptor+agonism+inhibits+transendothelial+migration+of+medullary+T+cells+to+lymphatic+sinuses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses</span></div><div class="casAuthors">Wei, Sindy H.; Rosen, Hugh; Matheu, Melanie P.; Sanna, M. Germana; Wang, Sheng-Kai; Jo, Euijung; Wong, Chi-Huey; Parker, Ian; Cahalan, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1228-1235</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate type 1 (S1P1) receptor agonists cause sequestration of lymphocytes in secondary lymphoid organs by a mechanism that is not well understood.  One hypothesis proposes that agonists act as "functional antagonists" by binding and internalizing S1P1 receptors on lymphocytes; a second hypothesis proposes instead that S1P1 agonists act on endothelial cells to prevent lymphocyte egress from lymph nodes.  Here, 2-photon imaging of living T cells in explanted lymph nodes after treatment with S1P1 agonists or antagonists has provided insight into the mechanism by which S1P1 agonists function.  The selective S1P1 agonist SEW2871 caused reversible slowing and "log-jamming" of T cells between filled medullary cords and empty sinuses, whereas motility was unaltered in diffuse cortex.  Removal or antagonist competition of SEW2871 permitted recovery of T cell motility in the parenchyma of the medulla and resumption of migration across the stromal endothelial barrier, leading to refilling of sinuses.  The authors' results provide visualization of transendothelial migration of T cells into lymphatic sinuses and suggest that S1P1 agonists act mainly on endothelial cell S1P1 receptors to inhibit lymphocyte migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT6yH1S8NBXbVg90H21EOLACvtfcHk0liqGqOu6kWW1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E&md5=1e8e381a3808c9231937e05a0c010b73</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fni1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1269%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.-K.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26atitle%3DSphingosine%25201-phosphate%2520type%25201%2520receptor%2520agonism%2520inhibits%2520transendothelial%2520migration%2520of%2520medullary%2520T%2520cells%2520to%2520lymphatic%2520sinuses%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D1228%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Selecting against S1P<sub>3</sub> enhances the acute cardiovascular tolerability of 3-(<i>N</i>-benzyl)aminopropylphosphonic acid S1P receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3501-3505&author=J.+J.+Haleauthor=G.+Dohertyauthor=L.+Tothauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=S.-Y.+Sunauthor=S.+Westauthor=H.+Xieauthor=N.+Nomuraauthor=H.+Rosenauthor=S.+Mandala&title=Selecting+against+S1P3+enhances+the+acute+cardiovascular+tolerability+of+3-%28N-benzyl%29aminopropylphosphonic+acid+S1P+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DSelecting%2520against%2520S1P3%2520enhances%2520the%2520acute%2520cardiovascular%2520tolerability%2520of%25203-%2528N-benzyl%2529aminopropylphosphonic%2520acid%2520S1P%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3501%26epage%3D3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0ljQBq_00oQ0LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Salomone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeber, C.</span><span> </span><span class="NLM_article-title">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fsj.bjp.0707581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18026125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=140-147&author=S.+Salomoneauthor=E.+M.+Pottsauthor=S.+Tyndallauthor=P.+C.+Ipauthor=J.+Chunauthor=V.+Brinkmannauthor=C.+Waeber&title=Analysis+of+sphingosine+1-phosphate+receptors+involved+in+constriction+of+isolated+cerebral+arteries+with+receptor+null+mice+and+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span></div><div class="casAuthors">Salomone, S.; Potts, E. M.; Tyndall, S.; Ip, P. C.; Chun, J.; Brinkmann, V.; Waeber, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacol. characterized.  Exptl. approach: The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P2 and S1P3 receptor null mice) and pharmacol. tools (phospho-FTY720, a S1P1/3/4/5 receptor agonist; SEW2871, a S1P1 receptor agonist, JTE-013, a S1P2 receptor antagonist, VPC23019, a S1P1/3 receptor antagonist).  Isolated basilar or peripheral (femoral, mesenteric resistance) arteries, from either rat or mouse, were studied in a wire myograph.  Key results: S1P concn.-dependently constricted basilar artery in rat, wild-type (WT) and S1P2 null mice, but barely affected vascular tone in S1P3 null mice.  Vasoconstriction to U46619 (a thromboxane analog) or to endothelin-1 did not differ between WT, S1P2 and S1P3 null mice.  JTE-013 inhibited not only S1P-induced vasoconstriction, but also KCl-, U46619- and endothelin-1-induced constriction.  This effect was obsd. in WT as well as in S1P2 null mice.  VPC23019 increased the concn.-dependent vasoconstriction to S1P in both rat and mouse basilar arteries with intact endothelium, but not in rat basilar artery without endothelium.  Phospho-FTY720 concn.-dependently constricted rat basilar arteries, but not femoral or mesenteric resistance arteries, while SEW2871 did not induce any response in the same arteries.  Conclusions and implications: S1P constricts cerebral arteries through S1P3 receptors.  The purported S1P2 receptor antagonist JTE-013 does not appear to be selective, at least in rodents.  Enhancement of S1P-induced contraction by VPC23019 might be related to blockade of S1P1 receptors and NO generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx6pcvW_Q37Vg90H21EOLACvtfcHk0ljQBq_00oQ0LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D&md5=1e8bef7d6f2df66b4436300fab09df06</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707581%26sid%3Dliteratum%253Aachs%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DPotts%26aufirst%3DE.%2BM.%26aulast%3DTyndall%26aufirst%3DS.%26aulast%3DIp%26aufirst%3DP.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWaeber%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520sphingosine%25201-phosphate%2520receptors%2520involved%2520in%2520constriction%2520of%2520isolated%2520cerebral%2520arteries%2520with%2520receptor%2520null%2520mice%2520and%2520pharmacological%2520tools%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taksugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P<sub>3</sub> receptor: investigation based on a new S1P<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Taksugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-phosphate+%28S1P%29+regulates+vascular+contraction+via+S1P3+receptor%3A+investigation+based+on+a+new+S1P3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTaksugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520regulates%2520vascular%2520contraction%2520via%2520S1P3%2520receptor%253A%2520investigation%2520based%2520on%2520a%2520new%2520S1P3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Removal of sphingosine 1-phosphate receptor-3 (S1P<sub>3</sub>) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P<sub>1</sub> agonists with reduced effect on heart rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901776q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3154-3168&author=M.+Hamadaauthor=M.+Nakamuraauthor=M.+Kiuchiauthor=K.+Marukawaauthor=A.+Tomatsuauthor=K.+Shimanoauthor=N.+Satoauthor=K.+Sugaharaauthor=M.+Asayamaauthor=K.+Takagiauthor=K.+Adachi&title=Removal+of+sphingosine+1-phosphate+receptor-3+%28S1P3%29+agonism+is+essential%2C+but+inadequate+to+obtain+immunomodulating+2-aminopropane-1%2C3-diol+S1P1+agonists+with+reduced+effect+on+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DMarukawa%26aufirst%3DK.%26aulast%3DTomatsu%26aufirst%3DA.%26aulast%3DShimano%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DAsayama%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DRemoval%2520of%2520sphingosine%25201-phosphate%2520receptor-3%2520%2528S1P3%2529%2520agonism%2520is%2520essential%252C%2520but%2520inadequate%2520to%2520obtain%2520immunomodulating%25202-aminopropane-1%252C3-diol%2520S1P1%2520agonists%2520with%2520reduced%2520effect%2520on%2520heart%2520rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3154%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P(1)) and hypertension (S1P(3)) in rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+clinically-tested+S1P+receptor+agonists%2C+FTY720+and+BAF312%2C+demonstrate+subtype-specific+bradycardia+%28S1P%281%29%29+and+hypertension+%28S1P%283%29%29+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520clinically-tested%2520S1P%2520receptor%2520agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520demonstrate%2520subtype-specific%2520bradycardia%2520%2528S1P%25281%2529%2529%2520and%2520hypertension%2520%2528S1P%25283%2529%2529%2520in%2520rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Brossard, P.; Hofmann, S.; Cavallaro, M.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Entry-into-Humans Study with ACT-128800, a Selective S1P1 Receptor Agonist: Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics</span>. Presented at ASCPT 2009, Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Washington DC, USA, March 18–21, 2009; PII-87;  <span class="citation_source-journal">Clin. Pharmcol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">S63</span><span class="NLM_x">–</span> <span class="NLM_lpage">S64</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=S63-S64&author=P.+Brossard&author=S.+Hofmann&author=M.+Cavallaro&author=A.+Halabi&author=J.+Dingemanse&title=Entry-into-Humans+Study+with+ACT-128800%2C+a+Selective+S1P1+Receptor+Agonist%3A+Tolerability%2C+Safety%2C+Pharmacokinetics%2C+and+Pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEntry-into-Humans%2520Study%2520with%2520ACT-128800%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%253A%2520Tolerability%252C%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%26jtitle%3DClin.%2520Pharmcol.%2520Ther.%26date%3D2009%26spage%3DS63%26epage%3DS64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P1/S1P5 Receptor Modulator BAF312 Indicates That S1P1 Rather Than S1P3 Mediates Transient Heart Rate Reduction in Humans</span>. Presented at the 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Düsseldorf, Germany,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>P437.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction</span>. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallström, E.</span><span> </span><span class="NLM_article-title">The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+J.+Crumbauthor=M.+Saltzmannauthor=M.+Rosenbergauthor=E.+Wallstr%C3%B6m&title=The+selective+S1P+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate%3A+translation+from+preclinical+to+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray N S; Hinterding K; Cooke N G; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb W J Jr; Saltzman M; Rosenberg M; Wallstrom E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P(1) and S1P(5 ) receptors.  S1P(1) receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclinical and human data.  EXPERIMENTAL APPROACH:  BAF312 was tested in a rat experimental autoimmune encephalomyelitis (EAE) model.  Electrophysiological recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  KEY RESULTS:  BAF312 effectively suppressed EAE in rats by internalizing S1P(1) receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4(+) T cells, T(naive) , T(central memory) and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P(3) receptors (associated with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  CONCLUSION AND IMPLICATIONS:  This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE_xcO_ghmTOLt9HypzAgQfW6udTcc2eaeWHCry2Wdyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D&md5=82575d2c2d2eeba851919e468e407c48</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%2BJ.%26aulast%3DSaltzmann%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DThe%2520selective%2520S1P%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%253A%2520translation%2520from%2520preclinical%2520to%2520clinical%2520studies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lhjlRqCBnNYLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Aktas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieseier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Fingolimod is a potential novel therapy for multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnrneurol.2010.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=20551946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=373-382&author=O.+Aktasauthor=P.+K%C3%BCryauthor=B.+Kieseierauthor=H.-P.+Hartung&title=Fingolimod+is+a+potential+novel+therapy+for+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod is a potential novel therapy for multiple sclerosis</span></div><div class="casAuthors">Aktas, Orhan; Kuery, Patrick; Kieseier, Bernd; Hartung, Hans-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">373-382</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Only moderately effective therapies are currently available for the treatment of multiple sclerosis (MS).  New treatments for MS that have neuroprotective properties as well as anti-inflammatory effects are needed.  Fingolimod could be one such potential treatment.  In this article, Aktas et al. examine the underlying biol. actions of this prospective new therapy, review the data from phase II and phase III oral fingolimod clin. trials and provide an update on the emerging field of sphingosine-1-phosphate receptor-mediated therapies for MS.  Fingolimod (also known as FTY720) is an orally available sphingosine-1-phosphate (S1P) receptor modulator that has unique and potent immunoregulatory properties.  Mechanistic studies indicate that on phosphorylation fingolimod can bind with high affinity to S1P1 receptors.  Persistent modulation of lymphocyte S1P1 receptors by fingolimod and the subsequent internalization of these receptors inhibits lymphocyte egress from the lymph nodes, and prevents these cells from infiltrating inflammatory lesions in the CNS.  Results of two phase III studies-FREEDOMS and TRANSFORMS-support previous phase II trial observations indicating that fingolimod exerts powerful anti-inflammatory effects in relapsing-remitting multiple sclerosis (MS).  Fingolimod might, therefore, be one of the first orally active drug therapies available for the treatment of relapsing-remitting MS.  Moreover, results from preclin. studies suggest that fingolimod might promote neural repair in vivo.  In this article, we review the background to these findings, present the proposed immunol. and neurobiol. profile of fingolimod, discuss the data from the FREEDOMS and TRANSFORMS trials, and provide an expert opinion regarding the future of next-generation S1P receptor modulators for MS therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbGeDeonkrpLVg90H21EOLACvtfcHk0lg1bVzcNZZawA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7s%253D&md5=11690f6c74fe1fcb1fee8325d1f7b066</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.76%26sid%3Dliteratum%253Aachs%26aulast%3DAktas%26aufirst%3DO.%26aulast%3DK%25C3%25BCry%26aufirst%3DP.%26aulast%3DKieseier%26aufirst%3DB.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DFingolimod%2520is%2520a%2520potential%2520novel%2520therapy%2520for%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D373%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Ingwersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuery, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieseier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy</span> <span class="citation_source-journal">Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.clim.2011.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=15-24&author=J.+Ingwersenauthor=O.+Aktasauthor=P.+Kueryauthor=B.+Kieseierauthor=A.+Boykoauthor=H.-P.+Hartung&title=Fingolimod+in+multiple+sclerosis%3A+mechanisms+of+action+and+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy</span></div><div class="casAuthors">Ingwersen, Jens; Aktas, Orhan; Kuery, Patrick; Kieseier, Bernd; Boyko, Alexey; Hartung, Hans-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fingolimod, also known as FTY720, has recently been approved by the regulatory authorities in the US, EU, Australia, Russia, among others, for the treatment of relapsing-remitting multiple sclerosis.  Fingolimod therefore represents the first oral drug for the treatment of this autoimmune disease of the central nervous system.  Fingolimod modulates sphingosine-1 phosphate receptors and has unique immunoregulatory properties.  Mechanistic studies from animal models have shown that fingolimod prevents immune cells from exiting from the lymphoid tissue and reaching the inflammatory tissue.  Indeed, two phase III studies that laid the basis for fingolimod's approval demonstrated that fingolimod efficiently improves the relapse rate compared to both placebo and one of the std. MS medications.  In this review, we will summarize the immunol. profile of fingolimod, discuss the possible direct neurobiol. effects that have been suggested recently and present the clin. data regarding the efficacy and safety profiles of this promising new drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3WTHZs_TktbVg90H21EOLACvtfcHk0lg1bVzcNZZawA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyqu74%253D&md5=e9b2428f7ca4370bb9ef17c428c99c7b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2011.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2011.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DIngwersen%26aufirst%3DJ.%26aulast%3DAktas%26aufirst%3DO.%26aulast%3DKuery%26aufirst%3DP.%26aulast%3DKieseier%26aufirst%3DB.%26aulast%3DBoyko%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DFingolimod%2520in%2520multiple%2520sclerosis%253A%2520mechanisms%2520of%2520action%2520and%2520clinical%2520efficacy%26jtitle%3DClin.%2520Immunol.%26date%3D2012%26volume%3D142%26spage%3D15%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+derivatives+as+potent%2C+orally+active+S1P1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520S1P1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span>ClinicalTrials.gov. Ponesimod in Patients with Relapsing-Remitting Multiple Sclerosis: Extension Study. <a href="http://clinicaltrials.gov/show/NCT01093326" class="extLink">http://clinicaltrials.gov/show/NCT01093326</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Ponesimod+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis%3A+Extension+Study.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01093326+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span>ClinicalTrials.gov. ACT-128800 in Relapsing-Remitting Multiple Sclerosis. <a href="http://clinicaltrials.gov/show/NCT01006265" class="extLink">http://clinicaltrials.gov/show/NCT01006265</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+ACT-128800+in+Relapsing-Remitting+Multiple+Sclerosis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01006265+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span>ClinicalTrials.gov. ACT-128800 in Patients with Moderate to Severe Chronic Plaque Psoriasis. <a href="http://clinicaltrials.gov/show/NCT01208090" class="extLink">http://clinicaltrials.gov/show/NCT01208090</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+ACT-128800+in+Patients+with+Moderate+to+Severe+Chronic+Plaque+Psoriasis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01208090+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28siponimod%29%2C+a+potent+and+selective+S1P+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528siponimod%2529%252C%2520a%2520potent%2520and%2520selective%2520S1P%2520receptor%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span>ClinicalTrials.gov. Long-Term Safety, Tolerability and Efficacy with BAF312 Given Orally in Patients with Relapsing-Remitting Multiple Sclerosis. <a href="http://clinicaltrials.gov/show/NCT01185821" class="extLink">http://clinicaltrials.gov/show/NCT01185821</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Long-Term+Safety%2C+Tolerability+and+Efficacy+with+BAF312+Given+Orally+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01185821+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>ClinicalTrials.gov. Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients with Relapsing-Remitting Multiple Sclerosis. <a href="http://clinicaltrials.gov/show/NCT00879658" class="extLink">http://clinicaltrials.gov/show/NCT00879658</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Safety%2C+Tolerability%2C+Efficacy+and+Optimal+Dose+Finding+Study+of+BAF312+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT00879658+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span>ClinicalTrials.gov. A Study of the Safety and Efficacy of ONO-4641 in Patients with Relapsing-Remitting Multiple Sclerosis (DreaMS). <a href="http://clinicaltrials.gov/show/NCT01081782" class="extLink">http://clinicaltrials.gov/show/NCT01081782</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+A+Study+of+the+Safety+and+Efficacy+of+ONO-4641+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis+%28DreaMS%29.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01081782+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomisato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimozato, T.</span><span> </span><span class="NLM_article-title">Discovery of CS-0777: a potent, selective, and orally active S1P<sub>1</sub> agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100301k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=368-372&author=T.+Nishiauthor=S.+Miyazakiauthor=T.+Takemotoauthor=K.+Suzukiauthor=Y.+Iioauthor=K.+Nakajimaauthor=T.+Ohnukiauthor=Y.+Kawaseauthor=F.+Naraauthor=S.+Inabaauthor=T.+Izumiauthor=H.+Yuitaauthor=K.+Oshimaauthor=H.+Doiauthor=R.+Inoueauthor=W.+Tomisatoauthor=T.+Kagariauthor=T.+Shimozato&title=Discovery+of+CS-0777%3A+a+potent%2C+selective%2C+and+orally+active+S1P1+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fml100301k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100301k%26sid%3Dliteratum%253Aachs%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIio%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DYuita%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DR.%26aulast%3DTomisato%26aufirst%3DW.%26aulast%3DKagari%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520CS-0777%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520S1P1%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T. L.</span><span> </span><span class="NLM_article-title">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.jneuroim.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22465063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=100-107&author=J.+B.+Moberlyauthor=D.+M.+Fordauthor=H.+Zahirauthor=S.+Chenauthor=T.+Mochizukiauthor=K.+E.+Truittauthor=T.+L.+Vollmer&title=Pharmacological+effects+of+CS-0777%2C+a+selective+sphingosine+1-phosphate+receptor-1+modulator%3A+results+from+a+12-week%2C+open-label+pilot+study+in+multiple+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients</span></div><div class="casAuthors">Moberly, James B.; Ford, Daniel M.; Zahir, Hamim; Chen, Shuquan; Mochizuki, Takashi; Truitt, Kenneth E.; Vollmer, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 modulator under investigation for treatment of multiple sclerosis (MS).  We conducted an open-label, pilot study in 25 MS patients to assess the safety, pharmacokinetics, pharmacodynamics and exploratory efficacy of oral CS-0777 (0.1, 0.3 and 0.6 mg), administered once weekly or every other week for 12 wk.  CS-0777 resulted in a pronounced, dose-dependent decrease in lymphocytes and CD4 T cell subsets, which returned to baseline within 4 wk after the last dose.  Overall, CS-0777 was safe and well-tolerated.  These results require confirmation in a double-blind, placebo-controlled and adequately powered phase 2 study in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUDMmZ5gpHLVg90H21EOLACvtfcHk0ljaCuXaNCSTfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D&md5=ce750c33bbfd69ba65304cb02f7c22f9</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DFord%26aufirst%3DD.%2BM.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26aulast%3DVollmer%26aufirst%3DT.%2BL.%26atitle%3DPharmacological%2520effects%2520of%2520CS-0777%252C%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%253A%2520results%2520from%2520a%252012-week%252C%2520open-label%2520pilot%2520study%2520in%2520multiple%2520sclerosis%2520patients%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D246%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and hear allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+novel+synthetic+immunosuppressant%2C+prolongs+graft+survival+and+attenuates+chronic+rejection+in+rat+skin+and+hear+allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520novel%2520synthetic%2520immunosuppressant%252C%2520prolongs%2520graft%2520survival%2520and%2520attenuates%2520chronic%2520rejection%2520in%2520rat%2520skin%2520and%2520hear%2520allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span>ClinicalTrials.gov. Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus. <a href="http://clinicaltrials.gov/show/NCT01294774" class="extLink">http://clinicaltrials.gov/show/NCT01294774</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Safety+and+Efficacy+of+KRP203+in+Subacute+Cutaneous+Lupus+Erythematosus.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01294774+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span>ClinicalTrials.gov. Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients. <a href="http://clinicaltrials.gov/show/NCT01375179" class="extLink">http://clinicaltrials.gov/show/NCT01375179</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+%26+Safety+in+Moderately+Active+Refractory+Ulcerative+Colitis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01375179+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span>ClinicalTrials.gov. Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients. <a href="http://clinicaltrials.gov/show/NCT01628393" class="extLink">http://clinicaltrials.gov/show/NCT01628393</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Safety+Study+of+RPC1063+in+Relapsing+Multiple+Sclerosis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01628393+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span>ClinicalTrials.gov. Dose Finding Study of MT-1303. <a href="http://clinicaltrials.gov/show/NCT01742052" class="extLink">http://clinicaltrials.gov/show/NCT01742052</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Dose+Finding+Study+of+MT-1303.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01742052+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selective S1P<sub>1</sub> receptor agonists for the treatment of inflammatory and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+J.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+progress+in+the+development+of+selective+S1P1+receptor+agonists+for+the+treatment+of+inflammatory+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0ljyXqzJmNWycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selective%2520S1P1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span> </span><span class="NLM_article-title">Synthetic sphingosine 1-phosphate receptor modulators: opportunities and potential pitfalls</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.2174%2F1568026611109060726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=21261590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=726-757&author=M.+H.+Bolliauthor=C.+Lescopauthor=O.+Nayler&title=Synthetic+sphingosine+1-phosphate+receptor+modulators%3A+opportunities+and+potential+pitfalls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic sphingosine 1-phosphate receptor modulators - opportunities and potential pitfalls</span></div><div class="casAuthors">Bolli, Martin H.; Lescop, Cyrille; Nayler, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">726-757</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) evokes a plethora of physiol. responses by stimulating members of a G protein-coupled receptor family, known as S1P receptors.  Currently five different mammalian S1P receptor subtypes, S1P1-5, each with a different cellular expression pattern, were identified.  The S1P1 receptor in particular has attracted major interest throughout the pharmaceutical industry following the breakthrough discovery that this S1P receptor subtype is critically involved in the regulation of lymphocyte trafficking through secondary lymphoid organs.  Since then, examples of synthetic S1P1 agonists with lymphocyte reducing and immunomodulating activity demonstrated efficacy in numerous preclin. models of autoimmune disease and transplantation.  Notably FTY720 (fingolimod), a pro-drug that is phosphorylated in vivo and converted into a non-selective S1P1,3,4,5 receptor agonist, has been widely used to increase the understanding of S1P1 receptor biol.  Results from recently completed phase III clin. trials using FTY720 paved the way for this non-selective S1P1 receptor agonist to become the first oral therapy in multiple sclerosis, with potential expansion into many other autoimmune diseases.  This review briefly outlines the field of S1P1 receptor biol. and summarizes recent approaches in medicinal chem. to discover potent and selective S1P1 receptor agonists.  In particular, the complexity of discovering a mol. akin to FTY720 but with an improved side-effect profile will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTTZ2jfUXEtrVg90H21EOLACvtfcHk0ljyXqzJmNWycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D&md5=9f6d05909fb5615126ea642f4cc19271</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060726%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26atitle%3DSynthetic%2520sphingosine%25201-phosphate%2520receptor%2520modulators%253A%2520opportunities%2520and%2520potential%2520pitfalls%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D726%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+advances+in+the+discovery+and+development+of+sphingosine-1-phosphate-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor agonists: a patent review (2010–2012)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1517%2F13543776.2013.783022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=817-841&author=E.+Robertsauthor=M.+Guerreroauthor=M.+Urbanoauthor=H.+Rosen&title=Sphingosine+1-phosphate+receptor+agonists%3A+a+patent+review+%282010%E2%80%932012%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012)</span></div><div class="casAuthors">Roberts, Edward; Guerrero, Miguel; Urbano, Mariangela; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">817-841</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The sphingosine-1-phosphate (S1P)-driven signaling regulates fundamental biol. functions, including cell proliferation, angiogenesis, endothelial cell chemotaxis, immune cell trafficking and mitogenesis.  A large body of research has been focusing on the development of immunosuppressive S1P1 receptor (S1P1-R) agonist mols.  The S1P1,3 - 5-R pan-agonist fingolimod (FTY720) has been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis.  However, FTY720 is now contraindicated in patients with compromised cardiac function.  Although the main adverse effect bradycardia has been linked to the S1P3-R activation, cardiovascular liabilities persist with more selective S1P1-R agonists that have entered clin. trials.  In contrast to the S1P1-R, the therapeutic application of the S1P2 - 5-Rs remains poorly explored.  Areas covered: This review provides the patent literature from 2010 to date on S1P-R agonist mols. and their relevant biol. properties.  Expert opinion: Limited progress has been made on agonists at S1P4,5-R subtypes, with some families of S1P5-R agonists showing promising results in animal models of age-related cognitive disorders.  A discrete no. of reviewed mols. are S1P1-R agonists with a promising clin. outlook in transplantation, inflammation, cancer and autoimmune settings.  Further preclin. and clin. studies will det. whether the new developed S1P1-R agonists do indeed improve the safety profile of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIrASpSMDS37Vg90H21EOLACvtfcHk0ljyXqzJmNWycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D&md5=405b6350b777d3040e2be21adf85d440</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.783022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.783022%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520agonists%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D817%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists - Part 1: From pyrazoles to thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9737</span><span class="NLM_x">–</span> <span class="NLM_lpage">9755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4014373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9737-9755&author=M.+H.+Bolliauthor=C.+M%C3%BCllerauthor=B.+Mathysauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=O.+Naylerauthor=M.+Reyauthor=S.+Meyerauthor=M.+Scherzauthor=G.+Schmidtauthor=B.+Steinerauthor=A.+Treiberauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists+-+Part+1%3A+From+pyrazoles+to+thiophenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm4014373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014373%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520-%2520Part%25201%253A%2520From%2520pyrazoles%2520to%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9737%26epage%3D9755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Alberola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradanos, P.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of 2-functionalized thiophenes by condensation of α-mercapto compounds with β-amino enone derivatives</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1080%2F00397919008053203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=2537-2547&author=A.+Alberolaauthor=J.+M.+Andresauthor=A.+Gonzalezauthor=R.+Pedrosaauthor=P.+Pradanos&title=Regioselective+synthesis+of+2-functionalized+thiophenes+by+condensation+of+%CE%B1-mercapto+compounds+with+%CE%B2-amino+enone+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 2-functionalized thiophenes by condensation of α-mercapto compounds with β-amino enone derivatives</span></div><div class="casAuthors">Alberola, Angel; Andres, Jose M.; Gonzalez, Alfonso; Pedrosa, Rafael; Pradanos, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2537-47</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Reaction of R1COCR2:CR3Cl (R1 = Me, Ph; R2 = H, Me; R3 = Me, Ph) with NaSCH2CO2Et gave 50-70% thiophenes I (R1-R3 as above, R4 = OEt).  R1COCH:CHN+Et3 (R1 = Et, Ph, 4-MeOC6H4, 4-O2NC6H4, Me2CH) reacted with HSCH2COR4 (R4 = HEt, Me, Ph) to give 70-90% R1COCH:CHSCH2COR4, which on reaction with EtONa/EtOH gave I (R1 as above, R2 = R3 = H, R4 = OEt, Me, Ph).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKt5xsJdc5LVg90H21EOLACvtfcHk0liSBMDtos5OqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D&md5=4d01fc252b1a3cad0f3ff24fbf19a50f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1080%2F00397919008053203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008053203%26sid%3Dliteratum%253Aachs%26aulast%3DAlberola%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DR.%26aulast%3DPradanos%26aufirst%3DP.%26atitle%3DRegioselective%2520synthesis%2520of%25202-functionalized%2520thiophenes%2520by%2520condensation%2520of%2520%25CE%25B1-mercapto%2520compounds%2520with%2520%25CE%25B2-amino%2520enone%2520derivatives%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D2537%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Kubiak, G. G.; Lythgoe, D. J.; Yu, Y.</span><span> </span><span class="NLM_article-title">Regio-Specific Synthesis of 4-Bromo-3-methyl-5-propoxy-thiophene-2-carboxylic Acid</span>. WO2008115912, Sep 25,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+G.+Kubiak&author=D.+J.+Lythgoe&author=Y.+Yu&title=Regio-Specific+Synthesis+of+4-Bromo-3-methyl-5-propoxy-thiophene-2-carboxylic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKubiak%26aufirst%3DG.%2BG.%26atitle%3DRegio-Specific%2520Synthesis%2520of%25204-Bromo-3-methyl-5-propoxy-thiophene-2-carboxylic%2520Acid%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Nahm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, S. M.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methoxy-<i>N</i>-methylamides as effective acylating agents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3815</span><span class="NLM_x">–</span> <span class="NLM_lpage">3818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FS0040-4039%2801%2991316-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1981&pages=3815-3818&author=S.+Nahmauthor=S.+M.+Weinreb&title=N-Methoxy-N-methylamides+as+effective+acylating+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methoxy-N-methylamides as effective acylating agents</span></div><div class="casAuthors">Nahm, Steven; Weinreb, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">3815-18</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">N-Methoxy-N-methylamides couple readily with both Grignard and organolithium reagents in THF to give ketones; tertiary alcs. were not formed even in the presence of large excesses of the organometallic compd.  E.g., treatment of Me(CH2)16CONMeOMe (I), prepd. from Me(CH2)16COCl and HNMeOMe.HCl (pyridine/CHCl3, room temp., 1 h), with 2 equiv MeMgBr (THF, 0°, 1 h) gave 94% Me(CH2)16COMe.  Hydride redn. of the N-methoxy-N-methylamides gave the corresponding aldehydes, together with small amts. of the primary alc.  E.g., I with excess LiAlH4 (THF, -78°, 5 min) gave 50% Me(CH2)16CHO and 25% Me(CH2)17OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSzB8ss9N34rVg90H21EOLACvtfcHk0liSBMDtos5OqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D&md5=ce1dc3bf2af883db320d90c4ff32616c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2991316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252991316-4%26sid%3Dliteratum%253Aachs%26aulast%3DNahm%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DS.%2BM.%26atitle%3DN-Methoxy-N-methylamides%2520as%2520effective%2520acylating%2520agents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1981%26volume%3D22%26spage%3D3815%26epage%3D3818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Su, D.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.-Y.</span><span> </span><span class="NLM_article-title">Methyl chlorodifluoroacetate a convenient trifluoromethylating agent</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">7689</span><span class="NLM_x">–</span> <span class="NLM_lpage">7690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=7689-7690&author=D.-B.+Suauthor=J.-X.+Duanauthor=Q.-Y.+Chen&title=Methyl+chlorodifluoroacetate+a+convenient+trifluoromethylating+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.-B.%26aulast%3DDuan%26aufirst%3DJ.-X.%26aulast%3DChen%26aufirst%3DQ.-Y.%26atitle%3DMethyl%2520chlorodifluoroacetate%2520a%2520convenient%2520trifluoromethylating%2520agent%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D7689%26epage%3D7690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Velker, J.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Thiophene Derivatives</span>. WO2006100635, Sep 28,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=J.+Velker&author=T.+Weller&title=Novel+Thiophene+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Thiophene%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Flaugh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowell, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, D. S.</span><span> </span><span class="NLM_article-title">Acid-catalyzed annelation of α-alkyl aldehydes and α,β-unsaturated ketones. A one-pot synthesis of 4,4-dimethyl-2-cyclohexen-1-one</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5399</span><span class="NLM_x">–</span> <span class="NLM_lpage">5400</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01314a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=5399-5400&author=M.+A.+Flaughauthor=T.+A.+Crowellauthor=D.+S.+Farlow&title=Acid-catalyzed+annelation+of+%CE%B1-alkyl+aldehydes+and+%CE%B1%2C%CE%B2-unsaturated+ketones.+A+one-pot+synthesis+of+4%2C4-dimethyl-2-cyclohexen-1-one"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjo01314a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01314a048%26sid%3Dliteratum%253Aachs%26aulast%3DFlaugh%26aufirst%3DM.%2BA.%26aulast%3DCrowell%26aufirst%3DT.%2BA.%26aulast%3DFarlow%26aufirst%3DD.%2BS.%26atitle%3DAcid-catalyzed%2520annelation%2520of%2520%25CE%25B1-alkyl%2520aldehydes%2520and%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520ketones.%2520A%2520one-pot%2520synthesis%2520of%25204%252C4-dimethyl-2-cyclohexen-1-one%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D5399%26epage%3D5400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Wuesthoff, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickborn, B.</span><span> </span><span class="NLM_article-title">The preparation of spiro[2.5]octan-6-one. Catalytic hydrogenation of a vinylcyclopropane</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01267a111" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1968&pages=1311-1312&author=M.+T.+Wuesthoffauthor=B.+Rickborn&title=The+preparation+of+spiro%5B2.5%5Doctan-6-one.+Catalytic+hydrogenation+of+a+vinylcyclopropane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjo01267a111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01267a111%26sid%3Dliteratum%253Aachs%26aulast%3DWuesthoff%26aufirst%3DM.%2BT.%26aulast%3DRickborn%26aufirst%3DB.%26atitle%3DThe%2520preparation%2520of%2520spiro%255B2.5%255Doctan-6-one.%2520Catalytic%2520hydrogenation%2520of%2520a%2520vinylcyclopropane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1968%26volume%3D33%26spage%3D1311%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Nicolaou, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Carboxyclic thromboxane A<sub>2</sub></span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1404</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00524a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=1404-1409&author=K.+C.+Nicolaouauthor=R.+L.+Magoldaauthor=D.+A.+Claremon&title=Carboxyclic+thromboxane+A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fja00524a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00524a028%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DCarboxyclic%2520thromboxane%2520A2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D1404%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Arai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span> </span><span class="NLM_article-title">An asymmmetric Simmons–Smith reaction</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">8254</span><span class="NLM_x">–</span> <span class="NLM_lpage">8256</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00312a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1985&pages=8254-8256&author=I.+Araiauthor=A.+Moriauthor=H.+Yamamoto&title=An+asymmmetric+Simmons%E2%80%93Smith+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fja00312a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00312a072%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DI.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DAn%2520asymmmetric%2520Simmons%25E2%2580%2593Smith%2520reaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1985%26volume%3D107%26spage%3D8254%26epage%3D8256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Mihovilovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. D.</span><span> </span><span class="NLM_article-title">Asymmetric Bayer–Villiger oxidations of 4-mono- and 4,4-disubstituted cyclohexanones by whole cells of engineered <i>Escherichia coli</i></span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo001292p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=733-738&author=M.+D.+Mihovilovicauthor=G.+Chenauthor=S.+Wangauthor=B.+Kyteauthor=F.+Rochonauthor=M.+M.+Kayserauthor=J.+D.+Stewart&title=Asymmetric+Bayer%E2%80%93Villiger+oxidations+of+4-mono-+and+4%2C4-disubstituted+cyclohexanones+by+whole+cells+of+engineered+Escherichia+coli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjo001292p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001292p%26sid%3Dliteratum%253Aachs%26aulast%3DMihovilovic%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DKyte%26aufirst%3DB.%26aulast%3DRochon%26aufirst%3DF.%26aulast%3DKayser%26aufirst%3DM.%2BM.%26aulast%3DStewart%26aufirst%3DJ.%2BD.%26atitle%3DAsymmetric%2520Bayer%25E2%2580%2593Villiger%2520oxidations%2520of%25204-mono-%2520and%25204%252C4-disubstituted%2520cyclohexanones%2520by%2520whole%2520cells%2520of%2520engineered%2520Escherichia%2520coli%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D733%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Natale, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, R. O.</span><span> </span><span class="NLM_article-title">An efficient, general synthesis of spiroalkanes and related derivatives</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1080%2F00304947709356865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaE1cXltVemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1977&pages=103-108&author=N.+R.+Nataleauthor=R.+O.+Hutchins&title=An+efficient%2C+general+synthesis+of+spiroalkanes+and+related+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient, general synthesis of spiroalkenes and related derivatives</span></div><div class="casAuthors">Natale, Nicholas R.; Hutchins, Robert O.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3-4-5</span>),
    <span class="NLM_cas:pages">103-8</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    </div><div class="casAbstract">Enamines I [Z = CH2, CH2CH2, (CH2)4, CH:CH] were converted to spiroalkenes II.  I were heated with MeCOCH:CH2, HOAc and NaOAc were added, and the mixts. were heated to give spiroalkenones III.  III were converted to their tosylhydrazones and the latter were treated with catechol borane to give the II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw27QGYj39TbVg90H21EOLACvtfcHk0liETp5otFQybQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXltVemtw%253D%253D&md5=1fb7414ec38915f7cd7cce9546a70ce2</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1080%2F00304947709356865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304947709356865%26sid%3Dliteratum%253Aachs%26aulast%3DNatale%26aufirst%3DN.%2BR.%26aulast%3DHutchins%26aufirst%3DR.%2BO.%26atitle%3DAn%2520efficient%252C%2520general%2520synthesis%2520of%2520spiroalkanes%2520and%2520related%2520derivatives%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D1977%26volume%3D9%26spage%3D103%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Knight, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nott, A. P.</span><span> </span><span class="NLM_article-title">Generation and synthetic utility of dianions derived from thiophenecarboxylic acids</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">1983</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1983&publication_year=1983&pages=791-794&author=D.+W.+Knightauthor=A.+P.+Nott&title=Generation+and+synthetic+utility+of+dianions+derived+from+thiophenecarboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DD.%2BW.%26aulast%3DNott%26aufirst%3DA.%2BP.%26atitle%3DGeneration%2520and%2520synthetic%2520utility%2520of%2520dianions%2520derived%2520from%2520thiophenecarboxylic%2520acids%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1983%26volume%3D1983%26spage%3D791%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaf, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P1 receptor modulation with cyclical recovery from lymphopenia amelioreates mouse model of multiple sclerosis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=166-174&author=P.+J.+Gonzalez-Cabreraauthor=S.+M.+Cahalanauthor=N.+Nguyenauthor=G.+Sarkisyanauthor=N.+B.+Leafauthor=M.+D.+Cameronauthor=T.+Kagoauthor=H.+Rosen&title=S1P1+receptor+modulation+with+cyclical+recovery+from+lymphopenia+amelioreates+mouse+model+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DSarkisyan%26aufirst%3DG.%26aulast%3DLeaf%26aufirst%3DN.%2BB.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DKago%26aufirst%3DT.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P1%2520receptor%2520modulation%2520with%2520cyclical%2520recovery%2520from%2520lymphopenia%2520amelioreates%2520mouse%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D166%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">Indole-propionic acid derivatives as potent, S1P<sub>3</sub>-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P<sub>1</sub>) receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2794</span><span class="NLM_x">–</span> <span class="NLM_lpage">2797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2794-2797&author=Q.+Mengauthor=B.+Zhaoauthor=Q.+Xuauthor=X.+Xuauthor=G.+Dengauthor=C.+Liauthor=L.+Luanauthor=F.+Renauthor=H.+Wangauthor=H.+Xuauthor=Y.+Xuauthor=H.+Zhangauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=T.+B.+Guoauthor=Y.+Zhaoauthor=W.+Zhangauthor=H.+Luauthor=X.+Lin&title=Indole-propionic+acid+derivatives+as+potent%2C+S1P3-sparing+and+EAE+efficacious+sphingosine-1-phosphate+1+%28S1P1%29+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLuan%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DIndole-propionic%2520acid%2520derivatives%2520as%2520potent%252C%2520S1P3-sparing%2520and%2520EAE%2520efficacious%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2794%26epage%3D2797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74285&author=M.+Reyauthor=P.+Hessauthor=M.+Clozelauthor=S.+Delahayeauthor=J.+Gatfieldauthor=O.+Naylerauthor=B.+Steiner&title=Desensitization+by+progressive+up-titration+prevents+first-dose+effects+on+the+heart%3A+guinea+pig+study+with+ponesimod%2C+a+selective+S1P1+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRey%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DDelahaye%26aufirst%3DS.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DDesensitization%2520by%2520progressive%2520up-titration%2520prevents%2520first-dose%2520effects%2520on%2520the%2520heart%253A%2520guinea%2520pig%2520study%2520with%2520ponesimod%252C%2520a%2520selective%2520S1P1%2520receptor%2520modulator%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Wasan, K. M.</span><span> </span><span class="NLM_article-title">The role of lymphatic transport in enhancing oral protein and peptide drug delivery</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2002&pages=1047-1058&author=K.+M.+Wasan&title=The+role+of+lymphatic+transport+in+enhancing+oral+protein+and+peptide+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWasan%26aufirst%3DK.%2BM.%26atitle%3DThe%2520role%2520of%2520lymphatic%2520transport%2520in%2520enhancing%2520oral%2520protein%2520and%2520peptide%2520drug%2520delivery%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2002%26volume%3D28%26spage%3D1047%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Yañez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knemeyer, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, K. B.</span><span> </span><span class="NLM_article-title">Intestinal lymphatic transport for drug delivery</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=923-942&author=J.+A.+Ya%C3%B1ezauthor=S.+W.+J.+Wangauthor=I.+W.+Knemeyerauthor=M.+A.+Wirthauthor=K.+B.+Alton&title=Intestinal+lymphatic+transport+for+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYa%25C3%25B1ez%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BW.%2BJ.%26aulast%3DKnemeyer%26aufirst%3DI.%2BW.%26aulast%3DWirth%26aufirst%3DM.%2BA.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26atitle%3DIntestinal%2520lymphatic%2520transport%2520for%2520drug%2520delivery%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D923%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Matt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weckebecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evenou, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span> </span><span class="NLM_article-title">Structure–activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6028</span><span class="NLM_x">–</span> <span class="NLM_lpage">6039</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200469u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6028-6039&author=J.+Wagnerauthor=P.+von+Mattauthor=B.+Fallerauthor=N.+G.+Cookeauthor=R.+Albertauthor=R.+Sedraniauthor=H.+Wiegandauthor=C.+Jeanauthor=C.+Beerliauthor=G.+Weckebeckerauthor=J.-P.+Evenouauthor=G.+Zenkeauthor=S.+Cottens&title=Structure%E2%80%93activity+relationship+and+pharmacokinetic+studies+of+sotrastaurin+%28AEB071%29%2C+a+promising+novel+medicine+for+prevention+of+graft+rejection+and+treatment+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm200469u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200469u%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3Dvon%2BMatt%26aufirst%3DP.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DWiegand%26aufirst%3DH.%26aulast%3DJean%26aufirst%3DC.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DWeckebecker%26aufirst%3DG.%26aulast%3DEvenou%26aufirst%3DJ.-P.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DCottens%26aufirst%3DS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520and%2520pharmacokinetic%2520studies%2520of%2520sotrastaurin%2520%2528AEB071%2529%252C%2520a%2520promising%2520novel%2520medicine%2520for%2520prevention%2520of%2520graft%2520rejection%2520and%2520treatment%2520of%2520psoriasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6028%26epage%3D6039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Grimont, J.; Le Goff, F.; Bourquin, G.; Silva, J.</span><span> </span><span class="NLM_article-title">Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR</span>. Presented at MipTec: The Leading European Event for Drug Discovery, Basel, Switzerland, Sep 20–24,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Grimont&author=F.+Le+Goff&author=G.+Bourquin&author=J.+Silva&title=Quality+Assessment+and+Concentration+Determination+of+Actelion%E2%80%99s+Compound+Solutions+by+Automated+LCMS+and+Quantitative+NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrimont%26aufirst%3DJ.%26atitle%3DQuality%2520Assessment%2520and%2520Concentration%2520Determination%2520of%2520Actelion%25E2%2580%2599s%2520Compound%2520Solutions%2520by%2520Automated%2520LCMS%2520and%2520Quantitative%2520NMR%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Seglen, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosså, J.</span><span> </span><span class="NLM_article-title">Attachment of rat hepatocytes in vitro to substrata of serum protein collagen, or concanavalin A</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2F0014-4827%2878%2990076-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaE1MXitVSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1978&pages=199-206&author=P.+O.+Seglenauthor=J.+Foss%C3%A5&title=Attachment+of+rat+hepatocytes+in+vitro+to+substrata+of+serum+protein+collagen%2C+or+concanavalin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Attachment of rat hepatocytes in vitro to substrata of serum protein, collagen, or concanavalin A</span></div><div class="casAuthors">Seglen, Per O.; Fossa, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    </div><div class="casAbstract">Isolated rat hepatocytes attached to, and spread on, the surface of polystyrene tissue culture dishes in the presence of serum.  The attachment was essentially complete in 30 min at 37°, whereas no attachment occurred at 0°.  Dead (trypan blue-stainable) cells did not attach; hence, the plating efficiency (percentage of cells attaching) was close to the percentage of intact cells in the hepatocyte suspension.  Attachment in the presence of serum was relatively independent of pH, but required divalent cations.  Mg2+ stimulated attachment more effectively than Ca2+, and a combination of both cations gave maximal attachment.  Cells did not attach readily to untreated dishes in the absence of serum, but attached to and spread on dishes precoated with adsorbed serum protein, concanavalin A (ConA), or a film of collagen.  The attachment-promoting activity in serum was destroyed by acid treatment, by heating to 70°, and by protease treatment.  It is, therefore, probably a protein, which, like collagen and ConA, can bind to receptors hepatocyte surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNVWSL9oLULrVg90H21EOLACvtfcHk0li1Y-wm_ScSgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXitVSqtw%253D%253D&md5=f23fe77ed9d9f43188571b536fe8f725</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0014-4827%2878%2990076-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4827%252878%252990076-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeglen%26aufirst%3DP.%2BO.%26aulast%3DFoss%25C3%25A5%26aufirst%3DJ.%26atitle%3DAttachment%2520of%2520rat%2520hepatocytes%2520in%2520vitro%2520to%2520substrata%2520of%2520serum%2520protein%2520collagen%252C%2520or%2520concanavalin%2520A%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1978%26volume%3D116%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">The prediction of human clearance from hepatic microsomal metabolism data</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11727321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=36-44&author=R.+S.+Obach&title=The+prediction+of+human+clearance+from+hepatic+microsomal+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human clearance from hepatic microsomal metabolism data</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Human liver microsomal intrinsic clearance has become a commonly measured parameter during drug discovery, and such data are used to design compds. predicted to possess optimal drug disposition characteristics.  Liver microsomal intrinsic clearance values can be scaled and used to predict hepatic clearance in humans.  Clearance, when combined with the vol. of distribution, dets. the half-life of a drug.  Hepatic clearance, when combined with absorption, dets. the oral bioavailability of a drug.  Half-life and oral bioavailability are key determinants of the dosing regimen, ie, size of dose and frequency of administration.  Thus, the accurate prediction of human clearance is important in the selection of new compds. for progression into development, as new drugs on the market must not only be efficacious and safe, but must also be convenient to use for patients and physicians.  Over the past decade, exploring methods whereby human clearance can be predicted from in vitro data has been an area of active research in drug metab. science.  Human liver microsomes have been a key tool in this research.  This in vitro system possesses many of the major drug metabolizing enzymes and is thus applicable to a wide variety of compds.  This review describes the theor. and practical aspects of predicting clearance from human liver microsomal intrinsic clearance data, a summary of advantages and shortcomings of this in vitro system, a synopsis of recent applications of human liver microsomal intrinsic clearance data in clearance predictions, and a discussion of potential future directions for this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsU3SBmySKm7Vg90H21EOLACvtfcHk0li1Y-wm_ScSgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D&md5=421bc7764c3d7f501b69aa97996d1db9</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DThe%2520prediction%2520of%2520human%2520clearance%2520from%2520hepatic%2520microsomal%2520metabolism%2520data%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D36%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Armarego, W. L. F.; Chai, C. L. L.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">6</span>th ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FB978-1-85617-567-8.50011-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=W.+L.+F.+Armarego&author=C.+L.+L.+Chai&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2FB978-1-85617-567-8.50011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-1-85617-567-8.50011-1%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DElsevier%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Buxbaum, E.</span> <span class="citation_source-book">Biophysical Chemistry of Proteins: An Introduction to Laboratory Methods</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1007%2F978-1-4419-7251-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Buxbaum&title=Biophysical+Chemistry+of+Proteins%3A+An+Introduction+to+Laboratory+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-7251-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-7251-4%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DE.%26btitle%3DBiophysical%2520Chemistry%2520of%2520Proteins%253A%2520An%2520Introduction%2520to%2520Laboratory%2520Methods%26pub%3DSpringer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhuo Wu, Feng Wei, Bin Wan, <span class="NLM_string-name hlFld-ContribAuthor">Yanghui Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed ipso,meta-Dimethylation of ortho-Substituted Iodoarenes via a Base-Controlled C–H Activation Cascade with Dimethyl Carbonate as the Methyl Source. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (12)
                                     , 4524-4530. <a href="https://doi.org/10.1021/jacs.0c13057" title="DOI URL">https://doi.org/10.1021/jacs.0c13057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c13057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c13057%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPd-Catalyzed%252Bipso%25252Cmeta-Dimethylation%252Bof%252Bortho-Substituted%252BIodoarenes%252Bvia%252Ba%252BBase-Controlled%252BC%2525E2%252580%252593H%252BActivation%252BCascade%252Bwith%252BDimethyl%252BCarbonate%252Bas%252Bthe%252BMethyl%252BSource%26aulast%3DWu%26aufirst%3DZhuo%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D17122020%26date%3D22032021%26volume%3D143%26issue%3D12%26spage%3D4524%26epage%3D4530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Yun  Xiao</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Anurag S.  Srivastava</span>, <span class="hlFld-ContribAuthor ">Soo S.  Ko</span>, <span class="hlFld-ContribAuthor ">Yanlei  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Cherney</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Guo</span>, <span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Dauh-Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Duraisamy  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Piramanayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Ding-Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen V.  Balimane</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Dana M.  Banas</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia J.  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Bethanne M.  Warrack</span>, <span class="hlFld-ContribAuthor ">Lois  Lehman-McKeeman</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, and <span class="hlFld-ContribAuthor ">T. G. Murali  Dhar</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9837-9854. <a href="https://doi.org/10.1021/acs.jmedchem.6b01099" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01099%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTricyclic%252BAgonists%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BEmploying%252BLigand-Based%252BDrug%252BDesign%26aulast%3DXiao%26aufirst%3DHai-Yun%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25072016%26date%3D20102016%26date%3D10112016%26date%3D11102016%26volume%3D59%26issue%3D21%26spage%3D9837%26epage%3D9854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Lauren  Haque</span>, <span class="hlFld-ContribAuthor ">Parag  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Tebben</span>, <span class="hlFld-ContribAuthor ">Michael A.  Galella</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Virna  Borowski</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Bethanne  Warrack</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Julia P.  Li</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, and <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6248-6264. <a href="https://doi.org/10.1021/acs.jmedchem.6b00373" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252Bof%252Ba%252BSeries%252Bof%252BEthanolamine-Based%252BDirect-Acting%252BAgonists%252Bof%252BSphingosine-1-phosphate%252B%252528S1P1%252529%26aulast%3DGilmore%26aufirst%3DJohn%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29032016%26date%3D01072016%26date%3D14072016%26date%3D16062016%26volume%3D59%26issue%3D13%26spage%3D6248%26epage%3D6264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Junqing  Guo</span>, <span class="hlFld-ContribAuthor ">Steve H.  Spergel</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Robert V.  Moquin</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Dana  Banas</span>, <span class="hlFld-ContribAuthor ">Richard  Liu</span>, <span class="hlFld-ContribAuthor ">Suzanne J.  Suchard</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Sandra  Rex-Rabe</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Bethanne  Warrack</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, and <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2820-2840. <a href="https://doi.org/10.1021/acs.jmedchem.6b00089" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00089%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSelective%252BAgonists%252Bof%252BSphingosine%252B1-Phosphate%252B1%252B%252528S1P1%252529%25253A%252BDiscovery%252Band%252BSAR%252Bof%252Ba%252BNovel%252BIsoxazole%252BBased%252BSeries%26aulast%3DWatterson%26aufirst%3DScott%2BH.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19012016%26date%3D10032016%26date%3D24032016%26date%3D28022016%26volume%3D59%26issue%3D6%26spage%3D2820%26epage%3D2840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel H.  Demont</span>, <span class="hlFld-ContribAuthor ">James M.  Bailey</span>, <span class="hlFld-ContribAuthor ">Rino A.  Bit</span>, <span class="hlFld-ContribAuthor ">Jack A.  Brown</span>, <span class="hlFld-ContribAuthor ">Colin A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Nigel  Deeks</span>, <span class="hlFld-ContribAuthor ">Simon J.  Dowell</span>, <span class="hlFld-ContribAuthor ">Colin  Eldred</span>, <span class="hlFld-ContribAuthor ">Pam  Gaskin</span>, <span class="hlFld-ContribAuthor ">James R. J.  Gray</span>, <span class="hlFld-ContribAuthor ">Andrea  Haynes</span>, <span class="hlFld-ContribAuthor ">David J.  Hirst</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Umesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Mary A.  Morse</span>, <span class="hlFld-ContribAuthor ">Greg J.  Osborne</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Renaux</span>, <span class="hlFld-ContribAuthor ">Gail A. L.  Seal</span>, <span class="hlFld-ContribAuthor ">Chris A.  Smethurst</span>, <span class="hlFld-ContribAuthor ">Simon  Taylor</span>, <span class="hlFld-ContribAuthor ">Robert  Watson</span>, <span class="hlFld-ContribAuthor ">Robert  Willis</span>, and <span class="hlFld-ContribAuthor ">Jason  Witherington</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 1003-1020. <a href="https://doi.org/10.1021/acs.jmedchem.5b01512" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01512%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTetrahydropyrazolopyridine%252Bas%252BSphingosine%252B1-Phosphate%252BReceptor%252B3%252B%252528S1P3%252529-Sparing%252BS1P1%252BAgonists%252BActive%252Bat%252BLow%252BOral%252BDoses%26aulast%3DDemont%26aufirst%3DEmmanuel%2BH.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D29092015%26date%3D22012016%26date%3D11022016%26date%3D11012016%26volume%3D59%26issue%3D3%26spage%3D1003%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Stefan  Abele</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Julien  Grimont</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, <span class="hlFld-ContribAuthor ">Gunther  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jürgen  Seifert</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, and <span class="hlFld-ContribAuthor ">Thomas  Weller</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 110-130. <a href="https://doi.org/10.1021/jm4014696" title="DOI URL">https://doi.org/10.1021/jm4014696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B%2525E2%252588%252592%252BPart%252B3%25253A%252BFrom%252BThiophenes%252Bto%252BPyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D23092013%26date%3D24122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D110%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Yonghui  Chen</span>, <span class="hlFld-ContribAuthor ">Qiumu  Xi</span>, <span class="hlFld-ContribAuthor ">Jinping  Hu</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Jia</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Structure–Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>82 </em>, 41-57. <a href="https://doi.org/10.1016/j.bioorg.2018.09.008" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DIdentification%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252Bof%252Bpotent%252Band%252Bselective%252Boxadiazole-based%252Bagonists%252Bof%252Bsphingosine-1-phosphate%252Breceptor%252B%252528S1P1%252529%26aulast%3DLiu%26aufirst%3DTianqi%26date%3D2019%26volume%3D82%26spage%3D41%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Bezençon</span>, <span class="hlFld-ContribAuthor ">Luboš  Remeň</span>, <span class="hlFld-ContribAuthor ">Sylvia  Richard</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>, <span class="hlFld-ContribAuthor ">Melanie  Kessler</span>, <span class="hlFld-ContribAuthor ">Eric A.  Ertel</span>, <span class="hlFld-ContribAuthor ">Richard  Moon</span>, <span class="hlFld-ContribAuthor ">Jacques  Mawet</span>, <span class="hlFld-ContribAuthor ">Thomas  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Bruno  Capeleto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and evaluation of Ca v 3.2-selective T-type calcium channel blockers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5326-5331. <a href="https://doi.org/10.1016/j.bmcl.2017.09.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bevaluation%252Bof%252BCa%252Bv%252B3.2-selective%252BT-type%252Bcalcium%252Bchannel%252Bblockers%26aulast%3DBezen%25C3%25A7on%26aufirst%3DOlivier%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5326%26epage%3D5331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 326-341. <a href="https://doi.org/10.1016/j.ejmech.2016.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B5%25253A%252BFrom%252Bamino-to%252Balkoxy-pyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2016%26volume%3D115%26spage%3D326%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>116 </em>, 222-238. <a href="https://doi.org/10.1016/j.ejmech.2016.03.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P%252B1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B4%25253A%252BAlkylaminomethyl%252Bsubstituted%252Baryl%252Bhead%252Bgroups%26aulast%3DLescop%26aufirst%3DCyrille%26date%3D2016%26volume%3D116%26spage%3D222%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward R.  Biehl</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 117-157. <a href="https://doi.org/10.1016/B978-0-08-100024-3.00005-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-100024-3.00005-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100024-3.00005-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100024-3.00005-2%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DBiehl%26aufirst%3DEdward%2BR.%26date%3D2015%26spage%3D117%26epage%3D157%26pub%3DElsevier%26date%3D2015%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of sphingosine 1-phosphate and fingolimod (FTY720).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the original HTS hit <b>1</b> and compounds <b>2</b>, <b>3</b>, and <b>4</b> as examples of novel lead series derived thereof.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of the Cyclohexane Fused Thiophen-2-ylcarboxylic Acids <b>8</b>–<b>12</b> and Methyl Ketones <b>13</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 1–24 h, 73–89% (distillation); (b) oxalyl chloride, DCM or CHCl<sub>3</sub>, 0–30 °C, 1–18 h, 81–89% crude; (c) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, THF, rt, 1 h; (d) NaOEt, EtOH, 50–75 °C, 1–18 h; (e) 2 N aqueous LiOH or NaOH, H<sub>2</sub>O, 70 °C, 2–3 h, 57–64% (over four steps); (f) <i>tert</i>- or <i>sec</i>-BuLi, THF, iodoalkane, −78 to −70 °C, 2–18 h, 53–86%; (g) NIS, CH<sub>3</sub>Cl/HOAc 1:1, rt, 24 h, 58%; or <b>8</b> as ethyl ester, Br<sub>2</sub>, AcOH, 50 °C, 4 h, 81%; (h) Cu(I) triflate, Cs<sub>2</sub>CO<sub>3</sub>, MeOH, 95 °C, 24 h (sealed vessel), 16–58%; (i) MeLi, diethyl ether, 20–30 °C, 1–2 h, 17–80%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 5-Trifluoromethylthiophen-2-yl Methyl Ketone Derivative <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>O</i>-dimethylhydroxylamine HCl, TBTU, Hünig’s base, DMSO, DMF, rt, 2 h, 95%; (b) LDA, I<sub>2</sub>, THF, −78 °C, 30 min, 52%; (c) ClF<sub>2</sub>COOMe, CuI, KF, DMF, 135 °C, 4 h, 92%; (d) MeLi, diethyl ether, 20–30 °C, 1–2 h, 75%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-hydroxy-3,5-dimethylbenzaldehyde, 1 N HCl in 2-propanol, EtOH, rt, 1–2 h, 65–87%; (b) 1 bar H<sub>2</sub>, Pd/C, EtOH, rt, 1–5 h, 78–96% (<b>21</b>); or 3-(4-formyl-2,6-dimethylphenyl)propenoic acid, NaOH, MeOH, rt, 3–18 h, 60–75%; (b) 10 bar H<sub>2</sub>, Pd/C, EtOH, Hünig’s base, 50–65 °C, 2–4 d; 45–78% (<b>33</b>); (c) 2-bromoethanol, 3-bromopropanol or (<i>R</i>)- or (<i>S</i>)-3-chloropropane-1,2-diol, 2 N aqueous NaOH, 2-propanol, 70 °C, 4–8 h, 57–74% (<b>22</b>–<b>25</b>); or <b>22</b> or <b>23</b>, methanesulfonyl chloride, Hünig’s base, DCM, rt, 1 h, quantitative crude, then appropriate amine, Hünig’s base, DMF, 75 °C, 7 h, 58–67% (<b>26</b>, <b>27</b>, <b>28</b>); or epichlorohydrin, 3 N aqueous NaOH, 2-propanol, rt, 16–21 h, 57–91%, then 7 N NH<sub>3</sub> in MeOH, 65 °C, 18 h (63–91%, <b>29</b>), then glycolic acid, Hünig’s base, TBTU, DCM, rt, 1–2 h, 45–67% (<b>3</b>); or epichlorohydrin as for <b>3</b>, then 2-aminoethanol, β-alanine or azetidine-3-carboxylic acid, EtOH, H<sub>2</sub>O, Hünig’s base, 85 °C, 5 h, 58–67% (<b>30</b>, <b>31</b>, <b>32</b>).</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Target Compounds Incorporating a [1,2,4]Oxadiazole Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-ethyl-4,<i>N</i>-dihydroxy-5-methylbenzamidine, TBTU, DMF, rt, 18 h, then dioxane, 100 °C, 20 h, 59–71%; (b) (<i>R</i>)- or <i>rac</i>-epichlorohydrin, isopropanol, 3 N aqueous NaOH, rt, 20 h, 53–84%; (c) 7 N NH<sub>3</sub> in methanol, 65 °C, 18 h, 86% quantitative (crude); (d) glycolic acid, TBTU, Hünig’s base, DCM, rt, 2–4 h, 36–70%; (e) (for <b>44</b>) (<i>S</i>)-<i>N</i>-(3-(2-ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methylphenoxy)-2-hydroxypropyl)-2-hydroxyacetamide, EDC, HOBt, DMF, rt, 24 h, then dioxane, 100 °C, 24 h, 6%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of 5-Mono- or Disubstituted 3-Ethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophene-1-carboxylic Acids and 1-(3-Ethyl-4,5,6,7-tetrahydrobenzo[<i>c</i>]thiophen-1-yl)ethanones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>t</i></sup>BuLi, THF, EtI, −100 to −70 °C, 2–18 h, 31–85%; (b) MeLi, diethyl ether, 20–30 °C, 1–2 h, 33–66%; (c) H<sub>2</sub>SO<sub>4</sub>, rt, 24 h, 70%, then 1 bar of H<sub>2</sub>, Pd/C, EA, rt, 24 h, quantitative;<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> (d) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 24 h; (e) oxalyl chloride, DCM or CHCl<sub>3</sub>, 0–30 °C, 1–18 h; (f) (1) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, rt, 1 h; (2) NaOEt, EtOH, 65–75 °C, 18 h; (3) 2 N aqueous LiOH or NaOH, H<sub>2</sub>O, 70 °C, 2–3 h; 23–47% (over steps d, e, f, b); (g) (1) Ph<sub>3</sub>PMeBr, NaH, toluene, DMSO, rt, 1 h, quantitative (crude);<a onclick="showRef(event, 'ref92 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref94">(92, 94)</a> (2) Et<sub>2</sub>Zn, CH<sub>2</sub>I<sub>2</sub>, toluene, −40 °C to rt, 18 h, then TFA, H<sub>2</sub>O, rt, 30 min, 90% (crude);<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> (h) (1) piperidine, ethanol, 85 °C, 24 h, then NaOAc, HOAc, 85 °C, 24 h, 63%; (2) 1 atm of H<sub>2</sub>, Pd/C, EA, rt, 90 min, 97%.<a onclick="showRef(event, 'ref91 ref95'); return false;" href="javascript:void(0);" class="ref ref91 ref95">(91, 95)</a>.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 24 h, 60–65%; (b) oxalyl chloride, CHCl<sub>3</sub>, rt, 30 min, 88% crude; (c) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, 30 °C, 2 h, 46%; (d) 1 N aqueous NaOH, EtOH, 70 °C, 1 h, 98%; (e) <sup><i>t</i></sup>BuLi, EtI, THF, −100 to −80 °C, 8 h, 50%; (f) <i>N</i>,<i>O</i>-dimethylhydroxylamine HCl, TBTU, Hünig’s base, DMF, rt, 3 h, 92%; (g) 2 N aqueous HCl, THF, 40 °C, 2 h, 96%; (h) NaBH<sub>4</sub>, MeOH, rt, 1 h, quantitative crude; (i) MeMgBr, THF, rt, 18 h, 82%; (j) MeMgBr, THF, rt, 3 h, 40–45%; (k) HNMe<sub>2</sub>, NaBH(OAc)<sub>3</sub>, EtOH, rt, 18 h, 50–66%; (l) MeMgBr, THF, rt, 3 h, 80% to quantitative (crude).</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of Thiophene-2-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, 0 °C to rt, 15 h, 66%; (b) oxalyl chloride, CHCl<sub>3</sub>, rt, 2 h, quantitative crude; (c) (1) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, rt, 15 h; (2) NaOEt, EtOH, 85 °C, 1 h; (3) 2 N aqueous LiOH, EtOH, rt, 48 h, 28–41%; (d) POCl<sub>3</sub>, DMF, 0 °C, 30 min, rt, 3 h, quantitative crude; (e) <sup><i>t</i></sup>BuLi, THF, MeI, −78 °C, 2 h, 65%; (f) LDA or <sup><i>t</i></sup>BuLi, THF, alkyl iodide or bromide, −78 °C, 2 h, 15–68%.</p></p></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Simplifying the bicyclo[3.1.0]hexane fused thiophene head.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures (a) and superposition of the X-ray structures (b, c) of the three thiophene-2-carboxylic acids <b>103</b> (red), <b>9</b> (yellow), and <b>97</b> (blue) using the thiophene ring as the anchor unit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/medium/jm-2013-01456d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Lymphocyte counts measured after administration of 10 mg/kg of either ketone <b>36</b> (A) or oxadiazole <b>42</b> (B) to male Wistar rats. Note the different range of the time axis for the two graphs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm401456d/production/images/large/jm-2013-01456d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401456d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 107 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verin, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersto, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrest, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span> </span><span class="NLM_article-title">Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1165%2Fajrcmb.24.6.4323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11415936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVWhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=711-719&author=F.+Liuauthor=A.+D.+Verinauthor=P.+Wangauthor=R.+Dayauthor=R.+P.+Werstoauthor=F.+J.+Chrestauthor=D.+K.+Englishauthor=J.+G.+N.+Garcia&title=Differential+regulation+of+sphingosine-1-phosphate-+and+VEGF-induced+endothelial+cell+chemotaxis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis: involvement of Giα2-linked Rho kinase activity</span></div><div class="casAuthors">Liu, Feng; Verin, Alexander D.; Wang, Peiyi; Day, Regina; Wersto, Robert P.; Chrest, Francis J.; English, Denis K.; Garcia, Joe G. N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">711-719</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">The authors compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor.  S1P-induced endothelial cell migration was max. at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/mL) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase).  Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification.  These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling.  Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/neg. Rho, or the addn. of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration.  Conversely, pharmacol. inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3' kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration.  Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration.  These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-assocd. kinase and p38 MAP kinase activation.  The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdSiUsOQr0MrVg90H21EOLACvtfcHk0lhmKxjRqNr1NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVWhsbc%253D&md5=57d11f81a89e65e37a4a05db38386606</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.24.6.4323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.24.6.4323%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DVerin%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DDay%26aufirst%3DR.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DChrest%26aufirst%3DF.%2BJ.%26aulast%3DEnglish%26aufirst%3DD.%2BK.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26atitle%3DDifferential%2520regulation%2520of%2520sphingosine-1-phosphate-%2520and%2520VEGF-induced%2520endothelial%2520cell%2520chemotaxis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2001%26volume%3D24%26spage%3D711%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase, sphingosine-1-phosphate, and apoptosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1585</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1585&publication_year=2002&pages=193-201&author=M.+Maceykaauthor=S.+G.+Payneauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+kinase%2C+sphingosine-1-phosphate%2C+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DPayne%26aufirst%3DS.%2BG.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252C%2520sphingosine-1-phosphate%252C%2520and%2520apoptosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1585%26spage%3D193%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Graeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1874</span><span class="NLM_x">–</span> <span class="NLM_lpage">1878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1874-1878&author=M.+Graelerauthor=E.+J.+Goetzl&title=Activation-regulated+expression+and+chemotactic+function+of+sphingosine+1-phosphate+receptors+in+mouse+splenic+T+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraeler%26aufirst%3DM.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DActivation-regulated%2520expression%2520and%2520chemotactic%2520function%2520of%2520sphingosine%25201-phosphate%2520receptors%2520in%2520mouse%2520splenic%2520T%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2002%26volume%3D16%26spage%3D1874%26epage%3D1878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dorsam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroogy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voice, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P<sub>1</sub> G protein-coupled receptor</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3500</span><span class="NLM_x">–</span> <span class="NLM_lpage">3507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2003&pages=3500-3507&author=G.+Dorsamauthor=M.+H.+Graelerauthor=C.+Seroogyauthor=Y.+Kongauthor=J.+K.+Voiceauthor=E.+J.+Goetzl&title=Transduction+of+multiple+effects+of+sphingosine+1-phosphate+%28S1P%29+on+T+cell+functions+by+the+S1P1+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDorsam%26aufirst%3DG.%26aulast%3DGraeler%26aufirst%3DM.%2BH.%26aulast%3DSeroogy%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DVoice%26aufirst%3DJ.%2BK.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DTransduction%2520of%2520multiple%2520effects%2520of%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520on%2520T%2520cell%2520functions%2520by%2520the%2520S1P1%2520G%2520protein-coupled%2520receptor%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D171%26spage%3D3500%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Sphingolipids in cell signalling: their function as receptor ligands, second messengers, and raft constituents</span> <span class="citation_source-journal">Curr. Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.2174%2F157339506775471929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=101-118&author=T.+Baumrukerauthor=A.+Billich&title=Sphingolipids+in+cell+signalling%3A+their+function+as+receptor+ligands%2C+second+messengers%2C+and+raft+constituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in cell signaling: their function as receptor ligands, second messengers, and raft constituents</span></div><div class="casAuthors">Baumruker, Thomas; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Current Immunology Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-118</span>CODEN:
                <span class="NLM_cas:coden">CIRUBM</span>;
        ISSN:<span class="NLM_cas:issn">1573-3955</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids have lately been recognized as important signaling mols. with an unexpected multitude of actions and mechanisms.  While we are currently just uncovering the tip of the iceberg, the available data give us an unprecedented understanding of how membrane rearrangements translate into the generation of intracellular lipid signaling mols. and further into secreted bioactive lipids.  Furthermore, new concepts such as the rheostat of sphingolipids show that fundamental principles in signaling also do apply to this class of mols.  The plethora of sphingolipids as well as sphingolipid modifying enzymes seem to comprise many novel, attractive, and pharmaceutically exploitable targets beyond sphingolipidoses, in applications ranging from autoimmune diseases and neurodegenerative conditions to cancer.  In this review, we summarize the mechanistic triad of action of sphingolipids as membrane/raft components, intracellular signaling mols., and secreted mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfFRnNDDtK57Vg90H21EOLACvtfcHk0lgE--P2Ka7k3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGks7g%253D&md5=9d05be8584cab71d6671ff33079a7b50</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F157339506775471929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157339506775471929%26sid%3Dliteratum%253Aachs%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DSphingolipids%2520in%2520cell%2520signalling%253A%2520their%2520function%2520as%2520receptor%2520ligands%252C%2520second%2520messengers%252C%2520and%2520raft%2520constituents%26jtitle%3DCurr.%2520Immunol.%2520Rev.%26date%3D2006%26volume%3D2%26spage%3D101%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsutake, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.plipres.2007.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17449104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksleksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=126-144&author=A.+Kiharaauthor=S.+Mitsutakeauthor=Y.+Mizutaniauthor=Y.+Igarashi&title=Metabolism+and+biological+functions+of+two+phosphorylated+sphingolipids%2C+sphingosine+1-phosphate+and+ceramide+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate</span></div><div class="casAuthors">Kihara, Akio; Mitsutake, Susumu; Mizutani, Yukiko; Igarashi, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-144</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are major lipid constituents of the eukaryotic plasma membrane.  Without certain sphingolipids, cells and/or embryos cannot survive, indicating that sphingolipids possess important physiol. functions that are not substituted for by other lipids.  One such role may be signaling.  Recent studies have revealed that some sphingolipid metabolites, such as long-chain bases (LCBs; sphingosine (Sph) in mammals), long-chain base 1-phosphates (LCBPs; sphingosine 1-phosphate (S1P) in mammals), ceramide (Cer), and ceramide 1-phosphate (C1P), act as signaling mols.  The addn. of phosphate groups to LCB/Sph and Cer generates LCBP/S1P and C1P, resp.  These phospholipids exhibit completely different functions than those of their precursors.  In this review, we describe recent advances in understanding the functions of LCBP/S1P and C1P in mammals and in the yeast Saccharomyces cerevisiae.  Since LCB/Sph, LCBP/S1P, Cer, and C1P are mutually convertible, regulation of not only the total amt. of the each lipid but also of the overall balance in cellular levels is important.  Therefore, we describe in detail their metabolic pathways, as well as the genes involved in each reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR2VCpyhKRq7Vg90H21EOLACvtfcHk0lgE--P2Ka7k3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksleksbY%253D&md5=e34947eaf24710a0c332884f05d1085e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2007.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2007.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DA.%26aulast%3DMitsutake%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DY.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DMetabolism%2520and%2520biological%2520functions%2520of%2520two%2520phosphorylated%2520sphingolipids%252C%2520sphingosine%25201-phosphate%2520and%2520ceramide%25201-phosphate%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2007%26volume%3D46%26spage%3D126%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.pharmthera.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17561264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=84-105&author=V.+Brinkmann&title=Sphingosine+1-phosphate+receptors+in+health+and+disease%3A+mechanistic+insights+from+gene+deletion+studies+and+reverse+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-105</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid that is critically involved in the embryonic development of the cardiovascular and central nervous systems.  In the adult, S1P can produce cytoskeletal re-arrangements in many cell types to regulate immune cell trafficking, vascular homeostasis and cell communication in the central nervous system.  S1P is contained in body fluids and tissues at different concns., and excessive prodn. of the pleiotropic mediator at inflammatory sites may participate in various pathol. conditions.  Gene deletion studies and reverse pharmacol. (techniques aiming to identify both ligands and function of receptors) provided evidence that many effects of S1P are mediated via five G-protein-coupled S1P receptor subtypes, and novel therapeutic strategies based on interaction with these receptors are being initiated.  The prototype S1P receptor modulator, FTY720 (fingolimod), targets four of the five S1P receptor subtypes and may act at several levels to modulate lymphocyte trafficking via lymphocytic and endothelial S1P1 and, perhaps, other inflammatory processes through addnl. S1P receptor subtypes.  A recently completed Phase II clin. trial suggested that the drug may provide an effective treatment of relapsing-remitting multiple sclerosis.  FTY720 is currently being evaluated in larger-scale, longer-term, Phase III studies.  This review provides an overview on S1P activities and S1P receptor function in health and disease, and summarizes the clin. experience with FTY720 in transplantation and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbwKhZo2vLrVg90H21EOLACvtfcHk0lgE--P2Ka7k3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D&md5=cacdb374439270734f34a0ca4771ca3d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DSphingosine%25201-phosphate%2520receptors%2520in%2520health%2520and%2520disease%253A%2520mechanistic%2520insights%2520from%2520gene%2520deletion%2520studies%2520and%2520reverse%2520pharmacology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D84%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hisano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawahara, A.</span><span> </span><span class="NLM_article-title">The functional roles of S1P in immunity</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1093%2Fjb%2Fmvs090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A280%3ADC%252BC38bhsVakug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2012&pages=305-311&author=Y.+Hisanoauthor=T.+Nishiauthor=A.+Kawahara&title=The+functional+roles+of+S1P+in+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The functional roles of S1P in immunity</span></div><div class="casAuthors">Hisano Yu; Nishi Tsuyoshi; Kawahara Atsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The lipid mediator sphingosine-1-phosphate (S1P) is generated within cells from sphingosine by two sphingosine kinases (SPHK1 and SPHK2).  Intracellularly synthesized S1P is released into the extracellular fluid by S1P transporters, including SPNS2.  Released S1P binds specifically to the G protein-coupled S1P receptors (S1PR1/S1P(1)-S1PR5/S1P(5)), which activate a diverse range of downstream signalling pathways.  Recent studies have proposed that one of the central physiological functions of intercellular S1P signalling is in lymphocyte trafficking in vivo because genetic disruption of SPHK1/2, SPNS2 or S1PR1/S1P(1) in mice induces a lymphopenia phenotype.  In this review, we discuss the current understanding of intercellular S1P signalling in the context of immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTNG8hBgzHx79KldV63DuefW6udTcc2eY5VGJeazxiCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bhsVakug%253D%253D&md5=0518eb05299bad2c3c7ee19c2df05f03</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvs090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvs090%26sid%3Dliteratum%253Aachs%26aulast%3DHisano%26aufirst%3DY.%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DKawahara%26aufirst%3DA.%26atitle%3DThe%2520functional%2520roles%2520of%2520S1P%2520in%2520immunity%26jtitle%3DJ.%2520Biochem.%26date%3D2012%26volume%3D152%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=265-269&author=J.+Chunauthor=E.+J.+Goetzlauthor=T.+Hlaauthor=Y.+Igarashiauthor=K.+R.+Lynchauthor=W.+Moolenaarauthor=S.+Pyneauthor=G.+Tigyi&title=International+Union+of+Pharmacology.+XXXIV.+Lysophospholipid+receptor+nomenclature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMoolenaar%26aufirst%3DW.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXXIV.%2520Lysophospholipid%2520receptor%2520nomenclature%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D265%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ishii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptors: signaling and biology</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1146%2Fannurev.biochem.73.011303.073731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15189145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=321-354&author=I.+Ishiiauthor=N.+Fukushimaauthor=X.+Yeauthor=J.+Chun&title=Lysophospholipid+receptors%3A+signaling+and+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptors: Signaling and biology</span></div><div class="casAuthors">Ishii, Isao; Fukushima, Nobuyuki; Ye, Xiaoqin; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321-354</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophospholipids (LPs), such as lysophosphatidic acid and sphingosine 1-phosphate, are membrane-derived bioactive lipid mediators.  LPs can affect fundamental cellular functions, which include proliferation, differentiation, survival, migration, adhesion, invasion, and morphogenesis.  These functions influence many biol. processes that include neurogenesis, angiogenesis, wound healing, immunity, and carcinogenesis.  In recent years, identification of multiple cognate G protein-coupled receptors has provided a mechanistic framework for understanding how LPs play such diverse roles.  Generation of LP receptor-null animals has allowed rigorous examn. of receptor-mediated physiol. functions in vivo and has identified new functions for LP receptor signaling.  Efforts to develop LP receptor subtype-specific agonists/antagonists are in progress and raise expectations for a growing collection of chem. tools and potential therapeutic compds.  The rapidly expanding literature on the LP receptors is herein reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJpFGxhumTLVg90H21EOLACvtfcHk0liV3hFa3r8wSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslags7g%253D&md5=0bb52f19cf0e1ec7f19bc8aa3f0b01a5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073731%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DI.%26aulast%3DFukushima%26aufirst%3DN.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520receptors%253A%2520signaling%2520and%2520biology%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D321%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnri1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15999095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=560-570&author=H.+Rosenauthor=E.+J.+Goetzl&title=Sphingosine+1-phosphate+and+its+receptors%3A+an+autocrine+and+paracrine+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span></div><div class="casAuthors">Rosen, Hugh; Goetzl, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a biol. active lysophospholipid that transmits signals through a family of G-protein-coupled receptors to control cellular differentiation and survival, as well as the vital functions of several types of immune cell.  In this Review article, the authors discuss recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles.  In an autocrine manner, through interactions with different G-protein-coupled receptors, S1P also enhances optimal mast-cell migration and release of pro-inflammatory mediators in allergic reactions.  S1P-S1P-receptor regulatory systems might therefore be novel targets for the therapy of diverse immunol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-Zo0R14YILVg90H21EOLACvtfcHk0liV3hFa3r8wSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D&md5=b680f6c9e29d407579ab7f056209d853</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnri1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1650%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520its%2520receptors%253A%2520an%2520autocrine%2520and%2520paracrine%2520network%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D560%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Meyer-zu-Heringdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobs, K. H.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2006&pages=923-940&author=D.+Meyer-zu-Heringdorfauthor=K.+H.+Jakobs&title=Lysophospholipid+receptors%3A+signalling%2C+pharmacology+and+regulation+by+lysophospholipid+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer-zu-Heringdorf%26aufirst%3DD.%26aulast%3DJakobs%26aufirst%3DK.%2BH.%26atitle%3DLysophospholipid%2520receptors%253A%2520signalling%252C%2520pharmacology%2520and%2520regulation%2520by%2520lysophospholipid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1768%26spage%3D923%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gardell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubi, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Emerging medicinal roles for lysophospholipid signaling</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.molmed.2005.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16406843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=65-75&author=S.+E.+Gardellauthor=A.+E.+Dubiauthor=J.+Chun&title=Emerging+medicinal+roles+for+lysophospholipid+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging medicinal roles for lysophospholipid signaling</span></div><div class="casAuthors">Gardell, Shannon E.; Dubin, Adrienne E.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The two lysophospholipids (LPs) lysophosphatidic acid and sphingosine 1-phosphate (S1P) regulate diverse biol. processes.  Over the past decade, it has become clear that medically relevant LP activities are mediated by specific G protein-coupled receptors, implicating them in the etiol. of a growing no. of disorders.  A new class of LP agonists shows promise for drug therapy: the exptl. drug FTY720 is phosphorylated in vivo to produce a potent S1P receptor agonist (FTY720-P) and is currently in Phase III clin. trials for kidney transplantation and Phase II for multiple sclerosis.  Recent genetic and pharmacol. studies on LP signaling in animal disease models have identified new areas in which interventions in LP signaling might provide novel therapeutic approaches for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjqDlFdQXDbVg90H21EOLACvtfcHk0lgViP4rKgokqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaku7Y%253D&md5=f82bde20b880c86f6bf660ae73c9a0ec</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2005.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2005.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGardell%26aufirst%3DS.%2BE.%26aulast%3DDubi%26aufirst%3DA.%2BE.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DEmerging%2520medicinal%2520roles%2520for%2520lysophospholipid%2520signaling%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D65%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangeer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.cellsig.2008.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18694820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=7-13&author=T.+Okadaauthor=T.+Kajimotoauthor=S.+Jahangeerauthor=S.+Nakamura&title=Sphingosine+kinase%2Fsphingosine+1-phosphate+signalling+in+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span></div><div class="casAuthors">Okada, Taro; Kajimoto, Taketoshi; Jahangeer, Saleem; Nakamura, Shun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids were once regarded as inert structural components of cell membranes.  Now these metabolites are generally believed to be important bioactive mols. that control a wide repertoire of cellular processes such as proliferation and survival of cells.  Along with these ubiquitous cell functions obsd. in many peripheral tissues sphingolipid metabolites, esp. sphingosine 1-phosphate, exert important neuron-specific functions such as regulation of neurotransmitter release.  This review summarizes physiol. and pathol. roles of sphingolipid metabolites emphasizing the role of sphingosine 1-phosphate in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvd7-soq4atbVg90H21EOLACvtfcHk0lgViP4rKgokqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI&md5=99538d7efb7f9866723a691e4d05f877</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2008.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2008.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKajimoto%26aufirst%3DT.%26aulast%3DJahangeer%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520signalling%2520in%2520central%2520nervous%2520system%26jtitle%3DCell.%2520Signalling%26date%3D2009%26volume%3D21%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in neural signalling and function</span> <span class="citation_source-journal">Acta Paediatr., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=40-43&author=S.+Milstienauthor=D.+Gudeauthor=S.+Spiegel&title=Sphingosine+1-phosphate+in+neural+signalling+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520in%2520neural%2520signalling%2520and%2520function%26jtitle%3DActa%2520Paediatr.%252C%2520Suppl.%26date%3D2007%26volume%3D96%26spage%3D40%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.coph.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16563863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=244-250&author=V.+Brinkmannauthor=T.+Baumruker&title=Pulmonary+and+vascular+pharmacology+of+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span></div><div class="casAuthors">Brinkmann, Volker; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-250</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Dysregulation of vasomotor tone, endothelial barrier function and immune cell trafficking are central to the pathol. of many lung diseases, including acute lung injury, adult respiratory distress syndrome, chronic obstructive pulmonary disease and asthma.  There is increasing evidence that the serum sphingolipid sphingosine 1-phosphate and its G-protein-coupled receptors are pivotal not only in the regulation of lymphocyte migration, but also in the maintenance of vascular homeostasis and the preservation of permeability barriers that sep. discrete compartments in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogmZxjsblpVLVg90H21EOLACvtfcHk0lgViP4rKgokqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D&md5=6e55263d754e331bcfa5d82ddc3eed7a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPulmonary%2520and%2520vascular%2520pharmacology%2520of%2520sphingosine%25201-phosphate%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D244%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Uhlig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulbins, E.</span><span> </span><span class="NLM_article-title">Sphingolipids in the lungs</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1164%2Frccm.200804-595SO" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18755926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2008&pages=1100-1114&author=S.+Uhligauthor=E.+Gulbins&title=Sphingolipids+in+the+lungs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in the lungs</span></div><div class="casAuthors">Uhlig, Stefan; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1100-1114</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  Sphingolipids such as sphingosine-1-phosphate (S1P), ceramide, or sphingomyelin are essential constituents of plasma membranes and regulate many (patho)physiol. cellular responses inducing apoptosis and cell survival, vascular permeability, mast cell activation, and airway smooth muscle functions.  The complexity of sphingolipid biol. is generated by a great variety of compds., diverse receptors, and often antagonistic functions of different sphingolipids.  For instance, apoptosis is promoted by ceramide and prevented by S1P, and pulmonary vascular permeability is increased by S1P2/3 receptors and by ceramide, whereas S1P1 receptors stabilize barrier integrity.  Several enzymes of the sphingolipid metab. respond to external stimuli such as sphingomyelinase isoenzymes that are activated by many stress stimuli and the sphingosine kinase isoenzymes that are activated by allergens.  The past years have provided increasing evidence that these processes contribute to pulmonary disorders including asthma, chronic obstructive pulmonary disease, acute lung injury, and cystic fibrosis.  Sphingolipid metab. offers several novel therapeutic targets for the treatment of lung diseases such as emphysema, asthma, cystic fibrosis, respiratory tract infection, sepsis, and acute lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1c1qpC7wtVLVg90H21EOLACvtfcHk0lgViP4rKgokqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D&md5=b10c3ec2970d660c9f4acd57657ae380</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1164%2Frccm.200804-595SO&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200804-595SO%26sid%3Dliteratum%253Aachs%26aulast%3DUhlig%26aufirst%3DS.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DSphingolipids%2520in%2520the%2520lungs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2008%26volume%3D178%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Augé, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nègre-Salvayre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvayre, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span> </span><span class="NLM_article-title">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FS0163-7827%2800%2900007-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=10799716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=207-229&author=N.+Aug%C3%A9author=A.+N%C3%A8gre-Salvayreauthor=R.+Salvayreauthor=T.+Levade&title=Sphingomyelin+metabolites+in+vascular+cell+signaling+and+atherogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span></div><div class="casAuthors">Auge, Nathalie; Negre-Salvayre, Anne; Salvayre, Robert; Levade, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-229</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 186 refs.  The atherosclerotic lesion most probably develops through a no. of cellular events which implicate all vascular cell types and include synthesis of extracellular proteins, cell proliferation, differentiation and death.  Sphingolipids and sphingolipid metabolizing enzymes may play important roles in atherogenesis, not only because of lipoprotein alterations but also by mediating a no. of cellular events which are believed to be crucial in the development of the vascular lesions such as proliferation or cell death.  Exogenous sphingolipids may mediate various biol. effects such as apoptosis, mitogenesis or differentiation depending on the cell type.  Moreover, several mols. present in the atherogenic lesion, such as oxidized LDL, growth factors or cytokines, which activate intracellular signaling pathways leading to vascular cell modifications, can stimulate sphingomyelin hydrolysis and generation of ceramide (and other metabolites as sphingosine-1-phosphate).  Here we review the potential implication of the sphingomyelin/ceramide cycle in vascular cell signaling related to atherosclerosis, and more generally the role of sphingolipids in the events obsd. during the atherosclerotic process as cell differentiation, migration, adhesion, retraction, proliferation and death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR0eHtIWIEnrVg90H21EOLACvtfcHk0ljyPMRGHz6Oow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D&md5=bc3809c124061cac95443445af340377</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0163-7827%2800%2900007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7827%252800%252900007-2%26sid%3Dliteratum%253Aachs%26aulast%3DAug%25C3%25A9%26aufirst%3DN.%26aulast%3DN%25C3%25A8gre-Salvayre%26aufirst%3DA.%26aulast%3DSalvayre%26aufirst%3DR.%26aulast%3DLevade%26aufirst%3DT.%26atitle%3DSphingomyelin%2520metabolites%2520in%2520vascular%2520cell%2520signaling%2520and%2520atherogenesis%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2000%26volume%3D39%26spage%3D207%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span> </span><span class="NLM_article-title">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fsj.bjp.0705934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15504747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=666-684&author=A.+E.+Alewijnseauthor=S.+L.+M.+Petersauthor=M.+C.+Michel&title=Cardiovascular+effects+of+sphingosine-1-phosphate+and+other+sphingomyelin+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.; Michel, Martin C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-684</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Upon various stimuli, cells metabolize sphingomyelin from the cellular plasma membrane to form sphingosylphosphorylcholine (SPC) or ceramide.  The latter can be further metabolized to sphingosine and then sphingosine-1-phosphate (S1P).  Apart from local formation, S1P and SPC are major constituents of blood plasma.  All four sphingomyelin metabolites (SMM) can act upon intracellular targets, and at least S1P and probably also SPC can addnl. act upon G-protein-coupled receptors.  While the mol. identity of the SPC receptors remains unclear, several subtypes of S1P receptors have been cloned and their distribution in cardiovascular tissues is described.  In the heart SMM can alter intracellular Ca2+ release, particularly via the ryanodine receptor, and conductance of various ion channels in the plasma membrane, particularly IK(Ach).  While the various SMM differ somewhat in their effects, the above alterations of ion homeostasis result in reduced cardiac function in most cases, and ceramide and/or sphingosine may be the mediators of the neg. inotropic effects of tumor necrosis factor.  In the vasculature, SMM mainly act as acute vasoconstrictors in most vessels, but ceramide can be a vasodilator.  SMM-induced vasoconstriction involves mobilization of Ca2+ from intracellular stores, influx of extracellular Ca2+ via L-type channels and activation of a rho-kinase.  Extended exposure to SMM, particularly S1P, promotes several stages of the angiogenic process like endothelial cell activation, migration, proliferation, tube formation and vascular maturation.  The authors propose that SMM are an important class of endogenous modulators of cardiovascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm47o1k_ITeLVg90H21EOLACvtfcHk0ljyPMRGHz6Oow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN&md5=b1f804471e653a56ad6794fd5092803f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705934%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26atitle%3DCardiovascular%2520effects%2520of%2520sphingosine-1-phosphate%2520and%2520other%2520sphingomyelin%2520metabolites%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D666%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McVerry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span> </span><span class="NLM_article-title">In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.cellsig.2004.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15494205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=131-139&author=B.+J.+McVerryauthor=J.+G.+N.+Garcia&title=In+vitro+and+in+vivo+modulation+of+vascular+barrier+integrity+by+sphingosine+1-phosphate%3A+mechanistic+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights</span></div><div class="casAuthors">McVerry, Bryan J.; Garcia, Joe G. N.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P), a biol. active lipid growth factor, induces robust endothelial cell activation resulting in cellular locomotion, vascular maturation and angiogenesis.  Recent work by our lab. has demonstrated S1P to enhance the cellular barrier function of the vascular endothelium.  S1P-induced modulation of vascular permeability is effected through profound cytoskeletal reorganization initiated by cell surface receptor-mediated G protein activation and downstream signaling via the Rho family of small GTPases.  The details of the downstream signaling mechanism remain an active area of in vitro investigation.  Translational investigation suggests a profound impact of S1P administration in the modulation of edema formation in disease state manifest as acute inflammatory lung injury in which increased vascular permeability is a hallmark feature.  These data support an exciting potential therapeutic role for S1P in vascular barrier enhancement necessary for the treatment of critically ill patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4F51YD2iELLVg90H21EOLACvtfcHk0ljyPMRGHz6Oow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D&md5=4d45ffb844dbe0853e55fb0a92a9b409</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DMcVerry%26aufirst%3DB.%2BJ.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520modulation%2520of%2520vascular%2520barrier%2520integrity%2520by%2520sphingosine%25201-phosphate%253A%2520mechanistic%2520insights%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yatomi, Y.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular disease</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.2174%2F138161206775474404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16472149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=575-587&author=Y.+Yatomi&title=Sphingosine+1-phosphate+in+vascular+biology%3A+possible+therapeutic+strategies+to+control+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases</span></div><div class="casAuthors">Yatomi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-587</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Blood platelets are very unique in that they store sphingosine 1-phosphate (Sph-1-P) abundantly (possibly due to the existence of highly active sphingosine kinase and a lack of Sph-1-P lyase) and release this bioactive lipid extracellularly upon stimulation.  Vascular endothelial cells (ECs) and smooth muscle cells (SMCs) respond dramatically to this platelet-derived bioactive lipid mainly through a family of G protein-coupled Sph-1-P receptors named S1P1, 2, 3, 4, and 5, originally referred to as EDG-1, 5, 3, 6, and 8, resp.  In fact, the importance of Sph-1-P in platelet-vascular cell interactions has been revealed in a no. of recent reports.  Through interaction with ECs, Sph-1-P can mediate physiol. wound healing processes such as vascular repair, although this important bioactive lipid can become atherogenic and thrombogenic, and cause or aggravate cardiovascular diseases esp. under certain pathol. conditions.  Sph-1-P induces vasoconstriction through interaction with SMCs.  It is likely that regulation of Sph-1-P biol. activities is important for the therapeutical purpose to control vascular disorders.  Particularly, the development of specific S1P receptor agonists or antagonists seems a reasonable strategy to selectively regulate the bioactivity of Sph-1-P, considering that a great diversity of Sph-1-P actions has been reported and that this diversity depends mainly on the S1P receptor subtype involved.  In this review, I will summarize recent findings on possible roles of Sph-1-P in vascular biol. and its therapeutical implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTzHZO1dz1pLVg90H21EOLACvtfcHk0lgRfeyjWAqY_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D&md5=8aaf620c15964f6b5a4db05df0f9c042</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F138161206775474404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474404%26sid%3Dliteratum%253Aachs%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DSphingosine%25201-phosphate%2520in%2520vascular%2520biology%253A%2520possible%2520therapeutic%2520strategies%2520to%2520control%2520vascular%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D575%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span> </span><span class="NLM_article-title">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.it.2007.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17276731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=102-107&author=H.+Rosenauthor=M.+G.+Sannaauthor=S.+M.+Cahalanauthor=P.+J.+Gonzalez-Cabrera&title=Tipping+the+gatekeeper%3A+S1P+regulation+of+endothelial+barrier+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span></div><div class="casAuthors">Rosen, Hugh; Sanna, M. Germana; Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The lysophospholipid sphingosine 1-phosphate (S1P) is a pleiotropic signaling lipid present constitutively in plasma, and secreted locally at elevated concns. at sites of inflammation.  S1P maintains essential variable homeostatic functions in addn. to inducing pathophysiol. through the activation of five specific high-affinity G-protein-coupled receptors.  Therefore, S1P can function as an extracellular rheostat regulating tonic and acutely evoked functions.  Although S1P receptors can regulate lymphoid development and lymphocyte trafficking, and different opinions exist on the roles of receptor agonism and functional antagonism in regulating lymphocyte recirculation, this personal perspective highlights the pivotal control points regulated by constitutive and induced S1P receptor tone at vascular endothelial and lymphatic endothelial barriers, through which S1P agonism impacts on both innate and adaptive immunity.  The authors also emphasize how specific, proof-of-concept chem. tools complement genetic approaches by enabling reversible perturbation of the S1P-S1P1 receptor axis and, thus, clarifying in vivo mechanisms in the absence of developmental compensations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5AFhhSUSlLVg90H21EOLACvtfcHk0lgRfeyjWAqY_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D&md5=2ccb920fd60591f904189b7e69597a99</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2007.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2007.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26atitle%3DTipping%2520the%2520gatekeeper%253A%2520S1P%2520regulation%2520of%2520endothelial%2520barrier%2520function%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26spage%3D102%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulders, A. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongsma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Vascular effects of sphingolipids</span> <span class="citation_source-journal">Acta Paediatr., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=44-48&author=M.+C.+Michelauthor=A.+C.+M.+Muldersauthor=M.+Jongsmaauthor=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Vascular+effects+of+sphingolipids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DMulders%26aufirst%3DA.%2BC.%2BM.%26aulast%3DJongsma%26aufirst%3DM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DVascular%2520effects%2520of%2520sphingolipids%26jtitle%3DActa%2520Paediatr.%252C%2520Suppl.%26date%3D2007%26volume%3D96%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Sphingolipid signalling in the cardiovascular system: good, bad or both?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.ejphar.2008.02.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18420192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2008&pages=292-302&author=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Sphingolipid+signalling+in+the+cardiovascular+system%3A+good%2C+bad+or+both%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipid signalling in the cardiovascular system: Good, bad or both?</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">292-302</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are biol. active lipids that play important roles in various cellular processes and the sphingomyelin metabolites ceramide, sphingosine and sphingosine-1-phosphate can act as signaling mols. in most cell types.  With the recent development of the immunosuppressant drug FTY720 (Fingolimod) which after phosphorylation in vivo acts as a sphingosine-1-phosphate receptor agonist, research on the role of sphingolipids in the immune and other organ systems was triggered enormously.  Since it was reported that FTY720 induced a modest, but significant transient decrease in heart rate in animals and humans, the question was raised which pharmacol. properties of drugs targeting sphingolipid signaling will affect cardiovascular function in vivo.  The answer to this question will most likely also indicate what type of drug could be used to treat cardiovascular disease.  The latter is becoming increasingly important because of the increasing population carrying characteristics of the metabolic syndrome.  This syndrome is, amongst others, characterized by obesity, hypertension, atherosclerosis and diabetes.  As such, individuals with this syndrome are at increased risk of heart disease.  Now numerous studies have investigated sphingolipid effects in the cardiovascular system, can we speculate whether certain sphingolipids under specific conditions are good, bad or maybe both.  In this review we will give a brief overview of the pathophysiol. role of sphingolipids in cardiovascular disease.  In addn., we will try to answer how drugs that target sphingolipid signaling will potentially influence cardiovascular function and whether these drugs would be useful to treat cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrn1VPopZK7Vg90H21EOLACvtfcHk0lgRfeyjWAqY_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D&md5=259b21af9aa684253974c6772861c859</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DSphingolipid%2520signalling%2520in%2520the%2520cardiovascular%2520system%253A%2520good%252C%2520bad%2520or%2520both%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D585%26spage%3D292%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate-specific G protein-coupled receptors as novel therapeutic targets for atherosclerosis</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=117-137&author=Y.+Okamotoauthor=F.+Wangauthor=K.+Yoshiokaauthor=N.+Takuwaauthor=Y.+Takuwa&title=Sphingosine-1-phosphate-specific+G+protein-coupled+receptors+as+novel+therapeutic+targets+for+atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DTakuwa%26aufirst%3DN.%26aulast%3DTakuwa%26aufirst%3DY.%26atitle%3DSphingosine-1-phosphate-specific%2520G%2520protein-coupled%2520receptors%2520as%2520novel%2520therapeutic%2520targets%2520for%2520atherosclerosis%26jtitle%3DPharmaceuticals%26date%3D2011%26volume%3D4%26spage%3D117%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lucke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">Endothelial functions of sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1159%2F000315109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=20502008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=87-96&author=S.+Luckeauthor=B.+Levkau&title=Endothelial+functions+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial Functions of Sphingosine-1-phosphate</span></div><div class="casAuthors">Lucke, Susann; Levkau, Bodo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The biol. active sphingolipid sphingosine-1-phosphate (S1P) plays key functions in the immune, inflammatory, and cardiovascular systems.  In the vasculature, S1P and its receptors are involved in vessel morphogenesis and angiogenesis during embryonic development and in the adult organism both under normal and pathol. conditions.  Via its actions on endothelial and smooth muscle cells, S1P regulates arterial tone, vascular permeability, and tissue perfusion.  Elevated local S1P levels during inflammation induce endothelial adhesion mols., recruit inflammatory cells, and activate dendritic cells.  At the same time, S1P activates a neg. feedback loop that consecutively seals endothelial cell-cell contacts, decreases vascular leakage, and inhibits cytokine-induced leukocyte adhesion.  Thus S1P dets. not only the build-up, magnitude, and duration of an inflammatory reaction but also the pace of its resoln.  This review focuses on the role S1P plays in endothelial function, its receptors and signalling pathways, and the role its major carrier high-d. lipoproteins (HDL) play in its bioavailability and transport.  We will also discuss the potential of interfering with S1P-S1P receptor interactions for the treatment of endothelial disorders and vascular pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgsnbdFMWkH7Vg90H21EOLACvtfcHk0lhUkYbfQIieJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D&md5=7cb409784dfea08b42abaa924e5b3bff</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1159%2F000315109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315109%26sid%3Dliteratum%253Aachs%26aulast%3DLucke%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3DEndothelial%2520functions%2520of%2520sphingosine-1-phosphate%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Oskeritzian, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.pharmthera.2007.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=17669501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=390-399&author=C.+A.+Oskeritzianauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+in+allergic+responses%2C+asthma+and+anaphylaxis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span></div><div class="casAuthors">Oskeritzian, Carole A.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-399</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in many cellular processes, acting not only as an extracellular ligand to its specific G protein-coupled receptors, but also as a putative intracellular messenger with yet unidentified targets.  Mast cells are tissue-dwelling pivotal early effectors of allergic responses, which produce and secrete S1P that can bind to its receptors present on mast cells to influence their activation and functions.  In this review, we will first discuss the current knowledge of S1P prodn. by two isoenzymes of sphingosine kinase (SphK).  Mechanisms of SphK activation will be discussed, with an emphasis on exptl. approaches developed to study their differential activation and biol. roles in the context of mast cells.  The relevance of mast cells in the etiol. of allergic disorders, asthma and anaphylaxis is well established.  In this review, this concept will be revisited, focusing on the contribution of S1P prodn. and secretion to the symptoms assocd. with dysregulated inflammatory responses.  To conclude, counteracting the proinflammatory effects of S1P could be envisioned as a therapeutic strategy to treat allergic disorders, exacerbated airway inflammation, and anaphylactic reactions, and various options will be discussed, such as the development of pharmacol. tools to inhibit SphKs, S1P neutralizing monoclonal antibody, and S1P receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU658KZB9wzbVg90H21EOLACvtfcHk0lhUkYbfQIieJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL&md5=6ca77f4bc8322527e1d6ad3db24b6244</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DOskeritzian%26aufirst%3DC.%2BA.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520in%2520allergic%2520responses%252C%2520asthma%2520and%2520anaphylaxis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D390%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rivera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span> </span><span class="NLM_article-title">The alliance of sphingosine-1-phosphate and its receptors in immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnri2400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18787560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=753-763&author=J.+Riveraauthor=R.+L.+Proiaauthor=A.+Olivera&title=The+alliance+of+sphingosine-1-phosphate+and+its+receptors+in+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The alliance of sphingosine-1-phosphate and its receptors in immunity</span></div><div class="casAuthors">Rivera, Juan; Proia, Richard L.; Olivera, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">753-763</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a biol. active metabolite of plasma membrane sphingolipids that is essential for immune cell trafficking.  Its concn. is increased in many inflammatory conditions, such as asthma and autoimmunity.  Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5).  Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogShP9St3JD7Vg90H21EOLACvtfcHk0lhUkYbfQIieJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI&md5=27e4cbfcd2f91fb1ff9cab462f0e44b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnri2400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2400%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DOlivera%26aufirst%3DA.%26atitle%3DThe%2520alliance%2520of%2520sphingosine-1-phosphate%2520and%2520its%2520receptors%2520in%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D753%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauschen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier-Schellersheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, R. N.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=524-528&author=M.+Ishiiauthor=J.+G.+Egenauthor=F.+Klauschenauthor=M.+Meier-Schellersheimauthor=Y.+Saekiauthor=J.+Vacherauthor=R.+L.+Proiaauthor=R.+N.+Germain&title=Sphingosine-1-phosphate+mobilizes+osteoclast+precursors+and+regulates+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DEgen%26aufirst%3DJ.%2BG.%26aulast%3DKlauschen%26aufirst%3DF.%26aulast%3DMeier-Schellersheim%26aufirst%3DM.%26aulast%3DSaeki%26aufirst%3DY.%26aulast%3DVacher%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DGermain%26aufirst%3DR.%2BN.%26atitle%3DSphingosine-1-phosphate%2520mobilizes%2520osteoclast%2520precursors%2520and%2520regulates%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D524%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span> </span><span class="NLM_article-title">New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1893-1900&author=A.+Huwilerauthor=J.+Pfeilschifter&title=New+players+on+the+center+stage%3A+sphingosine+1-phosphate+and+its+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26atitle%3DNew%2520players%2520on%2520the%2520center%2520stage%253A%2520sphingosine%25201-phosphate%2520and%2520its%2520receptors%2520as%2520drug%2520targets%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1893%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate signalling in cancer</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1042%2FBST20110602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22260672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=94-100&author=N.+J.+Pyneauthor=F.+Tonelliauthor=K.+G.+Limauthor=J.+S.+Longauthor=J.+Edwardsauthor=S.+Pyne&title=Sphingosine+1-phosphate+signalling+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate signalling in cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Tonelli, Francesca; Lim, Keng Gat; Long, Jaclyn S.; Edwards, Joanne; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an increasing body of evidence demonstrating a crit. role for the bioactive lipid S1P (sphingosine 1-phosphate) in cancer.  S1P is synthesized and metabolized by a no. of enzymes, including sphingosine kinase, S1P lyase and S1P phosphatases.  S1P binds to cell-surface G-protein-coupled receptors (S1P1-S1P5) to elicit cell responses and can also regulate, by direct binding, a no. of intracellular targets such as HDAC (histone deacetylase) 1/2 to induce epigenetic regulation.  S1P is involved in cancer progression including cell transformation/oncogenesis, cell survival/apoptosis, cell migration/metastasis and tumor microenvironment neovascularization.  In the present paper, we describe our research findings regarding the correlation of sphingosine kinase 1 and S1P receptor expression in tumors with clin. outcome and we define some of the mol. mechanisms underlying the involvement of sphingosine kinase 1 and S1P receptors in the formation of a cancer cell migratory phenotype.  The role of sphingosine kinase 1 in the acquisition of chemotherapeutic resistance and the interaction of S1P receptors with oncogenes such as HER2 is also reviewed.  We also discuss novel aspects of the use of small-mol. inhibitors of sphingosine kinase 1 in terms of allosterism, ubiquitin-proteasomal degrdn. of sphingosine kinase 1 and anticancer activity.  Finally, we describe how S1P receptor-modulating agents abrogate S1P receptor-receptor tyrosine kinase interactions, with potential to inhibit growth-factor-dependent cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryryplFV-76bVg90H21EOLACvtfcHk0ljKre6u9x-NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D&md5=e0f90be10095c1d682345caaf8cce2c0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1042%2FBST20110602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110602%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BS.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520signalling%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikumar, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate signaling and its role in disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.tcb.2011.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22001186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=50-60&author=M.+Maceykaauthor=K.+B.+Harikumarauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+signaling+and+its+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate signaling and its role in disease</span></div><div class="casAuthors">Maceyka, Michael; Harikumar, Kuzhuvelil B.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) is now recognized as a crit. regulator of many physiol. and pathophysiol. processes, including cancer, atherosclerosis, diabetes and osteoporosis.  S1P is produced in cells by two sphingosine kinase isoenzymes, SphK1 and SphK2.  Many cells secrete S1P, which can then act in an autocrine or paracrine manner.  Most of the known actions of S1P are mediated by a family of five specific G protein-coupled receptors.  More recently, it was shown that S1P also has important intracellular targets involved in inflammation, cancer and Alzheimer's disease.  This suggests that S1P actions are much more complex than previously thought, with important ramifications for development of therapeutics.  This review highlights recent advances in our understanding of the mechanisms of action of S1P and its roles in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0UHcgnAzcArVg90H21EOLACvtfcHk0ljKre6u9x-NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D&md5=93baaa54059ffec593c9e0092716f02e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2011.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2011.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520signaling%2520and%2520its%2520role%2520in%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2012%26volume%3D22%26spage%3D50%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=853-856&author=K.+Adachiauthor=T.+Koharaauthor=N.+Nakaoauthor=M.+Aritaauthor=K.+Chibaauthor=T.+Mishinaauthor=S.+Sasakiauthor=T.+Fujita&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+2-substituted-2-amino-1%2C3-propanediols%3A+discovery+of+a+novel+immunosuppressant%2C+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DNakao%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25202-substituted-2-amino-1%252C3-propanediols%253A%2520discovery%2520of%2520a%2520novel%2520immunosuppressant%252C%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D853%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masubuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span> </span><span class="NLM_article-title">FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">5037</span><span class="NLM_x">–</span> <span class="NLM_lpage">5044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=9590253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=5037-5044&author=K.+Chibaauthor=Y.+Yanagawaauthor=Y.+Masubuchiauthor=H.+Kataokaauthor=T.+Kawaguchiauthor=M.+Ohtsukiauthor=Y.+Hoshino&title=FTY720%2C+a+novel+immunosuppressant%2C+induces+sequestration+of+circulating+mature+lymphocytes+by+acceleration+of+lymphocyte+homing+in+rats.+I.+FTY720+selectively+decreases+the+number+of+circulating+mature+lymphocytes+by+acceleration+of+lymphocyte+homing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing</span></div><div class="casAuthors">Chiba, Kenji; Yanagawa, Yoshiki; Masubuchi, Yumi; Kataoka, Hirotoshi; Kawaguchi, Takafumi; Ohtsuki, Makio; Hoshino, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5037-5044</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">FTY720, given i.v. or orally at 0.03 mg/kg or more, prolonged skin allograft survival in a dose-dependent manner and showed more potent immunosuppressive activity than cyclosporin A (CsA) or tacrolimus (FK506) in MHC-incompatible rat strains of WKAH donors and F344 recipients.  However, unlike CsA or FK506, FTY720 up to 1000 nM did not affect IL-2 prodn. in allogeneic MLC.  Within 3-24 h after a single oral administration of FTY720 at 0.1-1 mg/kg, the no. of lymphocytes in the rats was markedly decreased in the peripheral blood and thoracic duct lymph and partially in spleen.  By contrast, the no. of lymphocytes in peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN), and Peyer's patches (PP) was increased at the same time.  I.v. transfusion of calcein-labeled rat lymphocytes into rats revealed that FTY720 accelerated lymphocyte homing to PLN, MLN, and PP, dose dependently.  Since FTY720-induced lymphocyte homing was completely blocked by simultaneous treatment of the calcein-labeled lymphocytes with mAbs against CD62L, CD49d, and CD11a before the transfusion, the acceleration of lymphocyte homing by FTY720 appears to be mediated by lymphocyte-homing receptors.  Thus, FTY720 sequesters circulating mature lymphocytes into PLN, MLN, and PP by acceleration of lymphocyte homing and thereby decreases the no. of lymphocytes in peripheral blood, thoracic duct lymph, and spleen.  Based on these observations, sequestration of circulating mature-lymphocytes is presumed to be a main mechanism of the immunosuppressive activity of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeImxxYccaHrVg90H21EOLACvtfcHk0lggZ1fd31fEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D&md5=db7da181424c790a0fb07c0dc60badae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DYanagawa%26aufirst%3DY.%26aulast%3DMasubuchi%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DOhtsuki%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DY.%26atitle%3DFTY720%252C%2520a%2520novel%2520immunosuppressant%252C%2520induces%2520sequestration%2520of%2520circulating%2520mature%2520lymphocytes%2520by%2520acceleration%2520of%2520lymphocyte%2520homing%2520in%2520rats.%2520I.%2520FTY720%2520selectively%2520decreases%2520the%2520number%2520of%2520circulating%2520mature%2520lymphocytes%2520by%2520acceleration%2520of%2520lymphocyte%2520homing%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D160%26spage%3D5037%26epage%3D5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Pinschewer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochsenbein, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odermatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengartner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinkernagel, R. M.</span><span> </span><span class="NLM_article-title">FTY720 immunosupression impairs effector T cell peripheral homing without affecting induction, expansion, and memory</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">5761</span><span class="NLM_x">–</span> <span class="NLM_lpage">5770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=5761-5770&author=D.+D.+Pinschewerauthor=A.+F.+Ochsenbeinauthor=B.+Odermattauthor=V.+Brinkmannauthor=H.+Hengartnerauthor=R.+M.+Zinkernagel&title=FTY720+immunosupression+impairs+effector+T+cell+peripheral+homing+without+affecting+induction%2C+expansion%2C+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinschewer%26aufirst%3DD.%2BD.%26aulast%3DOchsenbein%26aufirst%3DA.%2BF.%26aulast%3DOdermatt%26aufirst%3DB.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DHengartner%26aufirst%3DH.%26aulast%3DZinkernagel%26aufirst%3DR.%2BM.%26atitle%3DFTY720%2520immunosupression%2520impairs%2520effector%2520T%2520cell%2520peripheral%2520homing%2520without%2520affecting%2520induction%252C%2520expansion%252C%2520and%2520memory%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D5761%26epage%3D5770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinschewer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span> </span><span class="NLM_article-title">FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FS0041-1345%2800%2902126-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11266942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2htbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=530-531&author=V.+Brinkmannauthor=S.+Chenauthor=L.+Fengauthor=D.+Pinschewerauthor=Z.+Nikolovaauthor=R.+Hof&title=FTY720+alters+lymphocyte+homing+and+protects+allografts+without+inducing+general+immunosuppression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression</span></div><div class="casAuthors">Brinkmann, V.; Chen, S.; Feng, L.; Pinschewer, D.; Nikolova, Z.; Hof, R.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">530-531</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 12 refs.  The novel immunomodulator, FTY720, prolongs with remarkable potency the survival of allografted kidney, heart, liver, small bowel, and skin in animal models including nonhuman primates, and prevents the development of coronary artery disease and graft-vs.-host-disease (GVHD).  It interferes with the responsiveness of lymphocytes to chemokines, suppressing lymphocyte recirculation to the periphery and infiltration of T cells into grafted organs without impairment of immune responses to systemic viral infection.  Several expts. conducted on the efficiency of FTY720 are presented.  Topics covered include modulation of chemokine-driven lymphocyte migration; impairment of T-and B-cell function; and safety pharmacol. and clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-qZW0gPJe7Vg90H21EOLACvtfcHk0lggZ1fd31fEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2htbk%253D&md5=5692b6e5068ce7595c8f80d09aff82b7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2800%2902126-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252800%252902126-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DPinschewer%26aufirst%3DD.%26aulast%3DNikolova%26aufirst%3DZ.%26aulast%3DHof%26aufirst%3DR.%26atitle%3DFTY720%2520alters%2520lymphocyte%2520homing%2520and%2520protects%2520allografts%2520without%2520inducing%2520general%2520immunosuppression%26jtitle%3DTransplant.%2520Proc.%26date%3D2001%26volume%3D33%26spage%3D530%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lggZ1fd31fEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornancin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dévay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechtcheriakova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">47408</span><span class="NLM_x">–</span> <span class="NLM_lpage">47415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1074%2Fjbc.M307687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=13129923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=47408-47415&author=A.+Billichauthor=F.+Bornancinauthor=P.+D%C3%A9vayauthor=D.+Mechtcheriakovaauthor=N.+Urtzauthor=T.+Baumruker&title=Phosphorylation+of+the+immunomodulatory+drug+FTY720+by+sphingosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span></div><div class="casAuthors">Billich, Andreas; Bornancin, Frederic; Devay, Piroska; Mechtcheriakova, Diana; Urtz, Nicole; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">47408-47415</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The immunomodulatory drug FTY720 is phosphorylated in vivo, and the resulting FTY720 phosphate as a ligand for sphingosine-1-phosphate receptors is responsible for the unique biol. effects of the compd.  So far, phosphorylation of FTY720 by murine sphingosine kinase (SPHK) 1a had been documented.  We found that, while FTY720 is also phosphorylated by human SPHK1, the human type 2 isoform phosphorylates the drug 30-fold more efficiently, because of a lower Km of FTY720 for SPHK2.  Similarly, murine SPHK2 was more efficient than SPHK1a.  Among splice variants of the human SPHKs, an N-terminally extended SPHK2 isoform was even more active than SPHK2 itself.  Further SPHK superfamily members, namely ceramide kinase and a "SPHK-like" protein, failed to phosphorylate sphingosine and FTY720.  Thus, only SPHK1 and 2 appear to be capable of phosphorylating FTY720.  Using selective assay conditions, SPHK1 and 2 activities in murine tissues were measured.  While activity of SPHK2 toward sphingosine was generally lower than of SPHK1, FTY720 phosphorylation was higher under conditions favoring SPHK2.  In human endothelial cells, while activity of SPHK1 toward sphingosine was 2-fold higher than of SPHK2, FTY720 phosphorylation was 7-fold faster under SPHK2 assay conditions.  Finally, FTY720 was poorly phosphorylated in human blood as compared with rodent blood, in line with the low activity of SPHK1 and in particular of SPHK2 in human blood.  To conclude, both SPHK1 and 2 are capable of phosphorylating FTY720, but SPHK2 is quant. more important than SPHK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5e-dVWnBT7Vg90H21EOLACvtfcHk0li1MbAEYPjGBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D&md5=26820503680682863dc76a69ea02fc7e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307687200%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DD%25C3%25A9vay%26aufirst%3DP.%26aulast%3DMechtcheriakova%26aufirst%3DD.%26aulast%3DUrtz%26aufirst%3DN.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPhosphorylation%2520of%2520the%2520immunomodulatory%2520drug%2520FTY720%2520by%2520sphingosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D47408%26epage%3D47415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P<sub>2</sub> and S1P<sub>3</sub> receptors and Smad-independent signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14839</span><span class="NLM_x">–</span> <span class="NLM_lpage">14851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=14839-14851&author=K.+Sobelauthor=K.+Menyhartauthor=N.+Killerauthor=B.+Renaultauthor=Y.+Bauerauthor=R.+Studerauthor=B.+Steinerauthor=M.+H.+Bolliauthor=O.+Naylerauthor=J.+Gatfield&title=Sphingosine-1-phosphate+%28S1P%29+receptor+agonists+mediate+pro-fibrotic+responses+in+normal+human+lung+fibroblasts+via+S1P2+and+S1P3+receptors+and+Smad-independent+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobel%26aufirst%3DK.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DKiller%26aufirst%3DN.%26aulast%3DRenault%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DY.%26aulast%3DStuder%26aufirst%3DR.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DGatfield%26aufirst%3DJ.%26atitle%3DSphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonists%2520mediate%2520pro-fibrotic%2520responses%2520in%2520normal%2520human%2520lung%2520fibroblasts%2520via%2520S1P2%2520and%2520S1P3%2520receptors%2520and%2520Smad-independent%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D14839%26epage%3D14851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, J.</span><span> </span><span class="NLM_article-title">The vascular S1P gradient: cellular sources and biological significance</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=477-482&author=T.+Hlaauthor=K.+Venkataramanauthor=J.+Michaud&title=The+vascular+S1P+gradient%3A+cellular+sources+and+biological+significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DVenkataraman%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DJ.%26atitle%3DThe%2520vascular%2520S1P%2520gradient%253A%2520cellular%2520sources%2520and%2520biological%2520significance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1781%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Finding a way out: lymphocyte egress from lymphoid organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fni1545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18026082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1295-1301&author=S.+R.+Schwabauthor=J.+G.+Cyster&title=Finding+a+way+out%3A+lymphocyte+egress+from+lymphoid+organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a way out: lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Schwab, Susan R.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1301</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function.  The discovery that a small-mol. inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs.  S1P exists in higher concns. in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit.  Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes.  In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites.  We relate this model to work examg. the effects of S1P receptor agonists on endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWY-Rk111SmLVg90H21EOLACvtfcHk0li1MbAEYPjGBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J&md5=ccf7ef06130d3ebd218707ac92618f36</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fni1545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1545%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DFinding%2520a%2520way%2520out%253A%2520lymphocyte%2520egress%2520from%2520lymphoid%2520organs%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1295%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Pappu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regard, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=295-298&author=R.+Pappuauthor=S.+R.+Schwabauthor=I.+Cornelissenauthor=J.+P.+Pereiraauthor=J.+B.+Regardauthor=Y.+Xuauthor=E.+Camererauthor=Y.-W.+Zhengauthor=Y.+Huangauthor=J.+G.+Cysterauthor=S.+R.+Coughlin&title=Promotion+of+lymphocyte+egress+into+blood+and+lymph+by+distinct+sources+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPappu%26aufirst%3DR.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCornelissen%26aufirst%3DI.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DRegard%26aufirst%3DJ.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DY.-W.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DPromotion%2520of%2520lymphocyte%2520egress%2520into%2520blood%2520and%2520lymph%2520by%2520distinct%2520sources%2520of%2520sphingosine-1-phosphate%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D295%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goitsuka, R.</span><span> </span><span class="NLM_article-title">Lymphopenia induced by a novel selective S1P<sub>1</sub> antagonist structurally unrelated to S1P</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1821</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1821&publication_year=2012&pages=600-606&author=Y.+Fujiiauthor=H.+Ohtakeauthor=N.+Onoauthor=T.+Haraauthor=T.+Sakuraiauthor=S.+Takahashiauthor=T.+Takayamaauthor=Y.+Fukasawaauthor=F.+Shiozawaauthor=N.+Tsukaharaauthor=T.+Hirayamaauthor=Y.+Igarashiauthor=R.+Goitsuka&title=Lymphopenia+induced+by+a+novel+selective+S1P1+antagonist+structurally+unrelated+to+S1P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTakayama%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DY.%26aulast%3DShiozawa%26aufirst%3DF.%26aulast%3DTsukahara%26aufirst%3DN.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DGoitsuka%26aufirst%3DR.%26atitle%3DLymphopenia%2520induced%2520by%2520a%2520novel%2520selective%2520S1P1%2520antagonist%2520structurally%2520unrelated%2520to%2520S1P%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1821%26spage%3D600%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Quancard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollbuck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berst, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehlmayer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seuwen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersperger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassilana, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigaud, M.</span><span> </span><span class="NLM_article-title">A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.chembiol.2012.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22999882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2ktbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1142-1151&author=J.+Quancardauthor=B.+Bollbuckauthor=P.+Janserauthor=D.+Angstauthor=F.+Berstauthor=P.+Buehlmayerauthor=M.+Streiffauthor=C.+Beerliauthor=V.+Brinkmannauthor=D.+Gueriniauthor=P.+A.+Smithauthor=T.+J.+Seabrookauthor=M.+Traebertauthor=K.+Seuwenauthor=R.+Herspergerauthor=C.+Brunsauthor=F.+Bassilanaauthor=M.+Bigaud&title=A+potent+and+selective+S1P1+antagonist+with+efficacy+in+experimental+autoimmune+encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis</span></div><div class="casAuthors">Quancard, Jean; Bollbuck, Birgit; Janser, Philipp; Angst, Daniela; Berst, Frederic; Buehlmayer, Peter; Streiff, Markus; Beerli, Christian; Brinkmann, Volker; Guerini, Danilo; Smith, Paul A.; Seabrook, Timothy J.; Traebert, Martin; Seuwen, Klaus; Hersperger, Rene; Bruns, Christian; Bassilana, Frederic; Bigaud, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1142-1151</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lymphocyte trafficking is critically regulated by the Sphingosine 1-phosphate receptor-1 (S1P1), a G protein-coupled receptor that has been highlighted as a promising therapeutic target in autoimmunity.  Fingolimod (FTY720, Gilenya) is a S1P1 receptor agonist that has recently been approved for the treatment of multiple sclerosis (MS).  Here, we report the discovery of NIBR-0213, a potent and selective S1P1 antagonist that induces long-lasting redn. of peripheral blood lymphocyte counts after oral dosing.  NIBR-0213 showed comparable therapeutic efficacy to fingolimod in exptl. autoimmune encephalomyelitis (EAE), a model of human MS.  These data provide convincing evidence that S1P1 antagonists are effective in EAE.  In addn., the profile of NIBR-0213 makes it an attractive candidate to further study the consequences of S1P1 receptor antagonism and to differentiate the effects from those of S1P1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbbNhwIy5fA7Vg90H21EOLACvtfcHk0lgO_Zvr6lTJ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2ktbbK&md5=7cf4d66d138fa7f316ac971508e45058</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DBollbuck%26aufirst%3DB.%26aulast%3DJanser%26aufirst%3DP.%26aulast%3DAngst%26aufirst%3DD.%26aulast%3DBerst%26aufirst%3DF.%26aulast%3DBuehlmayer%26aufirst%3DP.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DP.%2BA.%26aulast%3DSeabrook%26aufirst%3DT.%2BJ.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DSeuwen%26aufirst%3DK.%26aulast%3DHersperger%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DBassilana%26aufirst%3DF.%26aulast%3DBigaud%26aufirst%3DM.%26atitle%3DA%2520potent%2520and%2520selective%2520S1P1%2520antagonist%2520with%2520efficacy%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1142%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the sphingosine 1-phosphate receptor, S1P<sub>1</sub>, on T-cells controls thymic emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+sphingosine+1-phosphate+receptor%2C+S1P1%2C+on+T-cells+controls+thymic+emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520controls%2520thymic%2520emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprak, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3351</span><span class="NLM_x">–</span> <span class="NLM_lpage">3355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3351-3355&author=J.+J.+Haleauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=G.+C.+Kooauthor=S.+L.+Koprakauthor=J.+J.+Jacksonauthor=H.+Rosenauthor=S.+Mandala&title=Potent+S1P+receptor+agonists+replicate+the+pharmacologic+actions+of+the+novel+immune+modulator+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DKoprak%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DJ.%2BJ.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DPotent%2520S1P%2520receptor%2520agonists%2520replicate%2520the%2520pharmacologic%2520actions%2520of%2520the%2520novel%2520immune%2520modulator%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3351%26epage%3D3355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.chembiol.2005.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=15975516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=703-715&author=E.+Joauthor=M.+G.+Sannaauthor=P.+J.+Gonzalez-Cabreraauthor=S.+Thangadaauthor=G.+Tigyiauthor=D.+A.+Osborneauthor=T.+Hlaauthor=A.+L.+Parrillauthor=H.+Rosen&title=S1P1-selective+in+vivo-active+agonists+from+high-throughput+screening%3A+off-the-shelf+chemical+probes+of+receptor+interactions%2C+signaling%2C+and+fate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">S1P1-Selective In Vivo-Active Agonists from High- Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate</span></div><div class="casAuthors">Jo, Euijung; Sanna, M. Germana; Gonzalez-Cabrera, Pedro J.; Thangada, Shobha; Tigyi, Gabor; Osborne, Daniel A.; Hla, Timothy; Parrill, Abby L.; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">703-715</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The essential role of the sphingosine 1-phosphate (S1P) receptor S1P1 in regulating lymphocyte trafficking was demonstrated with the S1P1-selective nanomolar agonist, SEW2871.  Despite its lack of charged headgroup, the tetraarom. compd. SEW2871 binds and activates S1P1 through a combination of hydrophobic and ion-dipole interactions.  Both S1P and SEW2871 activated ERK, Akt, and Rac signaling pathways and induced S1P1 internalization and recycling, unlike FTY720-phosphate, which induces receptor degrdn.  Agonism with receptor recycling is sufficient for alteration of lymphocyte trafficking by S1P and SEW2871.  S1P1 modeling and mutagenesis studies revealed that residues binding the S1P headgroup are required for kinase activation by both S1P and SEW2871.  Therefore, SEW2871 recapitulates the action of S1P in all the signaling pathways examd. and overlaps in interactions with key headgroup binding receptor residues, presumably replacing salt-bridge interactions with ion-dipole interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2m1otCJEz8LVg90H21EOLACvtfcHk0lgqdyw9DZsYDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D&md5=31a1a616e98d96ba6d9dfbb0a38ed39c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DOsborne%26aufirst%3DD.%2BA.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P1-selective%2520in%2520vivo-active%2520agonists%2520from%2520high-throughput%2520screening%253A%2520off-the-shelf%2520chemical%2520probes%2520of%2520receptor%2520interactions%252C%2520signaling%252C%2520and%2520fate%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D703%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fni1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=16273098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1228-1235&author=S.+H.+Weiauthor=H.+Rosenauthor=M.+P.+Matheuauthor=M.+G.+Sannaauthor=S.-K.+Wangauthor=E.+Joauthor=C.-H.+Wongauthor=I.+Parkerauthor=M.+D.+Cahalan&title=Sphingosine+1-phosphate+type+1+receptor+agonism+inhibits+transendothelial+migration+of+medullary+T+cells+to+lymphatic+sinuses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses</span></div><div class="casAuthors">Wei, Sindy H.; Rosen, Hugh; Matheu, Melanie P.; Sanna, M. Germana; Wang, Sheng-Kai; Jo, Euijung; Wong, Chi-Huey; Parker, Ian; Cahalan, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1228-1235</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate type 1 (S1P1) receptor agonists cause sequestration of lymphocytes in secondary lymphoid organs by a mechanism that is not well understood.  One hypothesis proposes that agonists act as "functional antagonists" by binding and internalizing S1P1 receptors on lymphocytes; a second hypothesis proposes instead that S1P1 agonists act on endothelial cells to prevent lymphocyte egress from lymph nodes.  Here, 2-photon imaging of living T cells in explanted lymph nodes after treatment with S1P1 agonists or antagonists has provided insight into the mechanism by which S1P1 agonists function.  The selective S1P1 agonist SEW2871 caused reversible slowing and "log-jamming" of T cells between filled medullary cords and empty sinuses, whereas motility was unaltered in diffuse cortex.  Removal or antagonist competition of SEW2871 permitted recovery of T cell motility in the parenchyma of the medulla and resumption of migration across the stromal endothelial barrier, leading to refilling of sinuses.  The authors' results provide visualization of transendothelial migration of T cells into lymphatic sinuses and suggest that S1P1 agonists act mainly on endothelial cell S1P1 receptors to inhibit lymphocyte migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT6yH1S8NBXbVg90H21EOLACvtfcHk0lgqdyw9DZsYDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E&md5=1e8e381a3808c9231937e05a0c010b73</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fni1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1269%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.-K.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26atitle%3DSphingosine%25201-phosphate%2520type%25201%2520receptor%2520agonism%2520inhibits%2520transendothelial%2520migration%2520of%2520medullary%2520T%2520cells%2520to%2520lymphatic%2520sinuses%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D1228%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Selecting against S1P<sub>3</sub> enhances the acute cardiovascular tolerability of 3-(<i>N</i>-benzyl)aminopropylphosphonic acid S1P receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3501-3505&author=J.+J.+Haleauthor=G.+Dohertyauthor=L.+Tothauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=S.-Y.+Sunauthor=S.+Westauthor=H.+Xieauthor=N.+Nomuraauthor=H.+Rosenauthor=S.+Mandala&title=Selecting+against+S1P3+enhances+the+acute+cardiovascular+tolerability+of+3-%28N-benzyl%29aminopropylphosphonic+acid+S1P+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DSelecting%2520against%2520S1P3%2520enhances%2520the%2520acute%2520cardiovascular%2520tolerability%2520of%25203-%2528N-benzyl%2529aminopropylphosphonic%2520acid%2520S1P%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3501%26epage%3D3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0ljLjBO4NssJNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Salomone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeber, C.</span><span> </span><span class="NLM_article-title">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fsj.bjp.0707581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=18026125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=140-147&author=S.+Salomoneauthor=E.+M.+Pottsauthor=S.+Tyndallauthor=P.+C.+Ipauthor=J.+Chunauthor=V.+Brinkmannauthor=C.+Waeber&title=Analysis+of+sphingosine+1-phosphate+receptors+involved+in+constriction+of+isolated+cerebral+arteries+with+receptor+null+mice+and+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span></div><div class="casAuthors">Salomone, S.; Potts, E. M.; Tyndall, S.; Ip, P. C.; Chun, J.; Brinkmann, V.; Waeber, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacol. characterized.  Exptl. approach: The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P2 and S1P3 receptor null mice) and pharmacol. tools (phospho-FTY720, a S1P1/3/4/5 receptor agonist; SEW2871, a S1P1 receptor agonist, JTE-013, a S1P2 receptor antagonist, VPC23019, a S1P1/3 receptor antagonist).  Isolated basilar or peripheral (femoral, mesenteric resistance) arteries, from either rat or mouse, were studied in a wire myograph.  Key results: S1P concn.-dependently constricted basilar artery in rat, wild-type (WT) and S1P2 null mice, but barely affected vascular tone in S1P3 null mice.  Vasoconstriction to U46619 (a thromboxane analog) or to endothelin-1 did not differ between WT, S1P2 and S1P3 null mice.  JTE-013 inhibited not only S1P-induced vasoconstriction, but also KCl-, U46619- and endothelin-1-induced constriction.  This effect was obsd. in WT as well as in S1P2 null mice.  VPC23019 increased the concn.-dependent vasoconstriction to S1P in both rat and mouse basilar arteries with intact endothelium, but not in rat basilar artery without endothelium.  Phospho-FTY720 concn.-dependently constricted rat basilar arteries, but not femoral or mesenteric resistance arteries, while SEW2871 did not induce any response in the same arteries.  Conclusions and implications: S1P constricts cerebral arteries through S1P3 receptors.  The purported S1P2 receptor antagonist JTE-013 does not appear to be selective, at least in rodents.  Enhancement of S1P-induced contraction by VPC23019 might be related to blockade of S1P1 receptors and NO generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx6pcvW_Q37Vg90H21EOLACvtfcHk0lj2TihzA86b4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D&md5=1e8bef7d6f2df66b4436300fab09df06</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707581%26sid%3Dliteratum%253Aachs%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DPotts%26aufirst%3DE.%2BM.%26aulast%3DTyndall%26aufirst%3DS.%26aulast%3DIp%26aufirst%3DP.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWaeber%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520sphingosine%25201-phosphate%2520receptors%2520involved%2520in%2520constriction%2520of%2520isolated%2520cerebral%2520arteries%2520with%2520receptor%2520null%2520mice%2520and%2520pharmacological%2520tools%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taksugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P<sub>3</sub> receptor: investigation based on a new S1P<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Taksugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-phosphate+%28S1P%29+regulates+vascular+contraction+via+S1P3+receptor%3A+investigation+based+on+a+new+S1P3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTaksugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520regulates%2520vascular%2520contraction%2520via%2520S1P3%2520receptor%253A%2520investigation%2520based%2520on%2520a%2520new%2520S1P3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Removal of sphingosine 1-phosphate receptor-3 (S1P<sub>3</sub>) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P<sub>1</sub> agonists with reduced effect on heart rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901776q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3154-3168&author=M.+Hamadaauthor=M.+Nakamuraauthor=M.+Kiuchiauthor=K.+Marukawaauthor=A.+Tomatsuauthor=K.+Shimanoauthor=N.+Satoauthor=K.+Sugaharaauthor=M.+Asayamaauthor=K.+Takagiauthor=K.+Adachi&title=Removal+of+sphingosine+1-phosphate+receptor-3+%28S1P3%29+agonism+is+essential%2C+but+inadequate+to+obtain+immunomodulating+2-aminopropane-1%2C3-diol+S1P1+agonists+with+reduced+effect+on+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DMarukawa%26aufirst%3DK.%26aulast%3DTomatsu%26aufirst%3DA.%26aulast%3DShimano%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DAsayama%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DRemoval%2520of%2520sphingosine%25201-phosphate%2520receptor-3%2520%2528S1P3%2529%2520agonism%2520is%2520essential%252C%2520but%2520inadequate%2520to%2520obtain%2520immunomodulating%25202-aminopropane-1%252C3-diol%2520S1P1%2520agonists%2520with%2520reduced%2520effect%2520on%2520heart%2520rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3154%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P(1)) and hypertension (S1P(3)) in rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+clinically-tested+S1P+receptor+agonists%2C+FTY720+and+BAF312%2C+demonstrate+subtype-specific+bradycardia+%28S1P%281%29%29+and+hypertension+%28S1P%283%29%29+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520clinically-tested%2520S1P%2520receptor%2520agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520demonstrate%2520subtype-specific%2520bradycardia%2520%2528S1P%25281%2529%2529%2520and%2520hypertension%2520%2528S1P%25283%2529%2529%2520in%2520rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Brossard, P.; Hofmann, S.; Cavallaro, M.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Entry-into-Humans Study with ACT-128800, a Selective S1P1 Receptor Agonist: Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics</span>. Presented at ASCPT 2009, Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Washington DC, USA, March 18–21, 2009; PII-87;  <span class="citation_source-journal">Clin. Pharmcol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">S63</span><span class="NLM_x">–</span> <span class="NLM_lpage">S64</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=S63-S64&author=P.+Brossard&author=S.+Hofmann&author=M.+Cavallaro&author=A.+Halabi&author=J.+Dingemanse&title=Entry-into-Humans+Study+with+ACT-128800%2C+a+Selective+S1P1+Receptor+Agonist%3A+Tolerability%2C+Safety%2C+Pharmacokinetics%2C+and+Pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEntry-into-Humans%2520Study%2520with%2520ACT-128800%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%253A%2520Tolerability%252C%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%26jtitle%3DClin.%2520Pharmcol.%2520Ther.%26date%3D2009%26spage%3DS63%26epage%3DS64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P1/S1P5 Receptor Modulator BAF312 Indicates That S1P1 Rather Than S1P3 Mediates Transient Heart Rate Reduction in Humans</span>. Presented at the 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Düsseldorf, Germany,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>P437.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction</span>. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallström, E.</span><span> </span><span class="NLM_article-title">The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+J.+Crumbauthor=M.+Saltzmannauthor=M.+Rosenbergauthor=E.+Wallstr%C3%B6m&title=The+selective+S1P+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate%3A+translation+from+preclinical+to+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray N S; Hinterding K; Cooke N G; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb W J Jr; Saltzman M; Rosenberg M; Wallstrom E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P(1) and S1P(5 ) receptors.  S1P(1) receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclinical and human data.  EXPERIMENTAL APPROACH:  BAF312 was tested in a rat experimental autoimmune encephalomyelitis (EAE) model.  Electrophysiological recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  KEY RESULTS:  BAF312 effectively suppressed EAE in rats by internalizing S1P(1) receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4(+) T cells, T(naive) , T(central memory) and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P(3) receptors (associated with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  CONCLUSION AND IMPLICATIONS:  This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE_xcO_ghmTOLt9HypzAgQfW6udTcc2eYBEQQk6jIWrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D&md5=82575d2c2d2eeba851919e468e407c48</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%2BJ.%26aulast%3DSaltzmann%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DThe%2520selective%2520S1P%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%253A%2520translation%2520from%2520preclinical%2520to%2520clinical%2520studies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lgtNQ4YdNfPlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Aktas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieseier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Fingolimod is a potential novel therapy for multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1038%2Fnrneurol.2010.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=20551946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=373-382&author=O.+Aktasauthor=P.+K%C3%BCryauthor=B.+Kieseierauthor=H.-P.+Hartung&title=Fingolimod+is+a+potential+novel+therapy+for+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod is a potential novel therapy for multiple sclerosis</span></div><div class="casAuthors">Aktas, Orhan; Kuery, Patrick; Kieseier, Bernd; Hartung, Hans-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">373-382</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Only moderately effective therapies are currently available for the treatment of multiple sclerosis (MS).  New treatments for MS that have neuroprotective properties as well as anti-inflammatory effects are needed.  Fingolimod could be one such potential treatment.  In this article, Aktas et al. examine the underlying biol. actions of this prospective new therapy, review the data from phase II and phase III oral fingolimod clin. trials and provide an update on the emerging field of sphingosine-1-phosphate receptor-mediated therapies for MS.  Fingolimod (also known as FTY720) is an orally available sphingosine-1-phosphate (S1P) receptor modulator that has unique and potent immunoregulatory properties.  Mechanistic studies indicate that on phosphorylation fingolimod can bind with high affinity to S1P1 receptors.  Persistent modulation of lymphocyte S1P1 receptors by fingolimod and the subsequent internalization of these receptors inhibits lymphocyte egress from the lymph nodes, and prevents these cells from infiltrating inflammatory lesions in the CNS.  Results of two phase III studies-FREEDOMS and TRANSFORMS-support previous phase II trial observations indicating that fingolimod exerts powerful anti-inflammatory effects in relapsing-remitting multiple sclerosis (MS).  Fingolimod might, therefore, be one of the first orally active drug therapies available for the treatment of relapsing-remitting MS.  Moreover, results from preclin. studies suggest that fingolimod might promote neural repair in vivo.  In this article, we review the background to these findings, present the proposed immunol. and neurobiol. profile of fingolimod, discuss the data from the FREEDOMS and TRANSFORMS trials, and provide an expert opinion regarding the future of next-generation S1P receptor modulators for MS therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbGeDeonkrpLVg90H21EOLACvtfcHk0lhUusUCsevgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7s%253D&md5=11690f6c74fe1fcb1fee8325d1f7b066</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.76%26sid%3Dliteratum%253Aachs%26aulast%3DAktas%26aufirst%3DO.%26aulast%3DK%25C3%25BCry%26aufirst%3DP.%26aulast%3DKieseier%26aufirst%3DB.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DFingolimod%2520is%2520a%2520potential%2520novel%2520therapy%2520for%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D373%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Ingwersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuery, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieseier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy</span> <span class="citation_source-journal">Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.clim.2011.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=15-24&author=J.+Ingwersenauthor=O.+Aktasauthor=P.+Kueryauthor=B.+Kieseierauthor=A.+Boykoauthor=H.-P.+Hartung&title=Fingolimod+in+multiple+sclerosis%3A+mechanisms+of+action+and+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy</span></div><div class="casAuthors">Ingwersen, Jens; Aktas, Orhan; Kuery, Patrick; Kieseier, Bernd; Boyko, Alexey; Hartung, Hans-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fingolimod, also known as FTY720, has recently been approved by the regulatory authorities in the US, EU, Australia, Russia, among others, for the treatment of relapsing-remitting multiple sclerosis.  Fingolimod therefore represents the first oral drug for the treatment of this autoimmune disease of the central nervous system.  Fingolimod modulates sphingosine-1 phosphate receptors and has unique immunoregulatory properties.  Mechanistic studies from animal models have shown that fingolimod prevents immune cells from exiting from the lymphoid tissue and reaching the inflammatory tissue.  Indeed, two phase III studies that laid the basis for fingolimod's approval demonstrated that fingolimod efficiently improves the relapse rate compared to both placebo and one of the std. MS medications.  In this review, we will summarize the immunol. profile of fingolimod, discuss the possible direct neurobiol. effects that have been suggested recently and present the clin. data regarding the efficacy and safety profiles of this promising new drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3WTHZs_TktbVg90H21EOLACvtfcHk0lhUusUCsevgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyqu74%253D&md5=e9b2428f7ca4370bb9ef17c428c99c7b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2011.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2011.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DIngwersen%26aufirst%3DJ.%26aulast%3DAktas%26aufirst%3DO.%26aulast%3DKuery%26aufirst%3DP.%26aulast%3DKieseier%26aufirst%3DB.%26aulast%3DBoyko%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DFingolimod%2520in%2520multiple%2520sclerosis%253A%2520mechanisms%2520of%2520action%2520and%2520clinical%2520efficacy%26jtitle%3DClin.%2520Immunol.%26date%3D2012%26volume%3D142%26spage%3D15%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+derivatives+as+potent%2C+orally+active+S1P1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520S1P1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span>ClinicalTrials.gov. Ponesimod in Patients with Relapsing-Remitting Multiple Sclerosis: Extension Study. <a href="http://clinicaltrials.gov/show/NCT01093326" class="extLink">http://clinicaltrials.gov/show/NCT01093326</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Ponesimod+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis%3A+Extension+Study.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01093326+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span>ClinicalTrials.gov. ACT-128800 in Relapsing-Remitting Multiple Sclerosis. <a href="http://clinicaltrials.gov/show/NCT01006265" class="extLink">http://clinicaltrials.gov/show/NCT01006265</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+ACT-128800+in+Relapsing-Remitting+Multiple+Sclerosis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01006265+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span>ClinicalTrials.gov. ACT-128800 in Patients with Moderate to Severe Chronic Plaque Psoriasis. <a href="http://clinicaltrials.gov/show/NCT01208090" class="extLink">http://clinicaltrials.gov/show/NCT01208090</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+ACT-128800+in+Patients+with+Moderate+to+Severe+Chronic+Plaque+Psoriasis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01208090+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28siponimod%29%2C+a+potent+and+selective+S1P+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528siponimod%2529%252C%2520a%2520potent%2520and%2520selective%2520S1P%2520receptor%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span>ClinicalTrials.gov. Long-Term Safety, Tolerability and Efficacy with BAF312 Given Orally in Patients with Relapsing-Remitting Multiple Sclerosis. <a href="http://clinicaltrials.gov/show/NCT01185821" class="extLink">http://clinicaltrials.gov/show/NCT01185821</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Long-Term+Safety%2C+Tolerability+and+Efficacy+with+BAF312+Given+Orally+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01185821+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>ClinicalTrials.gov. Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients with Relapsing-Remitting Multiple Sclerosis. <a href="http://clinicaltrials.gov/show/NCT00879658" class="extLink">http://clinicaltrials.gov/show/NCT00879658</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Safety%2C+Tolerability%2C+Efficacy+and+Optimal+Dose+Finding+Study+of+BAF312+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT00879658+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span>ClinicalTrials.gov. A Study of the Safety and Efficacy of ONO-4641 in Patients with Relapsing-Remitting Multiple Sclerosis (DreaMS). <a href="http://clinicaltrials.gov/show/NCT01081782" class="extLink">http://clinicaltrials.gov/show/NCT01081782</a> (accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+A+Study+of+the+Safety+and+Efficacy+of+ONO-4641+in+Patients+with+Relapsing-Remitting+Multiple+Sclerosis+%28DreaMS%29.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01081782+%28accessed+Aug+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomisato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimozato, T.</span><span> </span><span class="NLM_article-title">Discovery of CS-0777: a potent, selective, and orally active S1P<sub>1</sub> agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100301k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=368-372&author=T.+Nishiauthor=S.+Miyazakiauthor=T.+Takemotoauthor=K.+Suzukiauthor=Y.+Iioauthor=K.+Nakajimaauthor=T.+Ohnukiauthor=Y.+Kawaseauthor=F.+Naraauthor=S.+Inabaauthor=T.+Izumiauthor=H.+Yuitaauthor=K.+Oshimaauthor=H.+Doiauthor=R.+Inoueauthor=W.+Tomisatoauthor=T.+Kagariauthor=T.+Shimozato&title=Discovery+of+CS-0777%3A+a+potent%2C+selective%2C+and+orally+active+S1P1+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fml100301k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100301k%26sid%3Dliteratum%253Aachs%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIio%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DYuita%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DR.%26aulast%3DTomisato%26aufirst%3DW.%26aulast%3DKagari%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520CS-0777%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520S1P1%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T. L.</span><span> </span><span class="NLM_article-title">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2Fj.jneuroim.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=22465063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=100-107&author=J.+B.+Moberlyauthor=D.+M.+Fordauthor=H.+Zahirauthor=S.+Chenauthor=T.+Mochizukiauthor=K.+E.+Truittauthor=T.+L.+Vollmer&title=Pharmacological+effects+of+CS-0777%2C+a+selective+sphingosine+1-phosphate+receptor-1+modulator%3A+results+from+a+12-week%2C+open-label+pilot+study+in+multiple+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients</span></div><div class="casAuthors">Moberly, James B.; Ford, Daniel M.; Zahir, Hamim; Chen, Shuquan; Mochizuki, Takashi; Truitt, Kenneth E.; Vollmer, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 modulator under investigation for treatment of multiple sclerosis (MS).  We conducted an open-label, pilot study in 25 MS patients to assess the safety, pharmacokinetics, pharmacodynamics and exploratory efficacy of oral CS-0777 (0.1, 0.3 and 0.6 mg), administered once weekly or every other week for 12 wk.  CS-0777 resulted in a pronounced, dose-dependent decrease in lymphocytes and CD4 T cell subsets, which returned to baseline within 4 wk after the last dose.  Overall, CS-0777 was safe and well-tolerated.  These results require confirmation in a double-blind, placebo-controlled and adequately powered phase 2 study in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUDMmZ5gpHLVg90H21EOLACvtfcHk0ljbHwEubovytQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D&md5=ce750c33bbfd69ba65304cb02f7c22f9</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DFord%26aufirst%3DD.%2BM.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26aulast%3DVollmer%26aufirst%3DT.%2BL.%26atitle%3DPharmacological%2520effects%2520of%2520CS-0777%252C%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%253A%2520results%2520from%2520a%252012-week%252C%2520open-label%2520pilot%2520study%2520in%2520multiple%2520sclerosis%2520patients%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D246%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and hear allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+novel+synthetic+immunosuppressant%2C+prolongs+graft+survival+and+attenuates+chronic+rejection+in+rat+skin+and+hear+allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520novel%2520synthetic%2520immunosuppressant%252C%2520prolongs%2520graft%2520survival%2520and%2520attenuates%2520chronic%2520rejection%2520in%2520rat%2520skin%2520and%2520hear%2520allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span>ClinicalTrials.gov. Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus. <a href="http://clinicaltrials.gov/show/NCT01294774" class="extLink">http://clinicaltrials.gov/show/NCT01294774</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Safety+and+Efficacy+of+KRP203+in+Subacute+Cutaneous+Lupus+Erythematosus.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01294774+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span>ClinicalTrials.gov. Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients. <a href="http://clinicaltrials.gov/show/NCT01375179" class="extLink">http://clinicaltrials.gov/show/NCT01375179</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+%26+Safety+in+Moderately+Active+Refractory+Ulcerative+Colitis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01375179+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span>ClinicalTrials.gov. Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients. <a href="http://clinicaltrials.gov/show/NCT01628393" class="extLink">http://clinicaltrials.gov/show/NCT01628393</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Safety+Study+of+RPC1063+in+Relapsing+Multiple+Sclerosis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01628393+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span>ClinicalTrials.gov. Dose Finding Study of MT-1303. <a href="http://clinicaltrials.gov/show/NCT01742052" class="extLink">http://clinicaltrials.gov/show/NCT01742052</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Dose+Finding+Study+of+MT-1303.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01742052+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selective S1P<sub>1</sub> receptor agonists for the treatment of inflammatory and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+J.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+progress+in+the+development+of+selective+S1P1+receptor+agonists+for+the+treatment+of+inflammatory+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lgjZ9A7l7AtrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selective%2520S1P1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span> </span><span class="NLM_article-title">Synthetic sphingosine 1-phosphate receptor modulators: opportunities and potential pitfalls</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.2174%2F1568026611109060726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=21261590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=726-757&author=M.+H.+Bolliauthor=C.+Lescopauthor=O.+Nayler&title=Synthetic+sphingosine+1-phosphate+receptor+modulators%3A+opportunities+and+potential+pitfalls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic sphingosine 1-phosphate receptor modulators - opportunities and potential pitfalls</span></div><div class="casAuthors">Bolli, Martin H.; Lescop, Cyrille; Nayler, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">726-757</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) evokes a plethora of physiol. responses by stimulating members of a G protein-coupled receptor family, known as S1P receptors.  Currently five different mammalian S1P receptor subtypes, S1P1-5, each with a different cellular expression pattern, were identified.  The S1P1 receptor in particular has attracted major interest throughout the pharmaceutical industry following the breakthrough discovery that this S1P receptor subtype is critically involved in the regulation of lymphocyte trafficking through secondary lymphoid organs.  Since then, examples of synthetic S1P1 agonists with lymphocyte reducing and immunomodulating activity demonstrated efficacy in numerous preclin. models of autoimmune disease and transplantation.  Notably FTY720 (fingolimod), a pro-drug that is phosphorylated in vivo and converted into a non-selective S1P1,3,4,5 receptor agonist, has been widely used to increase the understanding of S1P1 receptor biol.  Results from recently completed phase III clin. trials using FTY720 paved the way for this non-selective S1P1 receptor agonist to become the first oral therapy in multiple sclerosis, with potential expansion into many other autoimmune diseases.  This review briefly outlines the field of S1P1 receptor biol. and summarizes recent approaches in medicinal chem. to discover potent and selective S1P1 receptor agonists.  In particular, the complexity of discovering a mol. akin to FTY720 but with an improved side-effect profile will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTTZ2jfUXEtrVg90H21EOLACvtfcHk0lgjZ9A7l7AtrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D&md5=9f6d05909fb5615126ea642f4cc19271</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060726%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26atitle%3DSynthetic%2520sphingosine%25201-phosphate%2520receptor%2520modulators%253A%2520opportunities%2520and%2520potential%2520pitfalls%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D726%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+advances+in+the+discovery+and+development+of+sphingosine-1-phosphate-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor agonists: a patent review (2010–2012)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1517%2F13543776.2013.783022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=817-841&author=E.+Robertsauthor=M.+Guerreroauthor=M.+Urbanoauthor=H.+Rosen&title=Sphingosine+1-phosphate+receptor+agonists%3A+a+patent+review+%282010%E2%80%932012%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012)</span></div><div class="casAuthors">Roberts, Edward; Guerrero, Miguel; Urbano, Mariangela; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">817-841</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The sphingosine-1-phosphate (S1P)-driven signaling regulates fundamental biol. functions, including cell proliferation, angiogenesis, endothelial cell chemotaxis, immune cell trafficking and mitogenesis.  A large body of research has been focusing on the development of immunosuppressive S1P1 receptor (S1P1-R) agonist mols.  The S1P1,3 - 5-R pan-agonist fingolimod (FTY720) has been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis.  However, FTY720 is now contraindicated in patients with compromised cardiac function.  Although the main adverse effect bradycardia has been linked to the S1P3-R activation, cardiovascular liabilities persist with more selective S1P1-R agonists that have entered clin. trials.  In contrast to the S1P1-R, the therapeutic application of the S1P2 - 5-Rs remains poorly explored.  Areas covered: This review provides the patent literature from 2010 to date on S1P-R agonist mols. and their relevant biol. properties.  Expert opinion: Limited progress has been made on agonists at S1P4,5-R subtypes, with some families of S1P5-R agonists showing promising results in animal models of age-related cognitive disorders.  A discrete no. of reviewed mols. are S1P1-R agonists with a promising clin. outlook in transplantation, inflammation, cancer and autoimmune settings.  Further preclin. and clin. studies will det. whether the new developed S1P1-R agonists do indeed improve the safety profile of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIrASpSMDS37Vg90H21EOLACvtfcHk0ljUXdybRuYTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D&md5=405b6350b777d3040e2be21adf85d440</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.783022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.783022%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520agonists%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D817%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists - Part 1: From pyrazoles to thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9737</span><span class="NLM_x">–</span> <span class="NLM_lpage">9755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4014373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9737-9755&author=M.+H.+Bolliauthor=C.+M%C3%BCllerauthor=B.+Mathysauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=O.+Naylerauthor=M.+Reyauthor=S.+Meyerauthor=M.+Scherzauthor=G.+Schmidtauthor=B.+Steinerauthor=A.+Treiberauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists+-+Part+1%3A+From+pyrazoles+to+thiophenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm4014373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014373%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520-%2520Part%25201%253A%2520From%2520pyrazoles%2520to%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9737%26epage%3D9755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Alberola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradanos, P.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of 2-functionalized thiophenes by condensation of α-mercapto compounds with β-amino enone derivatives</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1080%2F00397919008053203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=2537-2547&author=A.+Alberolaauthor=J.+M.+Andresauthor=A.+Gonzalezauthor=R.+Pedrosaauthor=P.+Pradanos&title=Regioselective+synthesis+of+2-functionalized+thiophenes+by+condensation+of+%CE%B1-mercapto+compounds+with+%CE%B2-amino+enone+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 2-functionalized thiophenes by condensation of α-mercapto compounds with β-amino enone derivatives</span></div><div class="casAuthors">Alberola, Angel; Andres, Jose M.; Gonzalez, Alfonso; Pedrosa, Rafael; Pradanos, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2537-47</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Reaction of R1COCR2:CR3Cl (R1 = Me, Ph; R2 = H, Me; R3 = Me, Ph) with NaSCH2CO2Et gave 50-70% thiophenes I (R1-R3 as above, R4 = OEt).  R1COCH:CHN+Et3 (R1 = Et, Ph, 4-MeOC6H4, 4-O2NC6H4, Me2CH) reacted with HSCH2COR4 (R4 = HEt, Me, Ph) to give 70-90% R1COCH:CHSCH2COR4, which on reaction with EtONa/EtOH gave I (R1 as above, R2 = R3 = H, R4 = OEt, Me, Ph).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKt5xsJdc5LVg90H21EOLACvtfcHk0ljUXdybRuYTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D&md5=4d01fc252b1a3cad0f3ff24fbf19a50f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1080%2F00397919008053203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008053203%26sid%3Dliteratum%253Aachs%26aulast%3DAlberola%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DR.%26aulast%3DPradanos%26aufirst%3DP.%26atitle%3DRegioselective%2520synthesis%2520of%25202-functionalized%2520thiophenes%2520by%2520condensation%2520of%2520%25CE%25B1-mercapto%2520compounds%2520with%2520%25CE%25B2-amino%2520enone%2520derivatives%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D2537%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Kubiak, G. G.; Lythgoe, D. J.; Yu, Y.</span><span> </span><span class="NLM_article-title">Regio-Specific Synthesis of 4-Bromo-3-methyl-5-propoxy-thiophene-2-carboxylic Acid</span>. WO2008115912, Sep 25,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+G.+Kubiak&author=D.+J.+Lythgoe&author=Y.+Yu&title=Regio-Specific+Synthesis+of+4-Bromo-3-methyl-5-propoxy-thiophene-2-carboxylic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKubiak%26aufirst%3DG.%2BG.%26atitle%3DRegio-Specific%2520Synthesis%2520of%25204-Bromo-3-methyl-5-propoxy-thiophene-2-carboxylic%2520Acid%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Nahm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, S. M.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methoxy-<i>N</i>-methylamides as effective acylating agents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3815</span><span class="NLM_x">–</span> <span class="NLM_lpage">3818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FS0040-4039%2801%2991316-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1981&pages=3815-3818&author=S.+Nahmauthor=S.+M.+Weinreb&title=N-Methoxy-N-methylamides+as+effective+acylating+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methoxy-N-methylamides as effective acylating agents</span></div><div class="casAuthors">Nahm, Steven; Weinreb, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">3815-18</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">N-Methoxy-N-methylamides couple readily with both Grignard and organolithium reagents in THF to give ketones; tertiary alcs. were not formed even in the presence of large excesses of the organometallic compd.  E.g., treatment of Me(CH2)16CONMeOMe (I), prepd. from Me(CH2)16COCl and HNMeOMe.HCl (pyridine/CHCl3, room temp., 1 h), with 2 equiv MeMgBr (THF, 0°, 1 h) gave 94% Me(CH2)16COMe.  Hydride redn. of the N-methoxy-N-methylamides gave the corresponding aldehydes, together with small amts. of the primary alc.  E.g., I with excess LiAlH4 (THF, -78°, 5 min) gave 50% Me(CH2)16CHO and 25% Me(CH2)17OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSzB8ss9N34rVg90H21EOLACvtfcHk0lgc1l0yi541vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D&md5=ce1dc3bf2af883db320d90c4ff32616c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2991316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252991316-4%26sid%3Dliteratum%253Aachs%26aulast%3DNahm%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DS.%2BM.%26atitle%3DN-Methoxy-N-methylamides%2520as%2520effective%2520acylating%2520agents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1981%26volume%3D22%26spage%3D3815%26epage%3D3818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Su, D.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.-Y.</span><span> </span><span class="NLM_article-title">Methyl chlorodifluoroacetate a convenient trifluoromethylating agent</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">7689</span><span class="NLM_x">–</span> <span class="NLM_lpage">7690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=7689-7690&author=D.-B.+Suauthor=J.-X.+Duanauthor=Q.-Y.+Chen&title=Methyl+chlorodifluoroacetate+a+convenient+trifluoromethylating+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.-B.%26aulast%3DDuan%26aufirst%3DJ.-X.%26aulast%3DChen%26aufirst%3DQ.-Y.%26atitle%3DMethyl%2520chlorodifluoroacetate%2520a%2520convenient%2520trifluoromethylating%2520agent%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D7689%26epage%3D7690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Velker, J.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Thiophene Derivatives</span>. WO2006100635, Sep 28,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=J.+Velker&author=T.+Weller&title=Novel+Thiophene+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Thiophene%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Flaugh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowell, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, D. S.</span><span> </span><span class="NLM_article-title">Acid-catalyzed annelation of α-alkyl aldehydes and α,β-unsaturated ketones. A one-pot synthesis of 4,4-dimethyl-2-cyclohexen-1-one</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5399</span><span class="NLM_x">–</span> <span class="NLM_lpage">5400</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01314a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=5399-5400&author=M.+A.+Flaughauthor=T.+A.+Crowellauthor=D.+S.+Farlow&title=Acid-catalyzed+annelation+of+%CE%B1-alkyl+aldehydes+and+%CE%B1%2C%CE%B2-unsaturated+ketones.+A+one-pot+synthesis+of+4%2C4-dimethyl-2-cyclohexen-1-one"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjo01314a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01314a048%26sid%3Dliteratum%253Aachs%26aulast%3DFlaugh%26aufirst%3DM.%2BA.%26aulast%3DCrowell%26aufirst%3DT.%2BA.%26aulast%3DFarlow%26aufirst%3DD.%2BS.%26atitle%3DAcid-catalyzed%2520annelation%2520of%2520%25CE%25B1-alkyl%2520aldehydes%2520and%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520ketones.%2520A%2520one-pot%2520synthesis%2520of%25204%252C4-dimethyl-2-cyclohexen-1-one%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D5399%26epage%3D5400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Wuesthoff, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickborn, B.</span><span> </span><span class="NLM_article-title">The preparation of spiro[2.5]octan-6-one. Catalytic hydrogenation of a vinylcyclopropane</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01267a111" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1968&pages=1311-1312&author=M.+T.+Wuesthoffauthor=B.+Rickborn&title=The+preparation+of+spiro%5B2.5%5Doctan-6-one.+Catalytic+hydrogenation+of+a+vinylcyclopropane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjo01267a111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01267a111%26sid%3Dliteratum%253Aachs%26aulast%3DWuesthoff%26aufirst%3DM.%2BT.%26aulast%3DRickborn%26aufirst%3DB.%26atitle%3DThe%2520preparation%2520of%2520spiro%255B2.5%255Doctan-6-one.%2520Catalytic%2520hydrogenation%2520of%2520a%2520vinylcyclopropane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1968%26volume%3D33%26spage%3D1311%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Nicolaou, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Carboxyclic thromboxane A<sub>2</sub></span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1404</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00524a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=1404-1409&author=K.+C.+Nicolaouauthor=R.+L.+Magoldaauthor=D.+A.+Claremon&title=Carboxyclic+thromboxane+A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fja00524a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00524a028%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DCarboxyclic%2520thromboxane%2520A2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D1404%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Arai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span> </span><span class="NLM_article-title">An asymmmetric Simmons–Smith reaction</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">8254</span><span class="NLM_x">–</span> <span class="NLM_lpage">8256</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00312a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1985&pages=8254-8256&author=I.+Araiauthor=A.+Moriauthor=H.+Yamamoto&title=An+asymmmetric+Simmons%E2%80%93Smith+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fja00312a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00312a072%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DI.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DAn%2520asymmmetric%2520Simmons%25E2%2580%2593Smith%2520reaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1985%26volume%3D107%26spage%3D8254%26epage%3D8256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Mihovilovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. D.</span><span> </span><span class="NLM_article-title">Asymmetric Bayer–Villiger oxidations of 4-mono- and 4,4-disubstituted cyclohexanones by whole cells of engineered <i>Escherichia coli</i></span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo001292p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=733-738&author=M.+D.+Mihovilovicauthor=G.+Chenauthor=S.+Wangauthor=B.+Kyteauthor=F.+Rochonauthor=M.+M.+Kayserauthor=J.+D.+Stewart&title=Asymmetric+Bayer%E2%80%93Villiger+oxidations+of+4-mono-+and+4%2C4-disubstituted+cyclohexanones+by+whole+cells+of+engineered+Escherichia+coli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjo001292p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001292p%26sid%3Dliteratum%253Aachs%26aulast%3DMihovilovic%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DKyte%26aufirst%3DB.%26aulast%3DRochon%26aufirst%3DF.%26aulast%3DKayser%26aufirst%3DM.%2BM.%26aulast%3DStewart%26aufirst%3DJ.%2BD.%26atitle%3DAsymmetric%2520Bayer%25E2%2580%2593Villiger%2520oxidations%2520of%25204-mono-%2520and%25204%252C4-disubstituted%2520cyclohexanones%2520by%2520whole%2520cells%2520of%2520engineered%2520Escherichia%2520coli%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D733%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Natale, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, R. O.</span><span> </span><span class="NLM_article-title">An efficient, general synthesis of spiroalkanes and related derivatives</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1080%2F00304947709356865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaE1cXltVemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1977&pages=103-108&author=N.+R.+Nataleauthor=R.+O.+Hutchins&title=An+efficient%2C+general+synthesis+of+spiroalkanes+and+related+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient, general synthesis of spiroalkenes and related derivatives</span></div><div class="casAuthors">Natale, Nicholas R.; Hutchins, Robert O.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3-4-5</span>),
    <span class="NLM_cas:pages">103-8</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    </div><div class="casAbstract">Enamines I [Z = CH2, CH2CH2, (CH2)4, CH:CH] were converted to spiroalkenes II.  I were heated with MeCOCH:CH2, HOAc and NaOAc were added, and the mixts. were heated to give spiroalkenones III.  III were converted to their tosylhydrazones and the latter were treated with catechol borane to give the II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw27QGYj39TbVg90H21EOLACvtfcHk0lgVUOjJPf_UfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXltVemtw%253D%253D&md5=1fb7414ec38915f7cd7cce9546a70ce2</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1080%2F00304947709356865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304947709356865%26sid%3Dliteratum%253Aachs%26aulast%3DNatale%26aufirst%3DN.%2BR.%26aulast%3DHutchins%26aufirst%3DR.%2BO.%26atitle%3DAn%2520efficient%252C%2520general%2520synthesis%2520of%2520spiroalkanes%2520and%2520related%2520derivatives%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D1977%26volume%3D9%26spage%3D103%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Knight, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nott, A. P.</span><span> </span><span class="NLM_article-title">Generation and synthetic utility of dianions derived from thiophenecarboxylic acids</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">1983</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1983&publication_year=1983&pages=791-794&author=D.+W.+Knightauthor=A.+P.+Nott&title=Generation+and+synthetic+utility+of+dianions+derived+from+thiophenecarboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DD.%2BW.%26aulast%3DNott%26aufirst%3DA.%2BP.%26atitle%3DGeneration%2520and%2520synthetic%2520utility%2520of%2520dianions%2520derived%2520from%2520thiophenecarboxylic%2520acids%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1983%26volume%3D1983%26spage%3D791%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaf, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P1 receptor modulation with cyclical recovery from lymphopenia amelioreates mouse model of multiple sclerosis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=166-174&author=P.+J.+Gonzalez-Cabreraauthor=S.+M.+Cahalanauthor=N.+Nguyenauthor=G.+Sarkisyanauthor=N.+B.+Leafauthor=M.+D.+Cameronauthor=T.+Kagoauthor=H.+Rosen&title=S1P1+receptor+modulation+with+cyclical+recovery+from+lymphopenia+amelioreates+mouse+model+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DSarkisyan%26aufirst%3DG.%26aulast%3DLeaf%26aufirst%3DN.%2BB.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DKago%26aufirst%3DT.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P1%2520receptor%2520modulation%2520with%2520cyclical%2520recovery%2520from%2520lymphopenia%2520amelioreates%2520mouse%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D166%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">Indole-propionic acid derivatives as potent, S1P<sub>3</sub>-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P<sub>1</sub>) receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2794</span><span class="NLM_x">–</span> <span class="NLM_lpage">2797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2794-2797&author=Q.+Mengauthor=B.+Zhaoauthor=Q.+Xuauthor=X.+Xuauthor=G.+Dengauthor=C.+Liauthor=L.+Luanauthor=F.+Renauthor=H.+Wangauthor=H.+Xuauthor=Y.+Xuauthor=H.+Zhangauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=T.+B.+Guoauthor=Y.+Zhaoauthor=W.+Zhangauthor=H.+Luauthor=X.+Lin&title=Indole-propionic+acid+derivatives+as+potent%2C+S1P3-sparing+and+EAE+efficacious+sphingosine-1-phosphate+1+%28S1P1%29+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLuan%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DIndole-propionic%2520acid%2520derivatives%2520as%2520potent%252C%2520S1P3-sparing%2520and%2520EAE%2520efficacious%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2794%26epage%3D2797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74285&author=M.+Reyauthor=P.+Hessauthor=M.+Clozelauthor=S.+Delahayeauthor=J.+Gatfieldauthor=O.+Naylerauthor=B.+Steiner&title=Desensitization+by+progressive+up-titration+prevents+first-dose+effects+on+the+heart%3A+guinea+pig+study+with+ponesimod%2C+a+selective+S1P1+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRey%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DDelahaye%26aufirst%3DS.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DDesensitization%2520by%2520progressive%2520up-titration%2520prevents%2520first-dose%2520effects%2520on%2520the%2520heart%253A%2520guinea%2520pig%2520study%2520with%2520ponesimod%252C%2520a%2520selective%2520S1P1%2520receptor%2520modulator%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Wasan, K. M.</span><span> </span><span class="NLM_article-title">The role of lymphatic transport in enhancing oral protein and peptide drug delivery</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2002&pages=1047-1058&author=K.+M.+Wasan&title=The+role+of+lymphatic+transport+in+enhancing+oral+protein+and+peptide+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWasan%26aufirst%3DK.%2BM.%26atitle%3DThe%2520role%2520of%2520lymphatic%2520transport%2520in%2520enhancing%2520oral%2520protein%2520and%2520peptide%2520drug%2520delivery%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2002%26volume%3D28%26spage%3D1047%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Yañez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knemeyer, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, K. B.</span><span> </span><span class="NLM_article-title">Intestinal lymphatic transport for drug delivery</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=923-942&author=J.+A.+Ya%C3%B1ezauthor=S.+W.+J.+Wangauthor=I.+W.+Knemeyerauthor=M.+A.+Wirthauthor=K.+B.+Alton&title=Intestinal+lymphatic+transport+for+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYa%25C3%25B1ez%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BW.%2BJ.%26aulast%3DKnemeyer%26aufirst%3DI.%2BW.%26aulast%3DWirth%26aufirst%3DM.%2BA.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26atitle%3DIntestinal%2520lymphatic%2520transport%2520for%2520drug%2520delivery%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D923%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Matt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weckebecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evenou, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span> </span><span class="NLM_article-title">Structure–activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6028</span><span class="NLM_x">–</span> <span class="NLM_lpage">6039</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200469u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6028-6039&author=J.+Wagnerauthor=P.+von+Mattauthor=B.+Fallerauthor=N.+G.+Cookeauthor=R.+Albertauthor=R.+Sedraniauthor=H.+Wiegandauthor=C.+Jeanauthor=C.+Beerliauthor=G.+Weckebeckerauthor=J.-P.+Evenouauthor=G.+Zenkeauthor=S.+Cottens&title=Structure%E2%80%93activity+relationship+and+pharmacokinetic+studies+of+sotrastaurin+%28AEB071%29%2C+a+promising+novel+medicine+for+prevention+of+graft+rejection+and+treatment+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm200469u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200469u%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3Dvon%2BMatt%26aufirst%3DP.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DWiegand%26aufirst%3DH.%26aulast%3DJean%26aufirst%3DC.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DWeckebecker%26aufirst%3DG.%26aulast%3DEvenou%26aufirst%3DJ.-P.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DCottens%26aufirst%3DS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520and%2520pharmacokinetic%2520studies%2520of%2520sotrastaurin%2520%2528AEB071%2529%252C%2520a%2520promising%2520novel%2520medicine%2520for%2520prevention%2520of%2520graft%2520rejection%2520and%2520treatment%2520of%2520psoriasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6028%26epage%3D6039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Grimont, J.; Le Goff, F.; Bourquin, G.; Silva, J.</span><span> </span><span class="NLM_article-title">Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR</span>. Presented at MipTec: The Leading European Event for Drug Discovery, Basel, Switzerland, Sep 20–24,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Grimont&author=F.+Le+Goff&author=G.+Bourquin&author=J.+Silva&title=Quality+Assessment+and+Concentration+Determination+of+Actelion%E2%80%99s+Compound+Solutions+by+Automated+LCMS+and+Quantitative+NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrimont%26aufirst%3DJ.%26atitle%3DQuality%2520Assessment%2520and%2520Concentration%2520Determination%2520of%2520Actelion%25E2%2580%2599s%2520Compound%2520Solutions%2520by%2520Automated%2520LCMS%2520and%2520Quantitative%2520NMR%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Seglen, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosså, J.</span><span> </span><span class="NLM_article-title">Attachment of rat hepatocytes in vitro to substrata of serum protein collagen, or concanavalin A</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2F0014-4827%2878%2990076-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADyaE1MXitVSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1978&pages=199-206&author=P.+O.+Seglenauthor=J.+Foss%C3%A5&title=Attachment+of+rat+hepatocytes+in+vitro+to+substrata+of+serum+protein+collagen%2C+or+concanavalin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Attachment of rat hepatocytes in vitro to substrata of serum protein, collagen, or concanavalin A</span></div><div class="casAuthors">Seglen, Per O.; Fossa, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    </div><div class="casAbstract">Isolated rat hepatocytes attached to, and spread on, the surface of polystyrene tissue culture dishes in the presence of serum.  The attachment was essentially complete in 30 min at 37°, whereas no attachment occurred at 0°.  Dead (trypan blue-stainable) cells did not attach; hence, the plating efficiency (percentage of cells attaching) was close to the percentage of intact cells in the hepatocyte suspension.  Attachment in the presence of serum was relatively independent of pH, but required divalent cations.  Mg2+ stimulated attachment more effectively than Ca2+, and a combination of both cations gave maximal attachment.  Cells did not attach readily to untreated dishes in the absence of serum, but attached to and spread on dishes precoated with adsorbed serum protein, concanavalin A (ConA), or a film of collagen.  The attachment-promoting activity in serum was destroyed by acid treatment, by heating to 70°, and by protease treatment.  It is, therefore, probably a protein, which, like collagen and ConA, can bind to receptors hepatocyte surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNVWSL9oLULrVg90H21EOLACvtfcHk0liebeCtoxPGpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXitVSqtw%253D%253D&md5=f23fe77ed9d9f43188571b536fe8f725</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0014-4827%2878%2990076-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4827%252878%252990076-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeglen%26aufirst%3DP.%2BO.%26aulast%3DFoss%25C3%25A5%26aufirst%3DJ.%26atitle%3DAttachment%2520of%2520rat%2520hepatocytes%2520in%2520vitro%2520to%2520substrata%2520of%2520serum%2520protein%2520collagen%252C%2520or%2520concanavalin%2520A%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1978%26volume%3D116%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">The prediction of human clearance from hepatic microsomal metabolism data</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm401456d&amp;key=11727321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm401456d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=36-44&author=R.+S.+Obach&title=The+prediction+of+human+clearance+from+hepatic+microsomal+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human clearance from hepatic microsomal metabolism data</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Human liver microsomal intrinsic clearance has become a commonly measured parameter during drug discovery, and such data are used to design compds. predicted to possess optimal drug disposition characteristics.  Liver microsomal intrinsic clearance values can be scaled and used to predict hepatic clearance in humans.  Clearance, when combined with the vol. of distribution, dets. the half-life of a drug.  Hepatic clearance, when combined with absorption, dets. the oral bioavailability of a drug.  Half-life and oral bioavailability are key determinants of the dosing regimen, ie, size of dose and frequency of administration.  Thus, the accurate prediction of human clearance is important in the selection of new compds. for progression into development, as new drugs on the market must not only be efficacious and safe, but must also be convenient to use for patients and physicians.  Over the past decade, exploring methods whereby human clearance can be predicted from in vitro data has been an area of active research in drug metab. science.  Human liver microsomes have been a key tool in this research.  This in vitro system possesses many of the major drug metabolizing enzymes and is thus applicable to a wide variety of compds.  This review describes the theor. and practical aspects of predicting clearance from human liver microsomal intrinsic clearance data, a summary of advantages and shortcomings of this in vitro system, a synopsis of recent applications of human liver microsomal intrinsic clearance data in clearance predictions, and a discussion of potential future directions for this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsU3SBmySKm7Vg90H21EOLACvtfcHk0liebeCtoxPGpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D&md5=421bc7764c3d7f501b69aa97996d1db9</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DThe%2520prediction%2520of%2520human%2520clearance%2520from%2520hepatic%2520microsomal%2520metabolism%2520data%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D36%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Armarego, W. L. F.; Chai, C. L. L.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">6</span>th ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1016%2FB978-1-85617-567-8.50011-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=W.+L.+F.+Armarego&author=C.+L.+L.+Chai&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2FB978-1-85617-567-8.50011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-1-85617-567-8.50011-1%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DElsevier%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Buxbaum, E.</span> <span class="citation_source-book">Biophysical Chemistry of Proteins: An Introduction to Laboratory Methods</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm401456d&amp;key=10.1007%2F978-1-4419-7251-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Buxbaum&title=Biophysical+Chemistry+of+Proteins%3A+An+Introduction+to+Laboratory+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-7251-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-7251-4%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DE.%26btitle%3DBiophysical%2520Chemistry%2520of%2520Proteins%253A%2520An%2520Introduction%2520to%2520Laboratory%2520Methods%26pub%3DSpringer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a href="/doi/suppl/10.1021/jm401456d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85453"></div></div></div></div></div><hr /></hr><p class="last">Experimental details on the synthesis and characterization of all target compounds and intermediates not described in the main text. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401456d/suppl_file/jm401456d_si_001.pdf">jm401456d_si_001.pdf (602.16 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401456d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm401456d%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401456d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b46dffbf3d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
